Structural and Epitope Characterization of Major Allergens from Dust Mite, BLO T 21 and DER F 7 by TAN KANG WEI
 
 
STRUCTURAL AND EPITOPE CHARACTERIZATION OF 
MAJOR ALLERGENS FROM DUST MITE,                                  




































STRUCTURAL AND EPITOPE CHARACTERIZATION 
OF MAJOR ALLERGENS FROM DUST MITE,                            














TAN KANG WEI 













A THESIS SUBMITTED 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
DEPARTMENT OF BIOLOGICAL SCIENCES 






I am heartily thankful to my supervisor, Assoc. Prof. Dr. Henry Mok, for his encouragement, 
patience, guidance and support throughout these years of my study. His critical thinking and 
advices really inspired me in doing my research. 
 
I would also like to extend my gratitude to Assoc. Prof. Dr. Chew, for being a resourceful and 
understanding collaborator. Special thanks to Prof. Yang and Assoc. Prof. Dr. Sivaraman for 
their sharing of ideas that have been wonderfully insightful for my studies in NMR and X-ray 
crystallography. 
 
Many thanks to Dr. Chan. Dr. Kartik, Dr. Shiva, Dr. Lin Zhi, Dr. Ong, Dr. Kumar, Dr. 
Chiradeep and Dr. Jobi for their generosity in sharing invaluable experience whenever I 
requested. You have been a great help throughout my candidature. Sang, Jack, Rishi, Jana, 
Wentao, and everyone in SBL as well as functional genomic lab 1 and 2, my heartfelf thanks 
for your delightful companionships and helpful advices for designing my experiments. 
 
To my beloved Xin Yu, thank you for always being there for me. Your love is a great 
motivation for my research that I will forever cherish. Special thanks for helping me to 
proofread this thesis with admirable patience and critical comments. 
 
My family and relatives who have been emotionally supportive from the day I stepped foot in 
Singapore, I am forever indebted to you for your understanding, patience and love. Without 





Table of Contents 
Acknowledgements………………………………………………………………...i 
       Table of Contents   ………………………………………………………………………ii 
 
Summary…………………………………...........................................................vii 
LIST OF TABLE………………………………………………………………....ix 
        LIST OF FIGURES…………………………………………………………………….x 
 
       LIST OF ABBREVIATIONS…………………………………………………….……xiii 
 
CHAPTER 1   INTRODUCTION…………………………………………………1 
1. Allergy…………………………………………………………………….1 
1.1 An introduction to allergy…………………………………………………..1 
1.2 Mechanisms of allergy……………………………………………………...3 
1.3 Dust mite…………………………………………………………………..6 
1.4 From structure determination to IgE epitope mapping ......................................9 
1.4.1 Structural biology of allergens ............................................................................... 9 
1.4.2 IgE epitope mapping of allergens ........................................................................ 12 
1.5 Specific immunotherapy…………………………………………………..15 
1.7 Group 21 Allergen from dust mite ................................................................19 
1.8 Group 7 Allergen from dust mite ..................................................................20 
1.9 Objectives and significance of this study ......................................................21 
CHAPTER 2   MATERIALS & METHODS .........................................................24 
2.1 Generation and subcloning of Blo t 21 and its mutants into expression vector .24 
2.1.1 Bacterial host strains………………………………………………………24 
2.1.2 Generation of DNA insert and Polymerase Chain Reaction ................................ 24 
2.2 Generation of DNA mutant insert for site directed mutagenesis ......................... 24 
2.3 Preparation of DH5-α competent cells ................................................................. 26 
iii 
 
2.4 Sub-cloning .......................................................................................................... 27 
2.5 Transformation of ligation mix into DH5-α competent cells. .............................. 27 
2.6 PCR screening of transformant ............................................................................ 28 
2.7 Isolation of DNA plasmid .................................................................................... 28 
2.8 Plasmid DNA sequencing .................................................................................... 29 
2.9 Protein expression and purification ...............................................................29 
2.9.1 Transformation of plasmid into BL21(DE3) competent cells .............................. 29 
2.9.2 Protein expression ................................................................................................ 29 
2.9.3 Protein purification using nickel-affinity chromatography .................................. 30 
2.9.4 Protein purification using GST affinity chromatograph ...................................... 31 
2.9.5 Thrombin digestion .............................................................................................. 31 
2.9.6 Gel filtration FPLC (Fast Protein Liquid Chromatography) ................................ 32 
2.10  Preparation of NMR sample………………………………………………32 
2.11 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) ....32 
2.12 Circular dichroism (CD) spectropolarimetry .................................................33 
2.12.1 Thermal denaturation experiments ....................................................................... 33 
2.13 Sequence alignment……………………………………………………….33 
2.14 Nuclear magnetic resonance and structural determination ..............................34 
2.14.1 NMR chemical shift assignments ........................................................................ 34 
2.14.1.1 2D 1H-15N HSQC spectrum ................................................................................. 34 
2.14.1.2 HNCACB and CBCA(CO)NH ............................................................................ 34 
2.14.1.3 C(CO)NH-TOCSY and H(CO)NH-TOCSY ........................................................ 35 
2.14.1.4 HCCH-TOCSY .................................................................................................... 35 
2.14.1.5 NOE distance restraints and hydrogen bond restraints ........................................ 36 
iv 
 
2.14.1.5.1  15N-edited NOESY ......................................................................................... 36 
2.14.1.5.2  13C-edited NOESY ......................................................................................... 37 
2.15 NOE assignments and structure calculation ...................................................37 
2.16 Immunoassay of Blo t 21………………………………………………….38 
2.16.1 Specific IgE binding ELISA experiment ............................................................. 38 
2.16.2 Endpoint inhibition ELISA experiment ............................................................... 38 
2.16.3 Peptide ELISA experiment .................................................................................. 39 
2.17 Sub-cloning, expression and purification of Der f 7 .......................................39 
2.18 Circular dichroism (CD) spectropolarimetry of Der f 7 ..................................41 
2.18.1 Thermal denaturation experiments ....................................................................... 41 
2.18.2 Chemical denaturation experiments ..................................................................... 41 
2.19 NMR studies of Der f 7…………………………………………………....42 
2.19.1 NMR chemical shift assignments ........................................................................ 42 
2.19.2 2D 1H-15N HSQC spectrum ................................................................................. 42 
2.19.2.1 HNCACB and CBCA(CO)NH ............................................................................ 42 
2.19.3 Ligand binding and pH titration studies of Der f 7 .............................................. 43 
2.19.4 15N relaxation studies of Der f 7 .......................................................................... 43 
2.20 Crystallization of Der f 7……………………………………………….….43 
2.21 Data collection and structure solution of SeMet Der f 7 .................................44 
2.22 Structure-based alignment and comparison ...................................................45 
2.23 Immunoassay for Der f 7 and Der p 7 ...........................................................45 
CHAPTER 3    BLOT21: RESULTS & DISCUSSION ..........................................46 
3.1 Resolving Blo t 21 Structure using NMR ......................................................46 
3.1.2 2D 1H-15N HSQC spectra of Blo t 21 ................................................................... 46 
v 
 
3.2 Chemical shifts assignment of Blo t 21 .........................................................47 
3.2.1 Backbone and side chain assignments ................................................................. 47 
3.2.2 Chemical shift index (CSI) .................................................................................. 50 
3.2.3 NOE assignment by CNS ..................................................................................... 51 
3.3 NMR Structure of Blo t 21………………………………………………...53 
3.4   3-D structures comparison of Blo t 21 with Blo t 5 and Der p 5 ...........................56 
3.5   The Allergenicity of Blot 21 Compared to Blo t 5, Der p 5 and Der f 21 ..............58 
3.6 Study on the Stability of Blo t 21, Der f 21, Blo t 5 and Der p 5 .....................61 
3.6.1 Circular Dichroism ............................................................................................... 61 
3.6.2 Thermal Denaturation Experiment ....................................................................... 62 
3.7 Site-directed mutagenesis and IgE epitope mapping of Blo t 21 ......................65 
3.9 Multiple mutations of epitope residues further reduce IgE binding .................73 
3.10 Residue “Asp-96” - A Unique IgE Epitopes in Blo t 21? ................................77 
3.12 Inhibition Assays………………………………………………………….80 
3.12.1 End-point Inhibition assays .................................................................................. 80 
 3.12.2 The effect of L73E mutation in Der p 5 ................................................................. 83 
3.12.4 Inhibition assays of Blo t 21 vs Der f 21 .............................................................. 86 
3.13 Peptide ELISA…………………………………………………………....88 
3.13.1 Surface charge distribution at the putative IgE interacting site ........................... 88 
3.13.2 Peptides show different IgE binding activities ..................................................... 90 
CHAPTER 4  DER F 7: RESULTS & DISCUSSION ............................................94 
4.1 Characterization of Der f 7……………………………………………..….94 
4.2 Crystallization and Data Collection of SeMet Recombinant Der f 7 ................96 
4.3 Crystal Structure of Der f 7…………………………………………..……98 
vi 
 
4.4 Structural homology………………………………………….…………..103 
4.5 NMR Studies on Der f 7………………………………………………….106 
4.6 IgE Epitope Mapping of Der f 7 .................................................................109 
4.6.1 Single Mutant D159A & Double Mutant L48A_F50A ...................................... 111 
4.6.2 Cross inhibition between Der f 7 and Der p 7 .................................................... 114 
4.6.3 Putative IgE epitopes on Der f 7 and Der p 7 .................................................... 115 
4.7 Ligand binding studies……………………………………………….…..118 
CHAPTER 5   CONCLUSION & FUTURE WORK ...........................................122 
5.1  Structural studies and imuno-characterization of Blo t 21 ......................................... 122 
5.2   Future direction: Blo t 21 ........................................................................................... 124 
5.3   Crystal structure and IgE epitopes of Der f 7 ............................................................ 125 
















 Allergic diseases have drawn worldwide attention since its discovery for more than a 
century ago. Currently, the prevalence of allergic diseases is rising steadily to an alarming 
state in both developed and developing countries, taking a toll on millions of lives. These 
diseases include asthma, atopic dermatitis (AD), rhinitis, anaphylaxis as well as food, drug 
and insect allergy. House dust mite (HDM) stands out as one of the major causative agents of 
allergic diseases owing to its ubiquitous presence in both temperate and tropical regions. To 
date, more than twenty groups of allergens have been isolated from dust mites and were 
shown to be highly antigenic. However, the underlying reasons of their allergenicity remain 
largely unknown. Therefore, extensive immune characterization aided by sophisticated 
structural studies is imperative in order to decipher the inherent features of these allergens and 
to develop a hypoallergen for specific immune therapy.  
 
 This thesis aims to describe the 3D structures and the IgE epitopes of two major 
allergens from dust mites, namely, Blo t 21 and Der f 7. The first part of this thesis focuses on 
Blo t 21, a major allergen from Blomia tropicalis. Blo t 21 showed limited cross-reactivity 
with its paralogue, Blo t 5, thus inferring that Blo t 21 should use unique epitopes to interact 
with IgE antibodies. The 3D structures of Blo t 21 and Blo t 5 (PDB: 2JMH) determined by 
NMR approaches shared high structural homology. However, some disparities of the local 
structure could be detected. The allergenicity test on the Blo t 21 mutants using ELISA 
demonstrated that residues Glu-74, Asp-79, Glu-89 and Asp-96 were the major IgE epitopes, 
with residues Glu-89 and Asp-96 forming a conformational epitope. The subsequent peptide 
ELISA experiments suggested the presence of a linear IgE epitope in Blo t 21, which 
exhibited distinct allergenicity compared to that described in Blo t 5 previously. These data 
could help to explain the limited cross reactivity between Blo t 21 and Blo t 5. The 
allergenicity and cross inhibition tests conducted on the homologous proteins, Der f 21 and 
Der p 5, indicated different antigenic properties as compared to Blo t 21 and Blo t 5. Further 
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analysis implied that the primary sequence, stability and 3D structure could contribute to the 
differences in these proteins. Therefore, the fundamental biophysical and structural 
characterizations on these allergens should be included while mapping their IgE epitopes.  
 
  The second part of this thesis describes the crystal structure and the IgE epitope 
mapping of Der f 7, a major group 7 allergen from Dermatophagoides farinae. Studies have 
shown that this allergen elicits strong immune response in mite-sensitized individuals. The 
crystal structure of Der f 7 is very similar to that of Der p 7, which was also solved by X-ray 
crystallography method (PDB: 3H4Z). However, it was reported that these two allergens 
showed dissimilar IgE binding activity, with a majority of the test subjects indicating higher 
sensitivity to Der p 7. Recently, attempts to map the IgE epitopes have been reported in two 
separate accounts. However, our results suggested that the proposed IgE binding residues, 
Leu-48, Phe-50 and Asp-159, might not be the major IgE epitopes of Der f 7. Based on the 
mapping of different residues between Der f 7 and Der p 7 on the crystal structures, we 
proposed that residues Lys-25, Asp-55 and Glu-124 could be responsible for the higher IgE 
binding activity of Der p 7. Nevertheless, the IgE epitopes of Der f 7 remained elusive thus 
far. In addition, the data pertaining to physical characterization and ligand binding studies of 
Der f 7 will be presented as well. These results may pave a way for understanding the 
allergenic properties of these proteins, and aid in the development of hypoallergens suitable 
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CHAPTER 1 INTRODUCTION 
1. Allergy 
1.1 An introduction to allergy 
 Clemens von Pirquet, an Austrian pediatrician, coined the word “Allergy” in 1906. 
Originated from the Greek word 'allos', which means “change in the native state”, the term 
'allergy' is now used to describe the altered immune response in a human body in response to 
the supposedly innocuous foreign substances, commonly known as allergens. The immune 
system in a healthy human body will function with an intricate balance to react appropriately 
to the intruding foreign substances while preventing the over-reaction against self-antigens or 
harmless foreign antigens. An occurrence of the excessive or uncontrolled immune response 
will lead to an immune disease known as “Hypersensitivity”. Hypersensitivity disorders 
include autoimmune diseases, in which the body immune system mistakes own cells or 
tissues as antigens, and the diseases that result in the hyper-reactive responses against non-
harmful environmental proteins or microbes. Gell and Coombs (1963) proposed that there are 
four types of hypersensitivity, distinguished by the immune-pathologenic mechanism and the 
type of mediators involved (Gell and Coombs 1963). The fifth type of hypersensitivity (Type 
V Hypersensitivity) was described as a rare, type 2-like hypersensitivity (Rajan 2003). Based 
on these classifications, allergy is synonymous with “Type I Hypersensitivity”, in which the 
immunoglobulin E (IgE) and IgG4 mediate the immune responses against foreign antigens. 
Commonly mentioned disorders observed in Type I Hypersensitivity include atopy, systemic 
anaphylaxis and asthma. 
 Atopy or atopic syndrome refers to the hereditary predisposition of an individual 
toward producing specific IgE antibodies against environmental antigens and subsequent 
development of immediate and acute allergic reactions (Abbas and Lichtman 2003). The 
cross-linking of the allergens to the IgE antibodies bound on the surface of mast cells or 
basophils triggers the release of the pro-inflammatory mediators (histamine, proteases, 
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chemokines, heparin), resulting in the clinical manifestation of diseases like atopic eczema, 
asthma and allergic rhinitis (Bousquet, Holt et al. 2008).   
 An antigen that can trigger immediate allergic responses upon exposure is defined as 
an allergen. Allergens are usually soluble proteins or chemicals that can induce the 
proliferation of the IgE antibodies circulating in the atopic patients. Some common allergens’ 
sources include animal products, drugs, foods, insect stings, fungal and pollens. Animal 
products include fur, dander, wool and the dust mite (Dermatophagoides pteronyssinus and 
Dermatophagoides farinae; and storage mite Blomia tropicalis) excretion (Hurtado and Parini 
1987; Fernandez, Martin-Esteban et al. 1993). Many atopic patients are known to be 
hypersensitive to certain drugs like penicillin, sulfonamides and local anesthetics, which 
sometimes cause complications in the medical practices. A more commonly known source of 
allergen is food. Some commonly known food allergens are celery, corn, eggs, certain fruits, 
seafood and nuts. Insect stings like bee venom and wasp venom are also widely known as a 
major source of allergens. Several genera of fungus are implicated as major allergen sources 
comprising Aspergillus, Cladosporium, Alternaria, Penicillium and Fusarium (Cromwell, 
1997). Pollen allergens which are known to cause hay fever include some species of grass like 
ryegrass Lolium perenne and timothy grass Phleum pratense; weeds such as ragweed 
Ambrosia and nettle (Urtica dioica); as well as those from trees like birch Betula verrucosa, 
alder Alnus serrulata and willow Salix fragilis (Cromwell,1997). 
        In the past three decades, there has been a spectacular increase in the prevalence of 
asthma and allergic disease worldwide (Holgate 2004). The prevalence of asthma increased 
75% from 1980 – 1994, with 160% increment in asthma rates among the children under the 
age of five (Centers for Disease Control, USA, 1998). World Health Organization (WHO) 
reported that in 2007, more than 300 million people suffered from asthma worldwide, with 
250,000 fatalities attributed to the disease annually. Asthma and allergic diseases have caused 
millions of people to suffer physical impairments and decrease in quality of life. For example, 
approximately 10.1 million missed work days for adults annually in US (Akinbami 2006); 
asthma was also responsible for 3,384 deaths in US (ALA age group analysis of NHIS 
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through 2005). Besides that, asthma also adds to the healthcare financial burden bore by a 
nation. In Singapore, for every 10,000 students examined in 2001, 1026 male students (~10 
%) and 757 (~7.5%) female students had asthma; and the incidence of asthma increased for 
both genders between 1991 and 2001 (Statistics Singapore Newsletter, 2003). In US, the 
annual economic cost of asthma is US$19.7 Million (ALA, USA, 2007) and according to the 
survey conducted in 2009 by National Heart, Lung and Blood Institute, USA, over USD$20 
billion were spent due to asthma per annum. On the other hand, around SGD$54 million were 
spent yearly by asthmatic patients in Singapore (Chew, Goh et al. 1999).  
Conventional clinical treatment for allergic diseases is designed to alleviate the 
symptoms and to suppress the allergic inflammation. For example, antihistamines drugs, 
anticholinergic agents or topical corticosteroids are commonly used to treat allergic rhinitis 
(Kay, 2001). Atopic dermatitis is normally treated with antihistamines and corticosteroids to 
control and suppress inflammation of the affected site (Roos, Geuer et al. 2004). Anti-
asthmatic drugs salbutamol and salmeterol are predominantly used to relieve asthmatic 
symptoms and for maintenance therapy (Kon and Barnes 1997). However, relieving the 
symptoms is not the most effective choice for long-term therapy. The advent of allergen-
specific immunotherapy provides a novel avenue to reverse the course of the disease and for 
prolonged protection against progression of allergic diseases (Valenta 2002; Niederberger and 
Valenta 2004). 
 
1.2 Mechanisms of allergy 
 There are three major components involved in an allergic reaction, namely, the 
allergen, the IgE and at least one type of effector cells such as mast cells, basophils or 
eosinophils (Abbas and Lichtman 2003). Besides that, the immune system also requires other 
cellular members such as antigen-presenting cells (APC) and lymphocyte cells to initiate and 
regulate of allergic reaction and disease progression. An invading allergen is captured by APC 
such as dendritic cells or cutaneous Langerhans’ cells and presented as T-cell peptide to 
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CD4+ T-cells in a major histocompatibility complex MHC class II-restricted manner (Abbas 
and Lichtman, 2003 and Kay, 2001). Consequently, the CD4+ cells are primed to differentiate 
into T helper 2 cells (Th2) followed by the release of Th2-type cytokines such as IL-4, IL-5, 
IL-9 and IL-13 (Kay, 2001). 
 The APC presents the antigen in the form of peptide fragments to the T-cells. The 
fragments bearing the T-cell epitopes are loaded onto the MHC and the formation of the 
MHC-peptides complexes will be recognized by the T-cells. Generally, there are two classes 
of MHC molecules; Class I MHC presents the peptides to the CD8+ cytolytic T-cells while 
the Class II MHC presents the peptides to the CD4+ helper T-cells. The Class II MHC-
peptide complex is recognized by the T-cell receptor (TCR) located on the surface of the T-
cells. Dendritic cells, macrophages and B lymphocyte cells are the common APCs that initiate 
the helper T-cells (Th). Dendritic cells and cutaneous Langerhans cells are known to present 
the allergens to Th2 cells in an MHC Class II manner in cases of asthma and eczema, 
respectively (Kay, 2001). 
 The Th2 cells will respond upon recognition of the MHC-peptide complexes by 
releasing an array of cytokines. Subsequently, the proliferation of specific IgE antibodies and 
the development of inflammation cells such as mast cells, basophils and eosinophils will be 
implemented. The cytokines that mediate the inflammatory and immune reactions are termed 
as “interleukin”. Interleukins-4 (IL-4) and IL-13 initiate the differentiation of B cells to 
undergo class switching of the constant region of immunoglobulin heavy chain (CH) to Fcε to 
produce IgE class antibodies specifically (Valenta 2002). IL-4 and IL-9 promote the 
development of mast cells, the major effector cells in releasing inflammation mediators (Kay, 
2001). IL-13 plays a key role in inducing airway hyper-responsiveness, goblet cell metaplasia 
and mucus hypersecretion (Wills-Karp, Luyimbazi et al. 1998), while the expansion and 
recruitment of eosinophils and basophils are induced collectively by IL-4, IL-5, IL-9 and IL-
13 (Kay, 2001). The cytokines secreted by Th1 or Th2 cells act as an autocrine growth factor 
to promote the proliferation of these cells while inhibiting the growth of the opposite cell type 
(Fernandez-Botran, Sanders et al. 1988; Gajewski and Fitch 1988; Liew and McInnes 2002). 
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For instance, IL-4 induces the growth of Th2 cells while inhibiting the proliferation of Th1 
cells. On the other hand, IFN-γ, a cytokine released by Th1 subset of cells promotes the 
expansion of Th1 cells but inhibits the proliferation of Th2 cells. 
 IgE antibodies bind to its receptor (Fc receptor) via the constant region, Fcε, on the 
heavy chain. Cross-linking of the FcεRI (high-affinity IgE receptor) present on the mast cells 
or basophils by allergen-bound IgE releases inflammatory mediators such as histamine, 
leukotrienes and lipid mediators (Kay 2008). This receptor is also present on the surface of 
APC where it assists in the IgE-mediated capturing of the allergen, enabling the allergen to be 
presented to the T-cells (Stingl and Maurer 1997). Based on the crystal structure of the 
FcεRIα and IgE-Fc complex, the α-chain of FcεRIα binds to the dimeric molecules of Cε3 
domain of the IgE (Garman, Wurzburg et al. 2000). FcεRIα does not aggregate in the absence 
of antigen; the aggregation of the receptors occurs only when IgE antibodies are bound to the 
receptor and cross-linked by allergens. Numerous signaling pathways initiated by the 
aggregation of FcεRI receptors on the surface of mast cells result in the secretion of various 
inflammatory mediators and cytokines (Turner and Kinet 1999). 
 The FcεRIα receptor is expressed on the surface of mast cells and basophils as a 
multimeric αβγ2 complex (Nadler, Matthews et al. 2000). The β chain and two γ chains act as 
a phosphoreceptor for Tyr kinases that are involved in signaling cascades. Each β and γ chains 
contains one Immunoreceptor Tyr-based Activation Motif (ITAM) in their respective cytosolic 
portions. The aggregation of FcεRIα receptors triggers the signal transduction that activates 
two main Tyr kinases, Lyn and Syk. The first kinase, Lyn, phosphorylates ITAMs of β and γ 
chains followed by the recruitment and activation of the second kinase, Syk to the ITAMs of γ 
chains (Abbas and Lichtman, 2003). The recruitment and activation of the kinases lead to the 
elaborated signalling events that ultimately result in the phosphorylation of myosin light 
chains by an activated protein kinase C. Finally, degranulation occurs when the actin-myosin 





















1.3 Dust mite 
 House dust mites are arachnids related to ticks, spiders and harvestmen (Colloff 
2009). These microscopic organisms belong to the phylum Arthropoda, subphylum 
Chelicerata, class Arachnida, order Acari, and suborder Astigmata. Dust mites are 
ubiquitously found, especially in human habitats, where the dust is accumulated in bedding, 
carpets and furniture. House dust provides a sustaining habitat for dust mites, where the food 
source - shed human skin scales – is abundant. The predominant dust mites species found in 
household dust, and the major source of allergens belong to the family Pyroglyphidae. The 
top three pyroglyphid species of house dust mites in terms of the frequency and abundance 
worldwide are D. farinae, D. pteronyssinus and Euroglyphus maynei (Colloff 2009). These 
species are more common in temperate climate such as continental Europe and North 
Figure 1.1 Mechanism of allergy diseases. During the first encounter, the allergen will be
presented by the APCs to Th2 cells triggering release of cytokines like IL-4 and Il-13.
These cytokines stimulate antibody class switching and production of IgE antibodies. Pro-
inflammatory mediators will be released by mast cells once mast cells-bound IgE
antibodies are cross-linked by the allergen, which ultimately results in acute allergic
reactions such as wheezing, asthma and sneezing. 
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America. On the other hand, storage mite B. tropicalis (family Echymyopodidae) has emerged 
as a more important species in tropics and subtropical regions. 
 Dust mites reproduce sexually and the stages in its life cycle are the egg, a six-legged 
larva, two eight legged nymphal stages (protonymph and tritonymph) and adult. Similar to 
insects, adult mites have exoskeleton, jointed appendages and a blood-filled body cavity 
(hemocoel) (Fernandez-Caldas 2002). However,  instead of having three pairs of legs like 
insects, mites have four. Dust mites are poikilothermic (unable to control body temperature), 
the length of their life cycle is thus dependent on the temperature of the habitat. The growth in 
population and egg-to-adult development of dust mites are controlled by both humidity and 
temperature (Hart 1998). In laboratory, dust mite requires a high relative humidity (RH) from 
75% to 80% to complete their life cycle, with an optimum temperature of approximately 25 
°C to 30 °C (Fernandez-Caldas 2002). The life span of the adults is approximately 4-6 weeks, 
during which time each female can produce 40-80 eggs. 
 The abundance of dust mites in household area is one of the main reasons why dust 
mite is the major cause of asthma attacks in the world. The body and the feces of dust mite are 
the major source of allergens. These “allergens” are the enzymes and other proteins from the 
mites that react potently as antigenic molecule. For example, Der p 1, a group 1 allergen 
isolated from D. pteronysinnus was shown to be strongly associated with the gut and faecal 
pellets, based on its amino acid sequence; the group 4 allergens are amylase, common 
functional enzymes found in most of the organisms (Colloff 2009). Based on the online 
resource Allergome (www.allergome.org), more than 20 groups of proteins from dust mites 
have been isolated and characterized, indicating the wide diversity of different proteins that 
are involved in causing allergic reactions (Table 1.1). These allergens are grouped according 
to their function, molecular weight and sequence identity, and numbered according to their 
chronological characterization. As it can be seen, group 1 and group 2 are the two 
predominant group of allergens from dust mites, with each of them accounting for more than 




 World Health Organization / International Union of Immunologic Societies 
Subcommittee (WHO/IUIS) recommended the nomenclature of allergens. This system 
comprises of the first three letters designating the genus, followed by one alphabet from the 
species and one numeral that describe the order of discovery of the allergen (King, Hoffman 
et al. 1994; Chapman, Pomes et al. 2007). For example, Der p 1 defines the first allergen 
proteins isolated from dust mite Dermatophagoides pteronyssinus while Der p 2 will be 
referring to the second isolated from the same mite. Similarly, Ara h 1 describes the first 
allergen isolated from peanut Arachis hypogaea. 
 Group 1 allergens are glycoproteins with sequence homology and protease function 
similar to cysteine proteases such as papain, actinidin and bromelin (Enrique, Malek et al. 
2008). The molecular weight of these allergens are around 25kD and were cloned from D. 
farinae, D. pteronyssinus, B. tropicalis and E. maynei. The IgE binding prevalence for group 
1 mite allergens is more than 90% of the tested population (Table 1.1). Group 2 allergens are 
another important group of allergen identified in dust mites. These proteins are highly heat 
resistant  and have a molecular weight of about 14 kDa. They consist of predominantly beta-
sheet structure with an immunoglobulin-like fold (ML-like) (Colloff 2009). Similarly, Group 













Group Biological Function Mw (kDa) % Prevalence 
1 Cystein protease 25 >90 
2 Niemann-Pick C2 homologue 14 >90 
3 Tyrpsin/serine protease 25 16-97 
4 Amylase 57 30-74 
5 Unknown 15 50-70 
6 Chymotrypsin/serine protease 27 40 
7 Innate Immunity 24 50 
8 Glutathaione-S-transferase 26 40 
9 Collagenolytic serine protease 26 90 
10 Tropomyosin 37 50-95 
11 Paramyosine 102 80 
12 Unknown 16 50 
13 Fatty acid binding protein 15 10-23 
14 Vitellogenien/apolipophorin-like 17.7 90 
15 98K Chitinase 62.5 70 
16 Gelsolin 55 35 
17 Calcium-binding protein 30 35 
18 Chitinase 60 60 
19 Anti-microbial peptide 7 10 
20 Arginine kinase 40 40 
21 Unknown (Group 5 analogue) 12 >50 
22 Group 2 analogue 14 50 





1.4 From structure determination to IgE epitope mapping 
1.4.1 Structural biology of allergens 
 The first available three-dimensional (3D) structure of an allergen was Bev t 1, a 
major birch pollen allergen identified in Betula verrucosa (Gajhede, Osmark et al. 1996). That 
was the first attempt to identify the structural attributes that would make a protein an allergen. 
Table 1.1 Classification of dust mite allergens (adapted and modified from www.allergome.org
and (Thomas, Smith et al. 2002). The allergens are grouped based on their function and sequence
similarity, and are numbered in chronological order of first isolation. 
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The structures of several other major allergens like Der f 2, a major dust mite allergen from D. 
pteronyssinus (Ichikawa, Hatanaka et al. 1998), and Phl p 2 (De Marino, Morelli et al. 1999), 
a timothy grass pollen allergen from Phleum pratense were also solved using both X-ray 
crystallography and NMR (Nuclear Magnetic Resonance). However, the structural analysis of 
the allergens was not fruitful as there were no conserved structural motifs or common 
structural themes that could indicate allergenicity due to the diversity of tertiary folds of 
different allergens (Valenta and Kraft 2002). 
 By classifying allergens into four structural families based on the experimental 3D 
structures and homology models, Aalberse (2000) has provided a systematic way to 
categorize allergens. In the same review, Aalberse proposed that all IgE epitopes are 
conformational as it involves residues from different parts of the linear protein sequence. 
However, this statement is questionable, as the recent study on Blo t 5, a major dust mite 
allergen isolated from B. tropicalis, has shown that this novel allergen harbors a linear epitope 
(Chan, Ong et al. 2008). Bet v 1, a major allergen which causes the birch pollen allergy, has 
been well characterized for its 3D structure and IgE epitope (Gajhede, Osmark et al. 1996; 
Mirza, Henriksen et al. 2000; Spangfort, Mirza et al. 2003). The 3D structure of Bet v 1 
consists of 7 β-strands and 3 α-helices forming a globular protein with molecular weight of 
around 17.5 kilo Dalton (kD). Holm and coworkers (2004) conducted a very comprehensive 
study in an attempt to mutate several surface residues of Bet v 1 to modulate its IgE binding 
properties. In this study, two mutants with four and nine surface amino acids substitutions 
respectively were generated. These mutations which cover up to five different areas on the 
surface of the allergen, have significantly changed the IgE binding properties of Bet v 1 
(Holm, Gajhede et al. 2004).  
 Der p 2 from dust mite D. Pteronyssinus is another major allergen that was 
extensively characterized. Both the NMR and X-ray crystallography structure of this 14-kDa 
protein have been solved. Der p 2 has a human immunoglobulin-like fold which consists of 
predominantly β-sheets, with a β barrel formed by two 3-stranded antiparallel β-sheets 
(Mueller, Benjamin et al. 1998; Derewenda, Li et al. 2002). The overall fold is being 
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maintained by 3 disulfide bridges; these disulfide bridges have been shown to be crucial for 
the structural integrity of the group 2 allergens. Derewenda et al (2002) identified a large 
hydrophobic cavity between the two β-sheets, which inferred that the group 2 allergens may 
bind to hydrophobic ligands and the binding could be important to its physiological function 
in dust mites (Derewenda, Li et al. 2002). However, there is no concrete evidence that 
describes any ligand as well as its binding to the protein.  
The structure of another important allergen from dust mite, Der p 1 has been resolved 
using X-ray crystallography technique (Meno, Thorsted et al. 2005; de Halleux, Stura et al. 
2006). Both forms of Der p 1, pro-Der p 1 and mature Der p 1, exhibited α-β structure, with a 
typical papain-like cysteine protease fold. The pro-peptide region comprised of 4 α -helices 
which extended and interacted with the active site, and was shown to cover several IgE 
epitopes on the mature protein domain (Meno, Thorsted et al. 2005). Similar to group 2 
allergens, three disulfide bridges were used to stabilize the overall structure of the mature 
protein, which also contained a magnesium binding site and dimerizes with an extensive 
dimeric interface (Kon and Barnes 1997). The crystal structure of the homologous protein, 
Der f 1 from D. farinae, which shared 80% sequence identity Der p 1 was also solved later 
(Chruszcz, Chapman et al. 2009). In this controversial report, the authors claimed that despite 
a high sequence and structural homology between these two proteins, the closer analysis of 
both structures revealed four different patches of surface exposed residues that may affect 
antibody binding. However, there is no proper assay or conclusive experimental data such as 
mutagenesis studies that can support their hypothesis. 
 There is experimental evidence implying that some allergens are capable of 
“reversible plasticity”, which describes that an allergen could assume different conformations 
and thus exposing varying degree of its IgE epitopes (Valenta and Kraft 2002). For example, 
the calcium-binding activity of birch pollen allergen, Bet v 3, was shown to influence the IgE 
binding capacity drastically. When a calcium ion was removed from Bet v 3 via EGTA 
treatment, the IgE binding was strongly reduced (Seiberler, Scheiner et al. 1994). Similar 
calcium-mediated modulation of the allergenicity was also observed in other calcium-binding 
12 
 
allergens from plants and fish (Wopfner, Dissertori et al. 2007). The calcium-binding induced 
structural changes had been reported in Bet v 4 and Phl p 7, in which the local movement 
within the EF-hand motif was involved (Valenta, Hayek et al. 1998; Wopfner, Dissertori et al. 
2007). It was proposed that the calcium-bound (open) form would expose the IgE epitopes 
that were buried in the calcium-depleted (apo-closed) form (Hayek, Vangelista et al. 1998; 
Niederberger, Hayek et al. 1999). Plasticity of allergen was also observed in the enhanced IgE 
binding following the interaction with IgG antibodies to the major birch pollen allergen, Bet v 
1 (Visco, Dolecek et al. 1996; Denepoux, Eibensteiner et al. 2000). However, there is no 
evidence that can prove the any alteration in the structure of Bet v 1 upon binding to IgG 
antibodies. Nevertheless, these data strongly suggest that allergens can exist in a highly 
dynamic form that could present their IgE epitope in varying degrees. In conclusion, the 
structural changes induced by biological functions or interaction with other molecules may 
affect the IgE binding activity of some allergens. 
 
1.4.2 IgE epitope mapping of allergens 
 Determination of the IgE epitope will help to distinguish the part of the protein that is 
responsible for IgE binding and thus cross-linking of the Fcε receptor to release pro-
inflammatory mediators. Strategic scanning mutations can be employed based on IgE epitope 
mapping, to modify the wild-type allergen into a hypoallergenic molecule (hypoallergen) that 
can be used as a potential vaccine for immunotherapy. In addition, information on the 
locations of the epitopes, their charges and distribution are crucial for understanding the basis 
of interaction between IgE antibodies and allergens.  
 Site-directed mutagenesis (SDM) is one of the most widely used and simplest 
methods to study the IgE epitope by identifying the individual residues that are involved in 
IgE binding. Subsequently, IgE detection assays like ELISA and immunoblot experiments are 
used to determine the viability of the potential hypoallergens. A single substitution of a 
putative IgE binding residue to Ala usually will not disrupt the secondary or tertiary structures 
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of the protein; hence, this is a powerful strategy that can be used to identify unique residues 
that are involved in IgE binding. In broad, potential candidates for mutagenesis study can be 
chosen either based on the sequence alignment with non-allergenic/allergic homologous 
proteins, or by analyzing the 3D structure of an allergen. Multiple sequence alignment with 
allergenic homologous proteins \enable\s the identification of conserved amino acid residues 
among other cross-reactive allergens; while the alignment with non-allergenic homologous 
proteins  help to determine unique residues in allergens that share different properties from 
those in the non-allergenic ones. Structural based selection provides more information like 
surface exposed/solvent accessible residues and their location in the 3D structure, e.g. surface 
exposed residues are most likely to be involved in the surface-surface interaction with IgE 
antibodies. Site-directed mutagenesis approaches have been successfully employed to map the 
IgE epitopes of Hev b 6.02 (Karisola, Mikkola et al. 2004), Der p 2 (Mueller, Smith et al. 
2001), Bet v 1 (Spangfort, Mirza et al. 2003), Der f 13 and Blo t 5 (Chan, Ong et al. 2006; 
Chan, Ong et al. 2008) 
 X-ray crystallography proves to be an important tool to study the structure of protein 
complexes. However, there is no available structure on the complex formed between IgE and 
allergen so far. To form the IgE-allergen complex, a large amount of homogenous IgE will 
need to be extracted. Unfortunately, the IgE antibodies are usually present in a very low titer 
in sera as compared to the other types of immunoglobulin. In addition, an allergen usually 
contains multiple IgE epitope that may bind to more than one IgE molecule, thus making the 
crystallization process more difficult (Fedorov, Ball et al. 1997). An indirect approach has 
been introduced using a monoclonal antibody (IgG) to form a complex with the allergen of 
interest. The monoclonal antibody used must be able to cross-inhibit sera IgE from binding to 
the allergen. Mirza and coworkers had successfully employed this approach to determine the 
structure of the complex formed between Fab fragment of a murine monoclonal antibody IgG, 
BV16 and the major pollen allergen Bet v 1. The limitation of this approach, however, is that 
the monoclonal IgG which inhibits the binding of IgE to Bet v 1 does not necessarily bind at 
the IgE epitope. The inhibition of IgE binding may be due to the steric hindrance caused by 
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the monoclonal IgG binding to adjacent IgE epitope (Mirza, Henriksen et al. 2000). To date, 
this is the only structure of an allergen-antibody complex; nevertheless, the structure of an 
allergen-IgE complex is yet to be determined. 
 Several other methods that are commonly employed to map the IgE epitopes include 
peptide mapping and specific point mutation involving proline or cysteine residues. In peptide 
mapping strategy, the whole allergen protein is fragmented into peptides with overlapping N-
terminal/ C-terminal sequences, which are used to estimate the region that interacts with the 
IgE antibodies. This method was proven to be successful in identifying the IgE epitopes of a 
major food allergen from English walnut (Juglans regia), Jug r 1 (Robotham, Teuber et al. 
2002), a major pollen allergen Juniperus ashei, Jun a 1 (Midoro-Horiuti, Mathura et al. 2003), 
and 13S globulin allergen from buckwheat Fagopyrum esculentum (Fag13S) (Sordet, 
Culerrier et al. 2009). However, peptide mapping strategy is only applicable in identifying the 
sequential/linear epitopes while most of the IgE epitopes are conformational (Aalberse et al., 
2000). Point mutations targeting prolines and cysteines have been shown to reduce the IgE 
binding capability of Der p 2, a major allergen from dust mite D. pteronysinnus (Takai, 
Ichikawa et al. 2000) and Asp f 2, a major fungus allergen from Aspergillus fumigatus 
(Banerjee, Kurup et al. 2002) respectively. However, the substitution of either proline or 
cysteine residues resulted in the disruption of the tertiary structure of proteins as these amino 
acids are essential in maintaining the structural integrity. Therefore, this strategy may not be 
reliable in identifying the IgE epitopes since the resulting conformational change of a protein 
does not delineate the true nature of the residues that are interacting with the IgE antibodies. 
Though these strategies may not be useful in defining the IgE epitope of an allergen, it had 
been demonstrated that they can be used to generate hypoallergenic molecules. 
 It has been shown that the IgE epitope can also be determined by measuring the 
amide proton exchange rates of the backbone amides in an allergen while binding to an 
antibody. In this technique, 15N-labeled allergen is allowed to bind to the antibody, which is 
immobilized on a column before the buffer containing 100 % D2O was added. Free amide 
hydrogen will exchange with deuterium in the buffer, while the amide hydrogen of the 
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residues in contact with antibody will be protected from exchange. Hence, the IgE epitope can 
be identified by assigning the remaining peaks in the 1H-15N HSQC spectrum. This approach 
has been successfully applied to map the IgE epitopes on Der p 2 which were also confirmed 
by mutagenesis studies (Mueller, Smith et al. 2001). However, this technique still employed 
monoclonal IgG as a large amount of antibody is required.  
 
1.5 Specific immunotherapy  
 Specific immunotherapy was practiced about a century ago even before humankind 
knew the IgE-mediated mechanism. With the rationale of “vaccination” against “airborne 
toxins”, this method was first used to alleviate the symptoms of hay fever and proved to be 
successful by Noon (1911). To date, specific immunotherapy has been extensively employed 
in numerous cases of allergy diseases. Several variations of administrating this method have 
been devised and it remains the only curative approach against allergy. However, thus far, 
respiratory allergy and hymenoptera venom allergy are the only accepted indications for 
specific immunotherapy. Jutel and coworkers demonstrated the depletion of Th2 cytokines 
such as IL-4 and IL-5 but the augmentation of Th1 cytokines’ secretion such as IFN-γ and IL-
12 with the immunotherapy using bee venom (Jutel, Pichler et al. 1995). Interleukin-4 (IL-4), 
IL-5 and IL-13 are involved in the development of Th2 cells while IFN-γ and IL-12 are the 
Th1-type cytokines that negatively regulate the development of Th2 cells. The main idea is to 
divert the T-cell responses from Th2 to Th1, in which the production of IgE antibodies is 
reduced while the production of IgG antibodies is induced. The IgG antibodies are also 
known as “blocking IgG antibodies” due to its ability to inhibit the IgE antibodies interacting 
with an allergen, thus preventing the cross-linking of Fcε receptors and the subsequent release 
of pro-inflammatory mediators (van Neerven, Wikborg et al. 1999; Holm, Gajhede et al. 
2004; Niederberger and Valenta 2004; Valenta, Niespodziana et al. 2011). 
 The major problem associated with the use of native allergen extracts as means of 
immunotherapy is the resultant local and systemic side effects such as anaphylactic shock 
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(Valenta, 2002). The British Committee for the Safety of Medicines reported 26 deaths due to 
immunotherapy administered via subcutaneous injection using natural allergens’ extracts in 
1986. More recently, immunotherapy attempts using birch pollen extracts have resulted in the 
production of IgE antibodies that bind to new allergenic components (Moverare, Elfman et al. 
2002). These incidents had raised concerns on the usefulness and risk/benefit ratio of 
immunotherapy using natural allergens’ extracts and therefore, prompted the development of 
the allergenic molecules with reduced allergenicity, known as hypoallergens. The main idea of 
hypoallergen is the modification of an allergenic molecule to reduce or abolish its 
allergenicity so it will not cause the IgE-mediated side effects (Valenta, 2002). Chemical 
modification has been shown to be able to reduce the allergenicity of Fel d 1, a major cat 
allergen (Versteeq et al., 2004). Nevertheless, recombinant DNA technology proves to be 
more a versatile tool in creating hypoallergen based on many promising results. 
 Recombinant DNA technology was widely used in the past few decades to modify 
allergens for allergen-specific immunotherapy. By modifying the specific regions in the DNA 
sequence, the corresponding IgE binding epitopes can be removed from an allergen, hence 
generating the hypoallergen. The hypoallergen should preserve the T-cell epitopes to retain its 
immunogenicity, enabling the induction of a non-Th2 type response (Akdis and Blaser 2001). 
At the same time, the proliferation of Th1 or regulatory T-cells leading to a  secretion of 
cytokines associated to these T-cells is expected (Kay, 2001). This is followed by the 
production of “blocking” IgG4 or IgA antibodies that can inhibit the binding of IgE to 
allergens. In this section, several strategies that are commonly used to remove the IgE epitope 
of an allergen while retaining its T-cell epitope will be discussed. 
 The IgE epitopes mapping strategies have been discussed in the earlier sections. As 
mentioned, point mutation approach was used to identify and to remove the residues involved 
in the binding with IgE antibodies. (Chan et al 2006) used site-directed mutagenesis to create 
the hypoallergenic mutant of Der f 13 with four point mutations. The integrity of the overall 
structure of the quadruple mutant was verified using circular dichroism (CD). Various 
immuno-assays have shown that the mutant demonstrated reduced IgE binding, but are still 
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capable of inducing T-cells proliferation. Blocking IgG antibodies were also raised from mice 
immunized with the quadruple mutant, indicating that this mutant retained its T-cell epitopes 
although the IgE epitopes have been removed. Similar methodology has been used to create a 
hypoallergen for the major dust mite allergen, Blo t 5 by mutating its sequential IgE epitope 
(Chan, Ong et al. 2008). 
 Most of the B-cell epitopes of an allergen is conformational (Aalberse et al. 2000), 
thus, the 3D structure of an allergen plays an important role in eliciting IgE-mediated 
responses. The disruption of the structural integrity has been attempted to generate the 
hypoallergen for the group 2 allergens from dust mites (Olsson, van Hage-Hamsten et al. 
1998; Takai, Ichikawa et al. 2000). The group 2 allergens from dust mites have 3 disulfide 
bonds formed by 6 conserved cysteine residues. It was demonstrated that by altering the 
cysteine residues of these allergens, the IgE binding capacities were drastically reduced; while 
the T-cell epitopes remained intact, thus making them a good candidate for hypoallergens. 
Similar approach was used to reduce the IgE binding capability of Asp f 2, a major fungus 
allergen (Banerjee et al., 2002). However, this approach seems to be useful for the allergens 
that maintain their structural integrity using disulfide bonds. In addition, these structurally 
compromised mutants may not be able to raise blocking IgG antibodies if the IgG antibodies 
are specific to both the structure and sequence of the wild-type allergen. 
 An interesting approach was proposed by Norman et al (1996) with the rationale of 
fragmenting the allergens in order to disrupt its IgE epitope while retaining the T-cell epitope. 
This method was first used on Fel d 1, a major cat allergen, in which a mixture of long 
peptides’ fragments (27 amino acids), which represent the major T-cell epitopes were derived 
from the allergen. However, the use of long peptides seemed to cause various adverse effects, 
including severe asthma (Norman, Ohman et al. 1996; Simons, Imada et al. 1996). It was 
suggested that the long peptide fragments might have retained a residual IgE binding 
capability and therefore, shorter peptides were designed for the subsequent experiments. This 
modification achieved an overall positive clinical efficacy without relevant adverse effects. 
Similar strategy was employed on Bet v 1, a major pollen allergen as well. In that experiment, 
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two recombinant fragments of Bet v 1 comprising residues 1-74 and residues 75-160 showed 
reduced allergenicity, while retaining their lymphoproliferative activity (Vrtala, Akdis et al. 
2000). Other studies on bee venom allergies such as Api m 1 using the peptide 
immunotherapy have shown an increased production of allergen-specific IgG4 in serum and 
IL-10 production in allergen-stimulated PBMC cultures (Mueller, Benjamin et al. 1998; 
Vrtala, Akdis et al. 2000). 
 Another approach to create a hypoallergens is to generate oligomers of allergens. In 
this method, several recombinant allergens are fused and expressed together as a single 
molecule. It was demonstrated that the generation of dimers and trimers of Bet v 1 could 
significantly reduce the skin prick reactivity while maintaining the ability to stimulate Bet v 
1-specific T-cell (Vrtala, Hirtenlehner et al. 1999). The recombinant fusion protein combining 
two bee venom major allergens, Api m 1 and Api m 2 from Apis mellifera, was shown to 
induce the T-cell proliferation but reduce IgE reactivity and histamine release (Kussebi, 
Karamloo et al. 2005). Karamloo and coworkers adopted the similar idea to generate a 
chimeric protein fusing three bee venom major allergens, Api m 1/2/3 that preserved the T-
cell epitopes from all three different allergens, but with the IgE epitopes disrupted (Karamloo, 
Schmid-Grendelmeier et al. 2005). 
 Recombinant DNA technology is a powerful method that has enabled the 
identification of IgE epitopes as well as the generation of immunogenic hypoallergens with 
reduced allergenicity.  This engineered hypoallergen should have reduced IgE binding 
capacity, thus reducing incidences of adverse side effects; and deviated T-cells pathway that 
favors the production of Th1 or regulatory T-cells cytokines. There is no perfect strategy to 
engineer a hypoallergen, but the availability of various strategies should enable the 





1.7 Group 21 allergen from dust mite 
 Group 21 is a relatively new group of allergen isolated from dust mite. To date, only 
three of its counterparts have been reported, i.e. Blo t 21, Der p 21 and Der f 21 based on the 
Allergome database (www.allergome.org). The biophysical and immunological 
characterization of Blot 21 and Der p 21 were described in separate accounts (Gao, Wang de 
et al. 2007; Weghofer, Dall'Antonia et al. 2008), but no structural information and cross-
reactivity data between these allergens is available thus far.  
 Gao and coworkers first described Blo t 21 as a paralogue to Blo t 5, a major group 5 
allergen isolated from B. tropicalis. The authors showed that Blo t 21 was a product of a 
single-copy gene that shared 39% protein sequence identity with Blo t 5. This 113-amino acid 
novel allergen reacted with 57.9% of the individuals attending outpatient allergy clinics over 
1.5 years; and more than 75% of the sensitized patients were shown to be co-sensitized to 
both Blo t 21 and Blo t 5. The major finding of that study was the low-to-moderate cross-
reactivity between Blo t 21 and Blo t 5, based on thirteen patients' sera. In three patients' sera, 
it was demonstrated that Blo t 21 was able to partially inhibit the IgE binding to Blo t 5, but 
Blo t 5 was not able to inhibit the IgE binding to Blo t 21. This result implied that Blo t 21 
could bear some unique IgE epitopes that was not found in Blo t 5. In order to prove the 
hypothesis, it would be necessary to solve the 3D structure to aid in the IgE epitopes mapping 
of Blo t 21. 
 Another well characterized group 21 allergen from dust mite is Der p 21, isolated 
from D. pteronysinnus. This allergen was shown to have high thermal stability and could be 
refolded easily based on the CD experiments. In terms of allergenicity, Der p 21 could bind to 
high levels of IgE antibodies and able to elicit high allergenic activity in the basophil 
activation experiments. One unique characteristic of Der p 21 as reported by Weghofer and 
coworkers (2008) was the dimerization of the protein based on the small-angle X-ray 
scattering experiments. It was later revealed that Blo t 21, despite being homologous to Der p 
21, in fact exists as a monomer in solution, regardless of its final concentration. Another 
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notable finding was the specific reactivity of the rabbit anti-Der p 21 serum with the crude 
extracts from D. pteronysinnus and D. farinae at 14 kDa and 28 kDa, which represent the 
approximate molecular weight of Der p 21 monomer and dimer, respectively. This anti-Der p 
21 serum was not able to exhibit visible reaction at the same position in other dust mites 
tested, including B. tropicalis. Additionally, it was also demonstrated that the rabbit anti-Der p 
21 IgG antibodies could inhibit the IgE binding in the mite-allergic patients' sera. These 
results indicated that Der p 21 and Blo t 21 were using different epitope residues to interact 
with specific IgE antibodies. However, there is no direct evidence showing that Der p 21 and 
Blo t 21 are not cross-reacting to each other. 
 
1.8 Group 7 allergen from dust mite 
Recently, the crystal structure of Der p 7, a major group 7 allergen from dust mite D. 
pteronysinnus has been reported (Mueller, Edwards et al. 2010). In the skin tests study, about 
53% of mite-allergic individuals were shown to react to Der p 7 (Shen, Lin et al. 1997). A 
more extensive study on the allergenic properties, however, was conducted on the 
homologous protein, Der f 7, which was isolated from D. farinae. Der f 7 shares 86% 
sequence identity with Der p 7 and these two allergens were shown to cross-react to each 
other. The homology modeling of Der f 7 using the crystal structure of Der p 7 as the template 
was used for the monoclonal antibody HD12 (mAbs HD12) and polyclonal IgE binding 
studies. Based on the immunodot blot experiments using overlapping peptides derived from 
Der f 7, Shen and coworkers (2011) identified Leu-48 and Phe-50 as the important residues 
interacting with the Der f 7-specific mAbs HD12. Interestingly, the substitution of Leu-48 to 
Ile-48 and Phe-50 to Leu-50 in Der p 7 resulted in the non-responsiveness towards the Der f 
7-specific mAbs HD12, thus suggesting that residues Leu-48 and Phe-50 were unique 
epitopes in Der f 7 (Shen, Tam et al. 2011). Subsequently, Chou and coworkers identified 
residue Asp-159, which is located in the loop region based on the model of Der f 7, as an 
important residue that interacted with the specific IgE antibody. It was also demonstrated that 
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Asp-159 was responsible for the IgE-mediated cross-reactivity between Der f 7 and Der p 7. 
However, this phenomenon was shown in only 2 of 30 sera tested (Chou, Tam et al. 2011). 
The characterization of the IgE/IgG epitopes of Der f 7 based on the homology model might 
not be accurate; high-resolution 3D structure of Der f 7 would provide detailed information 
such as the orientation of these IgE/IgG binding residues and correct surface charge 
distribution that could explain the allergenicity of this protein. Previously, the protein crystal 
of Der p 7 was obtained by adding the modified maltose-binding protein (MBP) to the N-
terminal of the protein. Even though the recombinant Der p 7 was readily crystallized at room 
temperature, they did not show good diffraction (Mueller, Edwards et al. 2010).  
 
1.9 Objectives and significance of this study 
The first part focused on the studies on Blo t 21. Blo t 21 was shown to bind specific IgE 
antibodies in more than 50% of atopic patients allergic to dust mite and thus is considered as a 
major dust mite allergen. Previous study concluded that the overall cross-reactivity between 
Blo t 21 and Blo t 5 was low-to-moderate despite their similarities (Gao, Wang de et al. 2007). 
In most cases, Blo t 5 was unable to inhibit the binding of IgE to Blo t 21, thus implying that 
the latter may harbor a different set of IgE epitopes as compared to Blo t 5. However, there is 
no report on the 3D structure and the IgE epitope responsible for the allergenicity of Blo t 21 
thus far.  
 The general objectives of this part were to study the structural characteristics of Blo t 
21, a novel group 21 allergen isolated from B. tropicalis  using NMR experiments and to 
investigate its IgE binding epitopes. The foundation of this research was based on the results 
of the previous study (Gao, Wang de et al. 2007). The blood sera obtained from the volunteers 
for all immunological experiments in our study was different from those that were used in the 
previous studies. Therefore, there are bound to be some inevitable discrepancies between our 
results, since the IgE profile is different among individuals. In vivo experiment such as mouse 
immunization was not conducted since it is not relevant to this study. 
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 The specific aims and the significance of the first part were: 
 
1) To solve the NMR structure of Blo t 21 and to examine its structural differences with 
Blo t 5. This is important as the differences in terms of allergenicity between these 
allergens could be due to the structural properties. 
2) To map the IgE epitopes of Blo t 21 by site-directed mutagenesis in order to identify 
specific residues involved in the binding to IgE antibodies. Information of the major 
IgE epitopes may help in understanding the antigenic properties of Blo t 21.   
3) To generate stable mutants of Blo t 21 with reduced IgE binding and mast cell cross-
linking ability. The mutant with significant reduction in IgE binding when compared 
to the wild-type protein can be used as a potential hypoallergen for immunotherapy 
purposes. 
4) To explain the differences in the allergenicity and lack of cross-reactivity between Blo 
t 21 and Blo t 5, as well as other similar allergens (Der f 21 and Der p 5) using their 
structural and immunological information. This may provide insight into the 
allergenic properties of these proteins. 
 
The second part of this thesis focused on Der f 7, a major group 7 allergen from dust 
mite. Der f 7 shared 86% sequence identity with Der p 7, however, there were evidence 
showing that these two proteins shared different allergencity (Shen, Chua et al. 1995). 
Additionally, the IgE epitope mapping of group 7 protein was inconclusive (Chou, Tam et al. 
2011). Therefore, by comparing the 3D structure of Der f 7 and Der p 7, we hoped to be able 
to identify their IgE epitopes. Apart from allergenicity, the ligand binding studies on Der f 7 
would be interesting as well. Previously, Mueller and coworkers (2010) showed that Der p 7 
was able to interact with polymyxin B (PB) but not the other ligands tested. Based on the 
structure-based homology search, there could be other ligands that were not tested previously. 
This is important as it was shown in other allergens that ligand binding could affect their 
allergencity (Thomas, Hales et al. 2005).  
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The general objectives of this part included structural determination of Der f 7 and 
identification of its IgE epitopes. In addition, the comparison of the structure, biophysical 
properties and allergenicity between Der f 7 and Der p 7 would be studied as well. Notably,  
most of the immunological studies on these proteins were done using monoclonal antibodies 
(Shen, Chua et al. 1993; Shen, Chua et al. 1995; Shen, Chua et al. 1995; Shen, Tam et al. 
2011),  only polyclonal IgE antibodies were used in our study as the study on monoclonal 
antibodies’ interaction with these proteins was beyond the scope of this thesis. 
 
 The specific aims and significance of the second part included: 
 
1. Structure determination of Der f 7 using NMR/X-ray crystallography approaches. The 
structure could be useful for the IgE epitope mapping studies. 
2. Comparing the physical properties between Der f 7 and Der p 7 using SDS-PAGE, 
circular dichroim, and NMR experiments. This may contribute to a better 
understanding of the differences of these allergens in terms of their allergenicity.  
3. Identifying the IgE epitopes of Der f 7 using site-directed mutagenesis approaches 
with the aid of the 3D structures. Information of the IgE epitopes may be important in 
explaining the allergenicity of this protein.  
4. Identifying the ligand(s) that bind to Der f 7 using NMR approaches. Ligand binding 
study may shed a light on the probable function of this protein. Additionally, 





CHAPTER 2 MATERIALS & METHODS 
2.1 Generation and subcloning of Blo t 21 and its mutants into expression vector 
2.1.1 Bacterial host strains 
Strain Genotye 
DH5-α F- Φ80dlacZΔM15 &(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-,mk+) 
phoA supE44 λ- thi-1 gyrA96 relA1 
BL21-DE3 F- ompT hsdSB(rB-mB-) gal dcm 
 
2.1.2 Generation of DNA insert and Polymerase Chain Reaction 
DNA insert was generated by polymerase chain reaction (PCR), using upstream 
oligonucleotide primer containing BamH I restriction site and downstream oligonucleotide 
primer containing stop codon and EcoR I restriction site. PCR reaction mix was prepared in 
50 μl mix containing 1 X Pfu buffer (20 mM Tris-HCl (pH 7.5 at 25°C), 8 mM MgCl2, 0.5 
mM DTT, 50 mg/ml BSA), 1 μl of wild-type Blo t 21 DNA template, 0.4 μM of each primers, 
200 μM of each dATP, dCTP, dGTP and dCTP, and 1 μl of 1 U KOD Hot Start Pfu DNA 
Polymerase (Novagen). 
 PCR was carried out for 30 cycles using 94°C for denaturation (15 sec), ~50 °C for 
annealing (30 sec) and 72°C for elongation (10 sec). The annealing temperature was adjusted 
accordingly to the melting temperature, Tm, of the primers used. The PCR product was 
analyzed on 1% agarose gel and purified using Gel Extraction Kit (QIAGEN) according to 
standard manufacturer’s protocol. 
 
2.2 Generation of DNA mutant insert for site-directed mutagenesis 
Mutants were generated by employing the modified QuikChangeTM Site-Directed 
Mutagenesis Kit (Stratagene) designed oligonucleotide primers (1st Base) with mismatches. 
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Primers were designed with mismatches base pairing being flanked on both 5’ and 3’ ends 
with about 9 to 15 bases each using the software GeneRunner. The list of mismatched primers 
for Blo t 21 could be seen in Table 2.1. The PCR using the high fidelity KOD Hot Start Pfu 
DNA Polymerase (Novagen) generated the whole plasmid consisting of mismatched bases. 
The methylated wild-type plasmids were digested by adding 1 μl of 1 U Dpn 1 Fast DigestTM 
restriction enzyme at 37°C for 30 minutes. The mixture was subsequently purified using the 
spin columns (QIAGEN) followed by direct transformation into BL21 (DE3) competent cells. 
The list of primers used is shown in Table 2.1. PCR amplification was carried out with similar 
procedure as described in section 2.1.2 except that the elongation time was adjusted to 3 min. 





Figure 2.1 Generation of site-directed mutants. The high fidelity Hot Start KOD DNA 
Polymerase enabled the amplification of the DNA insert together with the vector. Dpn 1
restriction enzyme was  used to digest the methylated unmutated parental DNA template.








2.3 Preparation of DH5-α competent cells 
Frozen glycerol stock of DH5α was streaked onto plain LB agar plate and incubated overnight 
at 37 °C. A fresh single colony was inoculated into 8 ml of LB broth and incubated in a shaker 
overnight at 37 °C. 1 ml of overnight culture was transferred into 100 ml of LB broth and 
incubated in a shaker at 37 °C with shaking speed of 200 rpm. Cells were grown until O.D600 



































5’ TTC CAA CGG GCA CTC AAG CGA 3’
5’ TCG CTT GAG TGC CCG TTG GAA 3’
5’ CGG GAA CTC GCA CGA ACT GAT 3’
5’ ATC AGT TCG TGC GAG TTC CCG 3’
5’ AAG CGA ACT GCA TTG GAT TTG 3’
5’ CAA ATC CAA TGC AGT TCG CTT 3’
5’ GAT TTG CTC GCA AAA TTC AAC TTT G 3’
5’ C AAA GTT GAA TTT TGC GAG CAA ATC 3’
5’ GCT ACT CAA GCA TTC CAT GAG 3’
5’ CTC ATG GAA TGC TTG AGT AGC 3’
5’ CGA TTC CAT GCA ATT GAA AAA TTC TTG 3’ 
5’ CAA GAA TTT TTC AAT TGC ATG GAA TCG 5’
5’ G CAT ATT ACT CAT GCA GTT GAT GAT 3’ 
5’ ATC ATC AAC TGC ATG AGT AAT ATG C 3’ 
5’ GAT GAT TTG GCA AAA ACC GGC 3’
5’ GCC GGT TTT TGC CAA ATC ATC 3’
5’ GAT TTG GAA GCA ACC GGC AAC 3’
5’ GTT GCC GGT TGC TTC CAA ATC 3’
5’ GGC AAC GCA GAT GAG AAG 3'
5’ CTT CTC ATC TGC GTT GCC GGT 3’
5’ GGC AAC AAA GCA GAG AAG GCA 3’
5’ TGC CTT CTC TGC TTT GTT GCC 3’
5’ GC AAC AAA GAT GCA AAG GCA CGA 3’
5’ TCG TGC CTT TGC ATC TTT GTT GC 3’
5’ C AAA GAT GAG GCA GCA CGA CTT 3’
5’ AAG TCG TGC TGC CTC ATC TTT G 3’
5’ ACC GTT TCT GCA GCT TTC ATC 3’
5’ GAT GAA AGC TGC AGA AAC GGT 3’
5’ GAA GGA TCA GCA GGA TAT TTC C 3’
5’ G GAA ATA TCC TGC TGA TCC TTC 3’
5’ GCA ACC GGT GCA TTG TTG TTG AAG3’
5’ CTT CAA CAA CAA  TGC ACC GGT TGC 3’
5’ GCT CTC CAA GCA CGA GTC CAA 3’
5’ TTG GAC TCG TGC TTG GAG AGC 3’
Table 2.1 List of primers used for PCR and mutagenesis studies. Primers with mismatches




°C. Supernatant was removed and cell pellets were resuspended gently with 40 ml of cold 
glycerol buffer (0.1 M CaCl2, 15% glycerol) and then incubated on ice for 30 minutes. Cells 
were spun at 3,500 rpm for another 10 minutes at 4 °C and the supernatant was removed. The 
pellet was resuspended carefully in 4 ml of cold glycerol buffer and incubated on ice for 2 
hours before aliquoted at 50 μl per tube and store at -80 °C. 
 
2.4 Subcloning 
For preparation of His-tagged proteins, DNA inserts were subcloned into pET-M, a modified 
pET-32a vector with S-tag and thioredoxin tag removed. For preparation of GST-tagged 
proteins, the inserts were subcloned into pGEX-4T-1 vector (Novagen). The DNA insert 
(about 50 ng/μl) was digested usingusing 10 U of BamH I Fast Digest TM and EcoR 1 Fast 
Digest TM (Fermentes) in total reaction volume of 20 μl. Two microliter of expression vector 
(about 50 ng/μl) was digested in a separate tube with another 10 U of the similar restriction 
enzyme in total reaction volume of 10 μl. Concentrated 10 X Fast Digest TM buffer was added 
accordingly. Both tubes were incubated in 37°C water bath for 30 minutes. 
        The plasmid and DNA insert digestion mixtures were purified using the spin column 
(QIAGEN) after the incubation and the ligation of DNA insert and plasmid were done by 
adding 1 μl of 10 X T4 ligase buffer and 1 μl of T4 ligase enzyme (Fermentes). Ligation was 
carried out for 2 hour at room temperature before transformation into DH5-α competent cell 
(refer section 2.1.6 for details). 
 
2.5 Transformation of ligation mix into DH5-α competent cells 
 Ligation reaction was added into 50 μl of DH5-α competent cells and kept on ice for 
15 minutes. Heat shock transformation was carried out by incubating the cells at 42 °C for 
exactly 90 seconds, followed by 2 minutes incubation on ice. 950 μl of LB broth were added 
into the tubes before incubation at 37 °C in shaker for one hour. Cells were spun at 6,000 rpm 
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for 2 minutes and 950 μl of the supernatant were removed. Cell pellet was resuspended with 
the remaining medium and plated on LB agar plated supplemented with 0.1 mg/ml ampicillin. 
Plates were incubated for overnight in a 37 °C incubator. 
 
2.6 PCR screening of transformant 
The presence of DNA insert into target plasmid was verified by PCR screening of colonies 
grown on LB-ampicillin agar plate prior to sequencing. At least five colonies from each plate 
were selected for the screening. Half of a colony was picked using a sterile pipette tip and 
resuspended with 100 μl of sterile water in an eppendorf tube. The suspension was boiled for 
five minutes, and subsequently centrifuged at 13,000 rpm for a minute. One microliter of the 
supernatant could be used DNA template for PCR reaction. 
 A PCR reaction cocktail of volume 10 μl was prepared containing 1 X Taq reaction 
buffer (50 mM KCl, 10 mM Tris-Cl pH 9.0, 1% Triton X-100), 0.75 mM MgCl2, 140 μM of 
each dATP, dCTP, dGTP and dCTP, 0.5 μM of each upstream primer and downstream primer; 
and 1.5 U of Taq DNA Polymerase (Promega). One microliter of DNA template was added 
into the mixture and 30 PCR cycles were carried out with 1 minute denaturation at 94 °C, 1 
minute annealing at 52 °C and I minute elongation at 72 °C for each cycle. The PCR products 
were analyzed on a 1.5% agarose gel for detection of DNA fragment of the appropriate size. 
 
2.7 Isolation of DNA plasmid 
Colonies that showed positive PCR screening results were cultured overnight in LB broth 
supplemented with 100 μg/ml ampicillin in a 37 °C shaking incubator. Cell pellets from 5 ml 
of overnight culture were recovered by centrifugation at 6,000 rpm for 15 minutes. DNA 
plasmid was extracted from pelleted cells usingQIAGEN Miniprep Kit (QIAGEN) and eluted 
with 40 μl of water according to the supplied protocol. 
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2.8 Plasmid DNA sequencing 
Two microliters of plasmid DNA containing about 250 ng of DNA was added with 3 μl of 
water, 1 μl of T7-promoter sequencing primer (3.2 μM), 2 μl of 5X Big Dye Buffer and 2 μl 
of Big Dye Terminator V3.1 (Applied Biosystems). Twenty-five cycles of PCR reaction were 
carried out with denaturation step at 96 °C for 30 seconds, annealing at 50 °C for 15 seconds 
and extension at 60 °C for 2 minutes. Following the sequencing cycle, a mixture of 3 μl of 3M 
sodium acetate, pH 4.6, 62.5 μl of 95 % ethanol and 24.5 μl of sterile water was added into 
each DNA samples for precipitation. After 15 minutes incubation at room temperature, the 
mixtures were spun at 13,000 rpm for 25 minutes at room temperature. Supernatant was 
removed, and the pellet was washed twice with 500 μl of 70% ethanol and centrifuged for 
another 5 minutes between each wash. Supernatant was carefully aspirated and sample was 
dried in a vacuum centrifuge before sequencing analysis on an automated sequencer, ABI 
PRISM 3100 (Applied Biosystems). 
 
2.9 Protein expression and purification  
2.9.1 Transformation of plasmid into BL21(DE3) competent cells 
Plasmid containing DNA insert or mutants was transformed into E. coli BL21 (DE3) cells for 
the expression of recombinant protein. Transformation procedure was carried out as described 
in section 2.1.6. BL21 (DE3) competent cells were prepared as discussed in section 2.1.4. 
 
2.9.2 Protein expression 
A single colony of E. coli BL21 cells containing the desired plasmid was picked and cultured 
overnight in 10 ml of LB broth containing 100 μg/ml ampicillin. Ten milliliters of overnight 
culture were inoculated into 1 liter of fresh LB broth containing 0.1 mg/ml ampicillin. 
Cultures were grown at 37 °C in a shaker with shaking speed of 200 rpm for approximately 3 
hours until the O.D600 reached approximately 0.6. Subsequently, IPTG was added at final 
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concentration of 0.3 mM to induce protein expression. The culture was further grown at 37 °C 
overnight at 200 rpm before harvesting by centrifugation at 6,000 rpm for 15 minutes at 4 °C. 
Cell pellets were kept at -20 °C until ready for purification. 
         Expression of 15N or 13C-labeled protein were carried out with similar conditions as 
mentioned above, except that the cells were grown in M9 minimal medium (Appendix I) 
supplemented with 15N-labeled ammonium chloride and/or 13C-labeled glucose. To obtain 
15N-labeled sample, cells were grown in 1 X M9 minimal medium in the presence of 13N-
ammonium chloride (Cambridge Isotope Laboratories) as the sole nitrogen source. For double 
labeled 15N and 13C-sample, 1 X M9 minimal medium with 15N-ammonium chloride and 13C-
glucose (Cambridge Isotope Laboratories) as the sole nitrogen and carbon source respectively 
was used. 
 
2.9.3 Protein purification using nickel-affinity chromatography 
Cells from 2 liters of culture were resuspended in 30 ml of nickel binding buffer (20 mM Tris-
Cl pH 8, 0.5 M NaCl, 5 mM immidazole). The suspension was sonicated for 3 minute each 
with 38 % sonication amplitude. Sonication was carried out for 4 rounds, and the lysate was 
centrifuged at 4 °C for 30 minutes at 18,000 rpm. The supernatant was collected for 
purification. Ni-NTA beads (QIAGEN) were charged with 10 ml of Nickel-charge buffer (50 
mM NiSO4), washed with water and equilibrated with 1 X Nickel binding buffer in a 
chromatography column. All supernatant was slowly loaded into the column and let flow at 
approximately 1 ml/min. The column was subsequently washed 15 times with 1 X nickel 
washing (20 mM Tris-Cl pH 8, 0.5 M NaCl, 20 mM immidazole) buffer to remove unbound 
proteins. His-tagged protein was eluted with 20 ml of nickel elution buffer (20 mM Tris-Cl 
pH 8, 0.5 M NaCl and 500 mM immidazole). The eluted protein was dialyzed overnight 




2.9.4 Protein purification using glutathione-sepharose affinity 
chromatography 
Cells from 2 liters of culture were resuspended in 30 ml of PBS (140 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4 and 1.8 mM KH2PO4, pH 7.4). The suspension was sonicated for 3 minute 
each with 38% sonication amplitude. Sonication was carried out for four rounds, and the 
sonication lysate was centrifuged for 30 minutes at 18,000 rpm and 4°C. The supernatant was 
collected for purification. All supernatant was slowly loaded into a column packed with 10 ml 
of glutathione-sepharose 4B beads (Amersham Biosciences) equilibrated with 1 X PBS. The 
column was subsequently washed 15 times with a total of 1 X PBS to remove unbound 
proteins. GST-tagged protein was eluted with 20 ml of glutathione elution buffer (50 mM 
Tris-Cl pH 8 and 10 mM reduced gluthathione) and analyzed by SDS-PAGE. Glutathione-
sepharose beads were regenerated by washing the column twice with column regeneration 
buffer 1 & 2 (Appendix II). 
 
2.9.5 Thrombin digestion 
Fusion tags (His-tag and GST-tag) attached to the N-terminal of recombinant protein were 
removed by thrombin digestion. Digestion was carried out in 50 mM Tris-Cl pH 8. Thrombin 
was added at 2 U/mg of protein and cleavage was carried out for 5 hours at room temperature. 
Cleaved recombinant proteins were further purified by gel filtration (refer section 2.2.6.) 
 On column cleavage was carried out immediately after the washing procedure. The 
same procedure was implemented for both Ni-NTA and GST affinity columns. Thrombin was 
added at approximately 2 U/mg of protein into the columns and the mixtures were 
resuspended by placing the columns on the orbital shaker at room temperature for 5 hours. 
The cleaved recombinant proteins were eluted and immediately passed through the gel 




2.9.6 Gel filtration FPLC (Fast Protein Liquid Chromatography) 
Gel filtration FPLC was carried out in a HiLoad 16/60 Superdex 75 pg (Amersham 
Biosciences) size exclusion chromatography column on AKTA FPLC System (Amersham 
Biosciences) using 50 mM Tris-Cl pH 7.9 with 500 mM NaCl as running buffer. Gel filtration 
column was pre-equilibrated with at least three column volumes (180 ml) of running buffer 
before use. Protein sample was concentrated to about 5 ml prior to loading into the column. 
Chromatography was carried out with a flow rate of 1 ml/min and a total volume of 180 ml. 
Eluted protein peaks were detected by absorbance at 280 nm and the fractions were analyzed 
with SDS-PAGE. 
 
2.10  Preparation of NMR sample 
Purified protein was concentrated to about 1 mM using an ultra-filtration concentrator 
(Centriprep YM—3, Millipore) and was exchanged into 50 mM phosphate buffer, pH 7 with 
addition of 5% deuterium oxide (Cambridge Isotope Laboratories). Concentrated protein (0.8 
mM) was centrifuged at 13,000 rpm and 4°C for at least 15 minutes before loading into a 5 
mm NMR Shigemi tube. 
 
2.11 Sodium dodecyl-sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was carried out according to the method described by Laemmli (1970). SDS-
PAGE gel was casted according to the table described in Appendix III using the Mini-
PROTEAN 3 system (Bio-Rad). Protein sample was mixed with an equal volume of 2 X SDS 
sample buffer and boiled for 10 minutes. Fifteen microliters of sample was loaded into each 
wells, and electrophoresis was carried out at 200 V until the marker dye reached the end of 
the gel (~55 minutes).The gel was stained with Coomassie blue staining solution for about 20 




2.12 Circular dichroism (CD) spectropolarimetry 
Circular dichroism experiments were carried out with 15 μM protein in 1 X PBS buffer. The 
spectra were acquired with a J-810 Spectropolarimeter (Jasco, Japan) using a quartz cuvette 
with 1 mm pathlength (Hellma, Germany). The spectra were recorded at wavelength region 
from 190 nm to 260 nm with 0.1 nm resolutions with a scan speed of 50 nm/min and a 
response time of 8 seconds, averaged over 5 scans. 
 
2.12.1 Thermal denaturation experiments 
Temperature denaturation experiments were carried out for Blo t 21 by recording the 
molecular ellipticity at 222 nm at which the change was most drastic with the increment of 
temperature. Spectra were recorded at the temperature slope of 1˚C/min with a resolution of 
0.1˚C over the range of 30˚C – 95˚C. 
 
2.13 Sequence alignment 
Amino acid sequence alignment was carried out using ClustalW (Higgins et al., 1994)  
software hosted at European Bioinformatics Institute server 
(EBI,http://www.ebi.ac.uk/Tools/). Amino acid sequences of all selected allergens from dust 
mites were acquired from GenBank (http://www.ncbi.nlm.nih.gov/) and Allergome database 
(www.allergome.com). Aligned amino acid residues were compared based on their distinctly 
different properties (charged residues/hydrophilic residues versus hydrophobic residues). The 
sequence of Blo t 21 was aligned with group 5 and group 21 allergens from different species 




2.14 Nuclear magnetic resonance and structural determination 
2.14.1 NMR chemical shift assignments  
3D heteronuclear NMR experiments were carried out to assign the backbone and side-chain 
chemical shifts using a 2D 1H-15N HSQC as a reference spectrum. All NMR experiments were 
carried out on a Bruker AVANCE 800 MHz spectrometer equipped with a cryoprobe. Samples 
were loaded into a 5 mm Shigemi NMR tube and all experiments were carried out at 298K. 
All data acquired were processed using NMRPipe (Delaglio, Grzesiek et al. 1995) and viewed 
and analyzed using NMRDraw (Delaglio, Grzesiek et al. 1995) and SPARKY (Goddard and 
Kneller). Computational processing was carried out on Dell Precision 360 workstation and 
SGI Origin 300 server. 
 
2.14.1.1 2D 1H-15N HSQC spectrum 
2D 1H-15N HSQC spectrum was used as a reference for backbone chemical shifts assignments 
by other 3D triple resonance experiments. The spectrum was acquired with 1024 complex 
points over a spectral width of 8012.8 Hz on the amide proton dimension. In the 15N 
dimension, 256 points were collected over 1774.3 Hz. Carrier frequencies for 1H and 15N were 
at 4.725 ppm and 117.0 ppm respectively. 
 
2.14.1.2 HNCACB and CBCA(CO)NH 
Backbone assignments were carried out by HNCACB and CBCA(CO)NH experiments. The 
CBCA(CO)NH experiment correlates both the Cα and Cβ chemical shift with the amide from 
the previous residue while HNCACB provides the intra-residue correlation of its own Cα and 
Cβ. These two experiments provided sufficient chemical shift information to complete the 
sequential assignments of all 15N, HN, Cα and Cβ resonances. 
 In HNCACB (Wittekind and Mueller, 1993), resonances of 1H and 15N of each amide 
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group were correlated with Cα and Cβ of the same residue, while the Cα and Cβ from the 
preceding residue would also be observed in the same amide strip but usually weaker. In the 
acquired F1 dimension (1H) of the experiment, 1024 points were collected over 8012.8 Hz 
spectral width. In the F2 dimension (15N), 68 points were collected over 1368.7 Hz of spectral 
width while the F3 dimension (13C) contained 104 points covering 7700 Hz spectral width or 
61 ppm. The carrier frequencies for F1, F2 and F3 dimensions were at 4.725 ppm, 119.5 ppm 
and 43.0 ppm respectively. 3D CBCA(CO)NH experiment (Grzesiek, Vuister et al. 1993) was 
carried out similarly using the same data points and spectral widths as above, except that the 
F2 dimension (15N) was recorded with 40 points. 
 
2.14.1.3 C(CO)NH-TOCSY and H(CO)NH-TOCSY         
Chemical shifts of all aliphatic 13 C were collected from C(CO)NH experiment (Grzesiek, 
Dobeli et al. 1992) that connected resonance of amide 1H and 15 N with 13C from preceding 
residue’s side-chain. A total of 1024 complex points were recorded over a spectral width of 
8012.8 Hz in the proton dimension (F1). In the amide 15N dimension (F2), 40 data points were 
recorded with spectral width of 1368.7 Hz while 104 data points covering 7700 Hz were 
recorded for the 13C dimension (F3). The carrier frequencies for F1, F2 and F3 dimensions 
were at 4.725 ppm, 118.83 ppm and 40.38 ppm respectively. 
 For H(CO)NH experiment (Montelione, Wuthrich et al. 1992), a total of 1024 
complex points were recorded over a spectral width of 8012.8 Hz in the F1 proton dimension. 
In the amide 15N dimension (F2), 40 data points were recorded with a spectral width of 1368.7 
Hz while 90 data points covering 3000 Hz were recorded for the proton dimension (F3). 
Carrier frequencies for F1, F2 and F3 were at 4.725 ppm, 118.83 ppm and 4.725 ppm. 
 
2.14.1.4 HCCH-TOCSY 
3D HCCH-TOCSY experiment was utilized to identify side-chain spin system by connecting 
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aliphatic 1H resonances with their attached 13C resonances (Wang and Zuiderweg 1995). The 
protein sample used in this experiment was prepared by exchanging 13C-labeled protein with 
deuterated phosphate buffer at pD 7 in 99.9% D2O. A total of 1024 complex points were 
collected for F1 dimension (1H) over 8012.8 Hz spectral width, while F2 dimension 
(indirectly detected 1H dimension) consists of 90 points over 3000 Hz spectral width. F3 
dimension (13C) was recorded with 104 data points over 7700 Hz of spectral width. The 
carrier frequencies for F1, F2 and F3 were at 4.725 ppm, 3.147 ppm and 40.135 ppm 
respectively. 
 
2.14.1.5 NOE distance restraints and hydrogen-bond restraints  
2.14.1.5.1  Hydrogen-deuterium exchange measurement 
Hydrogen bond restraints were determined by recording 1H-15N HSQC of 15N-labeled protein 
exchanged into 100% deuterium oxide buffer using lyophilization technique. The HSQC 
spectrum was acquired similarly as described in section 2.14.1.1. Peaks that appeared on the 
spectrum are the amide protons involved in the hydrogen-bonding with carbonyl groups and 
thus used as hydrogen bond restraints. 
 
2.14.1.5.2  15N-edited NOESY 
Amide proton distance constraints were derived from 3D 15N-edited Nuclear Overhauser 
Effect spectroscopy (NOESY) with 100 ms mixing time. Each cross-peak in a 15N-NOESY 
amide strip represents a NOE between amide protons to a nearby proton within around 5 Å 
distance. 1024 complex points were recorded for the F1 dimension corresponding to the 
directly detected 1H dimension over spectral width of 8012.8 Hz. For F2 dimension detecting 
the 15N, 60 complex points were detected over spectral width of 1650 Hz, while 256 complex 
points were recorded for spectral width of 5500 Hz for F3 dimension (1H). Carrier frequencies 
for F1, F2 and F3 were at 4.725 ppm, 118.19 ppm and 4.725 ppm respectively. 
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2.14.1.5.3  13C-edited NOESY 
13C-edited NOESY was recorded using 13C labeled protein in buffer containing 99.9% D2O 
with a mixing time of 100 ms. In 13C-NOESY, each cross-peaks represents the NOE between 
a nearby proton to the particular proton attached to backbone and side-chain 13 C. A total of 
1024 complex points were recorded for the F1 dimension corresponding to the directly 
detected 1H dimension over spectral width of 8012.8 Hz. F2 dimension detecting the 13C was 
recorded with 128 complex points over spectral width of 7000 Hz, while 256 complex points 
were recorded for spectral width of 4500 Hz for F3 dimension (1H). Carrier frequencies for 
F1, F2 and F3 were at 4.010 ppm, 47.56 ppm and 4.010 ppm respectively. 
 
2.15 NOE assignments and structure calculation 
Some of the NOEs were unambiguously assigned based on the secondary structure 
information derived from Chemical Shift Index (CSI) obtained using the Cα and Cβ chemical 
shifts deviation from the random coil values. NOEs from 15N-edited NOESY were 
particularly useful to identify NOEs between NH-NH and between NH-Hα. For α-helical type 
secondary structure, strong NOEs could be observed between NH(i+4)-Hα(i), and NH(i+3)-Hα(i) 
and these NOEs were not normally observed in β- strands. For β-strands, strong NOEs were 
often observed between Hα(i)-NH(i+1) as well as between amide protons from opposite β-
strands that formed β-sheets. These unique NOEs could  be used to unambiguously assign 
most of the NOEs connecting the backbone protons. 
 Unambiguously assigned NOEs were used to generate initial random structures in 
CNS (Crystallographic/NMR Refinement Software) version 1.1 developed by Brunger et al. 
(1998) to assist in the manual assignment of the remaining 15N-edited and 13C-edited NOE 
restraints which were divided into three groups corresponding to the upper-limit distance 
restraints of 2.9 Å (strong), 3.5 Å (medium) and 5.0 Å (weak). Dihedral angles predicted 
using the TALOS program (Cornilescu, Delaglio et al. 1999) were included as input data 
during the structural calculation. The simulated annealing protocols were set at 2000 steps for 
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the high-temperate annealing stage followed by 5000 steps of cooling stage using torsion 
angle dynamics. The energy minimization and violated constraints were analyzed and refined 
using CNS software. An ensemble of 100 structures was generated with which 20 lowest-
energy conformers were selected to represent the final 3D-fold of Blo t 21. The quality of the 
final structure ensemble was validated  with PROCHECK (Laskowski, Rullmannn et al. 
1996).  
 
2.16 Immunoassay of Blo t 21 
2.16.1 Specific IgE binding ELISA experiment 
For ELISA experiments, all proteins used were GST-tag fusion proteins for maximum binding 
on ELISA plate. The volumes of all reagents and sera used in ELISA experiments were at 100 
μl per well. Sera from patients were diluted at least 1:10 with PBS and pre-absorbed with 5 
mg/ml of GST protein overnight at 4°C. Wild-type Blo t 21 or mutants were coated overnight 
at 4°C onto Maxisorp ELISA plate (NUNC) at 1 μg protein per well. Plates were washed with 
PBS-T (PBS, 0.05% Tween 20) and blocked with PBS-1% BSA for half an hour at room 
temperature. The plates were washed with PBS-T and incubated with pre-absorbed sera for 4 
hours at room temperature. This was followed with three washes with PBS-T. Biotin 
conjugated anti-human IgE monoclonal antibody (BD Pharmingen) diluted 1:250 in PBS-
0.05% Tween 20 was added and incubated for another 2 hours. After washing with PBS-T, 
avidin conjugated HRP (BD Pharmingen) diluted 1:1000 in PBS-0.05%, Tween 20 was added 
and incubated for half an hour. The plates were then thoroughly washed with PBS-T and then 
100 μl of TMB substrate (Sigma Aldrich) was added. The color reaction was detected through 
absorbance measurements at 655 nm using an ELISA plate reader. All experiments were 
carried out in duplicates and results were reported as mean values with standard deviations. 
2.16.2 End-point inhibition ELISA experiment 
In a 100 μl reaction volume, 1 μg of GST-tagged protein was coated onto Maxisorp ELISA 
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plate (NUNC) overnight at 4°C. Sera were pre-absorbed with 5 mg/ml of GST protein and a 
single concentration (100 μg) of GST-tagged protein (inhibitors). After overnight incubation 
at 4˚C, plates were washed with PBS-T and blocked with 4% of full skimmed milk in PBS-
0.1% Tween 20 for 30 minutes at room temperature. The plates were washed again with PBS-
T and incubated with sera pre-absorbed with GST-tagged protein (inhibitors) for 2.5 hours at 
room temperature. Subsequent antibodies incubation and colorimetric development were 
performed as described in section 2.4.1. Results were presented as mean values from 
duplicates with standard deviations. 
 
2.16.3 Peptide ELISA experiment 
All peptides were conjugated with biotin at N-terminal separated by a Acp (Aminohexanoic 
acid) linker (GL Biochem, Shanghai). The volumes of all reagents and sera used in ELISA 
experiments were at 100 μl per well. Sera from patients were diluted at least 1:10 with PBS. 
Wild-type Blo t 21 or mutants were coated 24 hours at 4°C onto Streptavidin coated ELISA 
plates (NUNC) at 1 μg peptide per well. Plates were washed with PBS-T (PBS, 0.05% Tween 
20) and blocked with PBS-1% BSA for one hour at room temperature. The plates were 
washed with PBS-T and incubated with sera for 48 hours at 4°C. Following by washing 3 
times with PBS-T, alkaline phophatase conjugated anti-human IgE monoclonal antibody (BD 
Pharmingen) diluted 1:250 in PBS-1% Tween 20 was added and incubated for 6 hours at 
room temperature. The plates were then thoroughly washed with PBS-T and then 100 μl of 
PnPP substrate (Sigma Aldrich) was added. The color reaction was detected through 
absorbance measurements at 405 nm using an ELISA plate reader. All experiments were 
carried out in duplicates and results were reported as mean values with standard deviations. 
 
2.17 Sub-cloning, expression and purification of Der f 7  
Using specific primers 5’-CGGAATTCGATCCAATTCACTAT-3’ (Derf7_forward) and 5’-
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ATTTTTTTCCAATTCAAGCTTCG-3’ (Derf7_reverse), DNA coding for Der f 7 (from 
residues Asp18 to Asn 213) was amplified by PCR.  The first 17 residues of Der f 7 were 
predicted to be the signal peptide by the SignalP 4.0 server 
(http://www.cbs.dtu.uk/services/SignalP/)(Petersen, Brunak et al. 2011). The DNA fragment 
was subcloned between the EcoR I and Hind III restriction endonuclease sites of a modified 
pET-32a plasmid vector with the S-tag and thioredoxin tag removed and the last two residues 
of the thrombin cleavage site modified to merge with the BamH I site.   
 The correct sequence of the DNA insert was confirmed by sequencing before the 
plasmid was transformed into BL21 (DE3) competent cells for protein expression. Ten 
milliliter of overnight seed culture was inoculated into 1 liter of Luria Bertani broth (with 0.1 
mg/ml ampicillin) and was grown at 37 °C until the OD600 reached 0.6. The protein 
expression was induced with 0.3 mM IPTG and continued to grow a 20 °C overnight. Cell 
suspension was then harvested by centrifugation (4,000 rpm; 30 min, 4 °C) and resuspended 
in 30 ml of Ni-binding buffer (20 mM Tris-HCl, pH 8, 5 mM immidazole and 0.5 M NaCl). 
The cells were lysed by sonication at the amplitude of 38% for 3 minutes (1 second pulse on 
and 0.1 second pulse off) followed by centrifugation at 18,000 rpm at 4 °C for 30 minutes. 
The supernatant was then loaded into the Ni-NTA affinity column and let bind for 1 hour at 4 
°C. After vigorous washing with 500 ml of washing buffer (20 mM Tris-HCl pH 8, 30 mM 
immidazole and 0.5 M NaCl), the protein was eluted slowly using 20 ml of elution buffer (20 
mM Tris-HCl pH 8, 0.5 M immidazole and 0.5 M NaCl). Subsequently, the protein was 
dialyzed against buffer containing 50 mM Tris-HCl pH 8 and 0.5 M NaCl at 4 °C for at least 
16 hours. The overnight thrombin cleavage was carried out by adding 2U protease/mg of 
protein at room temperature after the dialysis. The recombinant Der f 7 without His-tag was 
then passed through a Superdex-200 gel filtration column using the similar buffer used for 
overnight dialysis.  L-selenoMet (SeMet) labeled Der f 7 was expressed using the same 
bacteria strain grown in M9 minimal medium, in which 25 mg/L of SeMet was added when 
the OD600 reached 0.6. Similar purification protocol for native recombinant Der f 7 was 
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implemented for the SeMet labeled Der f 7. 
 
2.18 Circular dichroism (CD) spectropolarimetry of Der f 7 
Circular dichroism experiments were carried out with 15 μM protein (Der f 7 and Der p 7) in 
50 mM Tris-HCl at diffrent pH (pH 4, pH 7 and pH 9). The spectra were acquired with a J-
810 Spectropolarimeter (Jasco, Japan) using a quartz cuvette with 1 mm pathlength (Hellma, 
Germany). The spectra were recorded at wavelength region from 190 nm to 260 nm with 0.1 
nm resolutions using a scan speed of 50 nm/min and a response time of 8 seconds, and were 
averaged over 10 scans. 
 
2.18.1 Thermal denaturation experiments 
Thermal denaturation experiments were carried out for Der f 7 and Der p 7 by recording the 
molecular ellipticity at 220 nm at which the change was most drastic with the increment of 
temperature. Spectra were recorded at the temperature slope of 1˚C/min with the resolution of 
0.1˚C over the range of 55˚C – 95˚C.  
 
2.18.2 Chemical denaturation experiments 
Urea-induced denturation was monitored at 220 nm at which the change was most drastic 
with the increment of urea concentration (M). Each spectrum was represented by and average 
10 scans, with the scan rate of 50 nm/min. The transition curve was plotted with the change of 





2.19 NMR studies of Der f 7 
2.19.1 NMR chemical shift assignments  
3D heteronuclear NMR experiments were carried out to assign the backboneand side-chain 
chemical shifts using a 2D 1H-15N HSQC as a reference spectrum. All NMR experiments were 
carried out on a Bruker AVANCE 800 MHz spectrometer equipped with a cryoprobe. Samples 
were loaded into a 5 mm NMR tube and all experiments were carried out at 313K. All data 
acquired were processed using NMRPipe (Delaglio, Grzesiek et al. 1995) and viewed and 
analyzed using NMRDraw (Delaglio, Grzesiek et al. 1995) and SPARKY (Goddard and 
Kneller). Computational processing was carried out on Dell Precision 360 workstation and 
SGI Origin 300 server. 
 
2.19.2 2D 1H-15N HSQC spectrum 
2D 1H-15N HSQC spectrum was used as a reference for backbone chemical shifts assignments 
by other 3D triple resonance experiments. The spectrum was acquired with 1280 complex 
points over a spectral width of 11160.7 Hz on the amide proton dimension. In the 15N 
dimension, 128 points were collected over 1865 Hz. Carrier frequencies for 1H and 15N were 
at 4.7 ppm and 117.5 ppm respectively. 
 
2.19.2.1 HNCACB and CBCA(CO)NH 
Backbone assignments were carried out  using HNCACB and CBCA(CO)NH experiments as 
described earlier in section 2.3.1.2. In the acquired F1 dimension (1H) of the experiment, 1280 
points were collected over 11160.7 Hz spectral widths. In the F2 dimension (15N), 92 points 
were collected over 1865 Hz of spectral width while the F3 dimension (13C) contained 116 
points covering 12072.4 Hz spectral width. The carrier frequencies for F1, F2 and F3 
dimensions were at 4.7 ppm, 118.5 ppm and 41.7 ppm respectively. 3D CBCA(CO)NH 
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experiment (Grzesiek, Vuister et al. 1993) was carried out similarly using the same data points 
and spectral widths as above, except that the F2 dimension (15N) was recorded with 40 points. 
 
2.19.3 Ligand binding and pH titration studies of Der f 7  
For ligand binding studies, the highly purified Der f 7 was dialyzed into 50 mM Tris buffer at 
pH7 and concentrated to 0.5 mM. 2D 1H15N-HSQC spectrums were acquired at 4 scans using 
similar parameters as described in section 2.19.2 with and without addition of polymyxin B 
(PB) at 1:1 dilution. For pH titration studies, the 15N-labeled Der f 7 was prepared in 50 mM 
Tris pH 7 at 0.25 mM protein concentration. The 2D 1H15N-HSQC spectrum was acquired 
similarly as described. Subsequently, the pH was adjusted using 0.1M NaOH solution, with 
the pH increased by approximately 0.5 for each titration until the final pH reached 9. Peaks 
perturbation during the pH change from 7 to 9 were estimated using the formula: 
√(ΔH)2+(ΔN*0.17)2 and plotted against residue numbers. 
 
2.19.4 15N relaxation studies of Der f 7 
The steady-state heteronuclear 1H-15N NOE experiment was carried out in an interleaved 
manner, with and without proton saturation (NOEon, NOEoff). The NOE effect was calculated 
as an error weighed average ratio of the peak intensities, with an error estimate obtained by 
propagating the base-plane noise. 
 
2.20 Crystallization of Der f 7 
 The highly purified protein was dialyzed into 10 mM HEPES pH 7 and concentrated 
to 8 mg/ml with an Amicon filter (Milipore, 10-kDa molecular weight cut-off) before 
crystallization.  Crystallization screening for the native Der f 7 was carried out using Index 
Screens (Hampton Research) employing the hanging-drop vapor-diffusion technique at 298 K 
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with 1 µl protein solution (8 mg/ml) and 1 µl reservoir solution. The initial crystal was 
obtained after ~24 hours from the reservoir solution containing 0.1 M Bis-Tris pH 7 and 28% 
Polyethylene glycol monomethyl ether (PEG MME) 2000. The crystallization was further 
optimized by varying the pH of the reservoir buffer, the concentration of the protein as well as 
the crystallizing temperature. Preliminary diffraction data using the native Der f 7 crystal 
were collected with an in-house X-ray machine (Bruker MICROSTAR X-ray generator and 
PLATINUM135 CCD detector) for screening of the best conditions for crystallization.   
 Crystallization of the SeMet was optimized based on the conditions used for 
crystallization of the native Der f 7.   The best diffracting crystals of recombinant Der f 7 were 
grown from a reservoir solution consisting of 0.1 M Bis-Tris pH 7.4 and 28% PEG MME 
2000 at 293 K. The SeMet crystal was selected for diffraction data collection using the 
synchrotron light source. 
 
2.21 Data collection and structure solution of SeMet Der f 7 
 The best crystal of SeMet labeled Der f 7 was picked up in a clean nylon loop and 
flash-cooled at 100 K in a nitrogen-gas stream without adding any cryoprotectant solution.  
Synchrotron data were collected at BL-13B beamline, NSRRC - National Synchrotron 
Radiation Research Center, Taiwan (NSRRC) Taiwan. X-ray fluorescence spectra recorded 
for the crystals of SeMet Der f 7 near the Se absorption edge were analyzed with the program 
CHOOCH.  Subsequent data set processing was done using the HKL-2000 program suite. 
Structure was solved by molecular replacement technique using PHASER program from the 
CCP4 suite (McCoy, Grosse-Kunstleve et al. 2007). Der p 7 (PDB code 3H4Z, sequence 
identity = 86%) was used as the search model. Model building was performed using the 
COOT program (Emsley and Cowtan 2004) and refinement was carried out using PHENIX 




2.22 Structure-based alignment and comparison  
Class Architecture Topology Homology (CATH) server (http://cathwww.biochem.ucl.ac.uk) 
developed by Pearl and coworkers was employed for pairwise sequence-based alignment 
(Pearl, Todd et al. 2005). For multiple 3D structure-based comparison, the DALI program was 
used (http://www.ebi.ac.uk/dali) (Holm and Sander 1998). 
 
2.23 Immunoassay for Der f 7 and Der p 7 
All immunoassays were done using the similar protocol as described in section 2.4.1 and 
2.4.2, except that Ni-NTA HisSorb™ ELISA plates (QIAGEN) were used instead of 
Maxisorp™ plates (NUNC). All proteins were His-tagged and prepared in 1 X PBS buffer. 













CHAPTER 3  BLOT21: RESULTS & DISCUSSION 
 
3.1 Resolving Blo t 21 Structure using NMR 
 
3.1.2 2D 1H-15N HSQC spectra of Blo t 21 
The two-dimensional (2D) 1H-15N HSQC spectrum showed a good dispersion of amide peaks 
with most of them having similar intensities (Figure 3.1). We counted ninety four amide peaks 
out of the predicted ninety six, residues Thr-19 and His-25 (second and eight residues in the 
modified construct) were missing in the 2D 1H-15N HSQC spectrum. It was later revealed that 
these residues were actually located near the N-terminus (Thr-19) and the small turn between 
Arg-23 and Glu-26 (His-25). We were able to locate these residues in other 3D spectrums 
(CC(CO)NH, HC(CO)NH and 15N-edited NOESY) and included them in the final structure 
calculation. Five peaks were particularly weak in the HSQC spectrum, i.e. residues Asn-18, 
Ala 20, Gln-22, Arg-23 and Thr-78. The first four residues were located in the N-terminus 
region while residue Thr-78 was located in the flexible loop between helices α2 and α3 of the 
protein. Overall, the overlapping of peaks was minimal in the 2D 1H-15N HSQC, and the 






























3.2 Sequence-specific assignment of Blo t 21 
3.2.1 Backbone and side-chain assignments 
Backbone chemical shifts were assigned using HNCACB and CBCA(CO)NH triple 
resonance experiments. First, we correlated all the amide peaks with the Cα and Cβ 
resonances of the same residue using the HNCACB spectrum (Figure 3.2A). Next, 
CBCA(CO)NH spectrum was used to correlate the amide peaks with the Cα and Cβ of the 
preceding residue (Figure 3.2B). The amide peaks were then linked together based on the 
chemical shifts of Cα and Cβ in both spectrum and then fitted into the sequence of Blo t 21 
Figure 3.1 Two Dimensional 1H-15N HSQC of Blo t 21. 98% amide cross-peaks of
Blo t 21 in the 2D 1H-15N HSQC spectrum were well resolved and have been
successfully assigned sequentially. Each peaks represents an amino acid and labeled








aided by the signature Cα and Cβ chemical shifts values of certain amino acids. For example, 
Ser and Thr residues have unique Cβ chemical shifts values that are higher than their Cα. In 
the HNCACB spectrum, Cβ of Ser and Thr cross-peaks are represented as a negative peak, 
thus, they can be easily identified in the amide strips. Another typical residue used for initial 
fitting is Ala, owing to its unique Cβ chemical shift values thatusually appeared at ≤20 ppm, 
much lower than other residues. Finally, Gly residues were also particularly helpful as there 
was only a Cα cross peak appearing in the HNCACB spectrum. 
 The backbone amide peaks of Blo t 21 were successfully assigned based on the 
information provided by the aforementioned experiments as well as the knowledge of the 
protein sequence. The sequential assignment of the amide peaks in the 2D 1H-15N HSQC was 
shown in Figure 3.2. The strip plots generated  with SPARKY software during the sequential 
assignment for the backbone amide peaks. Figure 3.2 showed an example of the sequential 
assignment displayed in the strip plots from residues Leu-41 to Arg-50 in Blo t 21. The Cα 
and Cβ chemical shift values were assigned for all residues accountable in the 2D 1H-15N 
HSQC. The assignment for the remaining chemical shifts for side-chain carbon was done 

































Figure 3.2 Sequential assignment of backbone chemical shifts of Blo t 21. A) Strip plots of 
HNCACB experiment, showing amide strips with Cα and Cβ resonances of the same residue 
from residues Leu-41 to Arg-50. Negative peaks correlated to Cβ resonances were displayed 
in red. B) CBCA(CO)NH experiment showing amide strips correlating Cα and Cβ resonances 
of the preceding residue.  
 
 
 In CC(CO)NH experiment, each amide strip correlateed the amide of a residue with 
all the aliphatic side-chain carbon chemical shifts of the preceding residue. The completeness 
of the backbone amide, Cα and Cβ chemical shifts assignment for all residues enabled the 
assignment of the remaining side-chain chemical shifts to be done easily based on the 
statistically calculated chemical shift values available in the Biological Magnetic Resonence 





checking of the sequential assignment for backbone amide. For example, the Cδ chemical 
shift of Ile and Leu residues usually appears at below 14 ppm; and Thr residue has a Cγ 
chemical shift which appears at around 20 ppm, distinguishing it from the Ser residue. For 
side-chain proton chemical shifts assignment, H(CCO)NH experiment was primarily used  as 
it can correlate the amide peak with protons from the preceding residue. Additionally, HCCH-
TOCSY experiment was also used to observe the linkage between side-chain carbons to its 
proton.  
 
3.2.2 Chemical shift index (CSI) 
Chemical Shift Index (CSI) employs the chemical shift values of all Cα and Cβ to determine 
the secondary structure of the protein and their boundaries (Wishart and Sykes, 1994). The 
deviation of the experimental Cα and Cβ chemical shift values against the random coil values 
for each specific type of amino acid was calculated based on following formula: 
 
                                           CSI = (Cα - CαRC) - (Cβ – CβRC) 
 
Cα = experimental chemical shifts of C-alpha 
Cβ = experimental chemical shifts of C-beta 
CαRC = standard random coil chemical shift values of C-alpha of the same residue 
CβRC = standard random coil chemical shift values of C-beta of the same residue 
 
The CSI for each amino acid residues was plotted against the residue numbers in a bar chart. 
In a typical CSI plot, a positive value represents α-helix secondary structure while a negative 
value would represent a β-strand region (Wishart, Sykes et al. 1992).  
 The CSI plot for Blo t 21 is shown in Figure 3.3. Based on the definition of the CSI 
value as described, Blo t 21 comprised of three α-helices probably connected by two tight 
turns or loops. The presence of three α-helical secondary structures agreed with the solved 
structures of the paralogous group 5 allergens, i.e. Blo t 5 (Naik, Chang et al. 2008) and Der p 
5 (Mueller et al. 2010), which adopted a triple helical bundle tertiary structure. Based on the 
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amino acid sequence identity (>31%), Blo t 21 could be sharing the similar folding topology 














3.2.3 NOE assignment by CNS 
The NOE assignment of Blo t 21 was completed manually using CNS (Crystallography/ 
NMR System) developed by Brunger et al (1998). For the initial structure calculation, only 
the unambiguously assigned NOEs were included, with a majority of short and medium range 
NOEs, as well as a few long-range NOEs. The long-range NOEs could be identified in both 
15N-edited and 13C-edited NOESY as well as the 2D-NOESY spectrums. The 15N-edited 
NOESY provided the spatial connectivity among the side-chain protons and the backbone 
amides while the side-chain-to-side-chain protons’ connectivity was identified in the 13C-
edited NOESY experiments. The 2D-NOESY experiment (using 100% deuterated NMR 
buffer) was especially useful in identifying the long-range NOEs between the aromatic amino 
acid residues (six Phe and one Tyr residues were present in Blo t 21) and other spatially 
connected residues (Figure 3.4A). Interestingly, only one Phe and Tyr residues were present in 
Figure 3.3 Chemical Shift Index of Blo t 21 generated using the chemical shift values of
all Cα and Cβ extracted from the triple resonance experiments. The overall plot indicates
that at least three α-helices are present in Blo t 21.  
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Blo t 5. The substitution of Phe residues in Blo t 21 may influence its overall folding as Phe 
amino acid was known to form important hydrophobic interactions within the core of a 
protein (Vondrasek, Bendova et al. 2005; Berka, Hobza et al. 2009). Based on the CSI plot as 
well as the circular dichroism experiments, Blo t 21 should contain predominantly α-helical 
secondary structure. Therefore, the typical NOE pattern for α-helical structure, i.e. dαN(i, i+3) 
and dαβ(i+3) were unambiguously assigned and used for the structural calculation. The initial 
structure of Blo t 21 that was calculated using the unambiguously assigned NOEs was used as 
a reference to assist in further assignment of the remaining NOE cross-peaks.  
 The statistics of the final NMR structure of Blo t 21 are shown in Table 3.1. A total of 
1729 NOEs was included for the structure calculation using CNS. Most of the NOEs assigned 
were intra-residue NOEs and sequential NOEs; about 216 NOEs were belonged to long-range 
NOEs. Few long-range NOEs were expected as Blo t 21 assumed a relatively simple triple α-
helical bundle tertiary structure. We used the CSI plot to aid in identifying the residues that 
were involved in forming the α-helical secondary structure. For instance, residue His-36 
should be located in the α-helical region, and based on the 15N-edited NOESY spectrum, its 
amide proton shows a typical α-helical NOE cross-peaks pattern, i.e. NH-NH NOEs were 
observed from residues Thr-35, Glu-37 and Val-38, as well as several other NOEs between 
NH of His-36 and Hα, Hβ from Thr-35. Some weak NOEs from the Hγ of residues Leu-32, 
Thr-35 and Glu-37 could be observed as well. The distance constraints were manually 
included for the structure calculation depends on the intensities of the NOE peaks observed in 
the NOESY spectra. In the example presented, the NOEs from Thr-35 and Glu-37 amides 
were considered “strong” while the NOE from residue Val-38 was considered “weak”. All 
ambiguous protons were considered as pseudo-atoms and labeled with “#” since there was no 
























Figure 3.4 Assignment of NOESY spectrums. A) showed aromatic strips from 2D-NOESY 
spectrum acquired using deuterated NMR buffer. B) showed amide strips from 15N-NOESY. 
Residue His-36 is shown as a representative for residues in α-helix. 
 
3.3 NMR Structure of Blo t 21 
 The cDNA of Blo t 21 was modified by removing the N-terminus signal peptide 
(sixteen hydrophobic residues) and an additional seventeen amino acid residues based on the 
sequence alignment with Blo t 5. The 3D structure of Blo t 5 showed that this region (Leu-1 – 
Val-17) is unstructured and significant improvement of the 2D 1H15N-HSQC spectra could be 
achieved by excluding it from the construct of Blo t 21. Similar removal of the N-terminus 
flexible region based on sequence alignment was conducted on Der p 5 (PDB: 3MQ1), 















It was also shown that the exclusion of this flexible region did not affect the IgE binding 
(Mueller, Edwards et al. 2010). The NMR sample of Blo t 21 was prepared as mentioned in 
the previous chapter and did not show visible precipitation and degradation within 48 hours. 
Multiple additional peaks were observed in the 2D 1H-15N HSQC indicated that Blo t 21 
started to degrade after 48 hours. Therefore, fresh samples were prepared for subsequent 
experiments to ensure the accuracy of the data collected. 
 The 3D structure of Blo t 21 was determined by employing the angle and distance 
restraints derived from a series of heteronuclear multidimensional NMR experiments as 
described in chapter 2. About 98% of the backbone amides and 97% of the nonlabile and non-
aromatic protons were successfully assigned. A total of 1729 NOE restraints and 171 TALOS 
angle restraints were used to calculate the 3D structure of Blo t 21 using the CNS software. 
More detailed statistics of the solution structure can be seen in Table 3.1. The final structure 
wass represented as a 20 lowest-energy CNS conformer with backbone and all R.M.S.D of 
0.82 +/- 0.22 Å and 1.61 +/- 0.17 Å respectively (Figure 3.5A). Overall, the 3D structure of 
Blo t 21 consists of three α-helices aligned in an antiparallel, clockwise manner, forming an 
elongated helical bundle. Individual helices are composed of residues Thr 19 - Thr 44 (α1), 
Glu 49 – Glu-74 (α2) and Leu 82 - Asp 111 (α3), respectively, connected by two tight turns, 
encompassing residues Gly 45 – Asp 48 (L1) and Leu 75 – Asp-81 (L2) (Figure 3.5C). 
Additionally, there is a short “kink” observed in the N-terminus helices, between residues 
Arg-23 and Glu-26. This peculiar structure was further validated by re-examination of the 
NOESY spectrum, in which no NOE pattern suggesting the formation of α-helical secondary 
structure could be observed (Figure 3.5B). Like most of the other inhalant allergens, Blo t 21 
contains a fairly high percentage of basic (15%) and acidic (20.4%) residues. The surface of 
the Blo t 21 is highly charged with predominant distribution of surface exposed acidic 
residues (Figure 3.5D). An overlay of Blo t 21 with Blo t 5 yielded a Cα R.M.S.D of 3.39 Å,  
indicating similar folding topology but different local structures, i.e. side-chain orientations.  
 The 3D structure of Blo t 21 is, not surprisingly, very similar to that of Blo t 5 (PDB: 
2JMH). However, some differences could be observed when both structures were analyzed in 
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detail. For instance, the total number of long-range NOEs that could be unambiguously 
assigned in Blo t 21 is 216, compared to 156 that were reported by Naik and coworkers 
(2008). The extra long-range NOEs found in Blo t 21 are most likely contributed by the 
aromatic side chains. There are six Phe and one Tyr residues found in Blo t 21 compared to 
only one Phe and Tyr found in Blo t 5. Among six Phe residues, three are located in the 
hydrophobic core of Blo t 21, which suggests apparent involvement in the contribution of 
hydrophobic interactions. Indeed, a handful of long-range NOEs could be identified from the 
aromatic side chains of these residues based on the 2D-NOESY spectrum obtained using the 
deuterated buffer. A more detailed comparison between the 3D structure of Blo t 21 and Blo t 
5 will be presented in the following section. 
A. Experimental Restraints  
Total NOEs 1729 
   Intraresidues (i,j) 523 
   Interresidue, sequential (|i, j| = 1) 454 
   Interresidue, medium range (1< (|i-j| ≤ 5 )     416 
   Interresidue, long-range (|i-j| ≥ 5 216 
   Hydrogen-bond restraints 21 
Dihedral angle restraints (φ, ψ) 171 
B. Violations (mean ± s.d.)  
    Distance constraints (Å) 0.02 ± 4e-04 
    Dihedral angle constraints (˚) 0.18 ± 0.02 
Deviations from idealized covalent geometry  
    Bond lengths (Å) 0.002 ± 6e-05 
    Bond angles (˚) 0.41 ± 0.005 
    Impropers (˚) 0.33 ± 0.01 
Average pairwise r.m.s. deviation  
    Back bone (Å):  0.82 +/- 0.22 
    Heavy atom (Å):  1.61 +/- 0.17 
C. PROCHECK Ramachandran plot analysis (%)  
   Most Favored Regions (%) 92.3 
   Additional Allowed Regions (%) 6
   Generously Allowed Regions (%) 0.4 
   Disallowed Regions (%) 1.3 
 
Table 3.1 The Overall Statistics of 20 lowest-Energy Ensemble of Blo t 21 NMR 
Structure. A total of 1729 NOE restraints and 171 TALOS angle restraints were included in 
the structure calculation. The overall violations are minimal and most of the residues located 

























3.4   3D structures comparison of Blo t 21 with Blo t 5 and Der p 5 
 The 3D structures of Blo t 5 and Der p 5 were resolved using NMR and X-ray 
crystallography, respectively. (Naik, Chang et al. 2008; Mueller, Edwards et al. 2010). Both 
proteins consist of three α helices aligned in an antiparallel, clockwise fashion. The 
superimposition of the 3D structures of Blo t 21 with Blo t 5 and Der p 5 yielded the Cα 
R.M.S.D of 2 Å and 3.39 Å, respectively (Figure 3.6A and 3.6B). The overall folding 




Figure 3.5 NMR Structure of Blo t 21. A) Twenty lowest energy ensembles of NMR
structure of Blo t 21. B) 3D structure of Blo t 21 shown in ribbon diagram. C) Secondary
structure topology of Blo t 21. D) Surface charge diagram of Blo t 21 generated using
software MOLMOL (Koradi, Billeter et al. 1996) 
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the N-terminus α-1 is apparently different in these proteins. 
 In Blo t 5, the N-terminus α-1 is more inclined to α-2, while in Blo t 21, the N-
terminus α-1 is aligned in parallel to α-3, with a small “kink” between Arg-23 and Glu-26, 
which is absent in Blo t 5 (Figure 3.6A). The dimerization of Der p 5 as indicated in the 
crystal structure was proposed to be concentration and pH dependent. It was confirmed that 
Der p 5 was predominantly monomeric at neutral pH and low concentration using solution 
scattering techniques. The N-terminus α-1 of Der p 5 was completely detached from both α-2 
and α-3 and interacted with the N-terminus α-1 from another molecule to form a dimer 
(Mueller, Gosavi et al. 2010). In addition, a study on Der p 21, another group 21 allergen from 
D. pteronysinnus suggested that this protein could also form a dimer, based on the small-angle 
X-ray scattering experiments (Weghofer, Dall'Antonia et al. 2008). However, there is no 
experimental evidence suggesting that Blo t 21 is capable of oligomerization, at least at 
neutral pH. Our NOESY spectrums also did not show any plausible inter-molecular 
interaction to enable the dimerization of Blo t 21. Instead, many long-range NOEs, especially 
those from 13C-edited NOESY spectra, could be unambiguously assigned among the three α-
helices in Blo t 21, which disprove the possible “splaying” of the N-terminus α-1 in order to 
accommodate another molecule as indicated by the Der p 5 crystal structure. Nevertheless, the 
α-2 and α-3 of Der p 5, Blo t 5 and Blo t 21 are very similar. Interestingly, the α-2 and α-3 of 
Der p 5 and Blo t 21 (Figure 3.6B) seemed to be superimposed much better as compared to 































3.5   The Allergenicity of Blot 21 Compared to Blo t 5, Der p 5 and Der f 21 
 The studies on the allergenicity of Blo t 5 compared to Der p 5 were conducted by 
Kuo and coworkers in 2003. Direct ELISA experiments conducted on two different 
populations (Taiwanese and Malaysian) demonstrated low correlation of IgE reactivity 
between Blo t 5 and Der p 5. In addition, the authors had also investigated the cross-reactivity 
between these two allergens. Both heterologous absorption and dose-response inhibition 
studies demonstrated that Blo t 5 and Der p 5 reacted with unique IgE epitopes. Besides the in 
A. B. 
C. 
Figure 3.6 Superimposition of the NMR structure of Blo t 21 (Cyan) with A) Blo t 5
(Green) and B) Der p 5 (Red) yielding the Cα r.m.s.d. of 3.39 Å and 2 Å, respectively. C)
The α-2 and α-3 of three proteins are very similar but their N-terminus α-1 are oriented in




vitro experiments, in vivo skin prick test was also employed to further evaluate the IgE cross-
reactivity of these two allergens. The test revealed significant levels of differential reactivity 
between Blo t 5 and Der p 5 when tested on nineteen asthmatic children, with Blo t 5 elicited 
the overall bigger diameter of erythema and wheal, which implied higher allergenicity. In 
conclusion, this study suggested that Blo t 5 and Der p 5 were two distinctively different 
allergens (Kuo, Cheong et al. 2003). 
 In this section, we compare the allergenicity among Blot 21, Blo t 5, Der p 5 and Der 
f 21. As mentioned earlier, the allergenicity and the cross-reactivity of Blo t 5 and Der p 5 
were shown to be low and thus, these proteins should use distinct IgE epitopes (Kuo, Cheong 
et al. 2003). The properties of Der p 21, another group 21 allergen from dust mite D. 
pteronysinnus were reported by Weghofer and coworkers in 2008. Der p 21 shared 69% 
amino acid sequence identity with Der f 21, and it was shown to highly react to patients' IgE 
antibodies. This allergen also demonstrated high level of allergenicity based on the basophil 
activation experiments. Despite the average sequence identity of approximately 40% with 
group 5 allergens from dust mite (Der p 5, Blo t 5 and Lep d 5), Der p 21 exhibited no 
relevant cross-reactivity with any of the group 5 allergens tested. The comparison in terms of 
allergenicity among the group 21 allergens from dust mites has not been reported thus far. It 
would be interesting to investigate the allergenicity as well as the cross-reactivity between 
Blo t 21 and Der f 21, which share 32% sequence identity. In our study, Der f 21 was used in 
place of Der p 21 as the latter was not available.  
 The allergenicity of an allergen depends predominantly on the distribution of surface 
exposed residues, which is closely associated to its 3D structure. The structural properties and 
the sequence identity of Blo t 21, Der f 21, Blo t 5 and Der p 5 were compared in the previous 
sections. Overall, these proteins consist of three α-helices arranged in an antiparallel fashion 
separated by two flexible loops; and they share the protein sequence identity ranged from 26 – 
39%. However, despite these similarities, they differ significantly in terms of allergenicity. As 
shown in Figure 3.7, Blo t 5 has the overall highest allergenicity followed by Blo t 21, Der f 
21 and Der p 5. There are some exceptional cases such as sera P3 and P12, which 
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weresignificantly more sensitized against Blo t 21 compared to Blo t 5. Other examples are 
sera P6 and P10, which demonstrated higher sensitivity to Der f 21 when compared to Blo t 
21. In general, these results suggest that all these proteins could interact with the IgE 
antibodies in different manners, and different sera would present distinct binding profiles to 
















 The low correlation of the IgE reactivity was quite unexpected as the putative IgE 
epitopes mapped on Blo t 5 are highly conserved in Blo t 21, Der p 5 and Der f 21 as shown 
in the sequence alignment (refer to section 3.7). The disparity in terms of allergenicity 
between Blo t 21 and Blo t 5 could be due to the distribution of the IgE epitopes in these 
proteins based on their 3D structures. Moreover, the additional unique epitope that could be 
present in Blo t 21 would also contribute to the interaction with different IgE antibodies. The 
overall lower allergenicity of Der p 5 could be explained by the substitution of residue Glu for 
Leu at the position corresponding to Glu-76 in Blo t 5. However, the allergenicity profile of 
Figure 3.7 The allergenicity of Blo t 21, Der f 21, Der p 5 and Blo t 5. Overall, Blo t 5
(white bars) has the highest allergenicity among all sera, followed by Blo t 21 (black bars),
Der f 21 (dark gray bars) and Der p 5 (light gray bars). All proteins were tagged with GST




Der f 21 could not be comprehended because even though all the putative IgE epitopes 
mapped in Blo t 5 are conserved in this allergen, Der f 21 did not seem to behave similarly as 
either Blo t 5 or Blo t 21. This phenomenon was especially prominent in sera P8, which 
showed no sensitivity to Der f 21 despite the evidently high reactivity to Blo t 5 and Blo t 21. 
Based on these results, Der f 21 should be a unique allergen that uses different IgE epitopes to 
exhibit its allergenicity. 
 In an attempt to investigate the discrepancies of the allergenicity among Blo t 21, Der 
f 21, Blo t 5 and Der p 5, we have conducted several experiments including cross inhibition 
assays and direct ELISA experiments using the whole proteins as well as the peptides derived 
from these proteins. The details of these experiments will be presented in the late sections. 
 
3.6 Study on the stability of Blo t 21, Der f 21, Blo t 5 and Der p 5 
3.6.1 Circular Dichroism  
 The 3D structures of Blo t 21, Blo t 5 and Der p 5 have been solved and we found that 
these proteins, despite sharing similar tertiary fold and moderate sequence identity with each 
other (>31%), are in fact quite different in certain aspects, i.e. the alignment of the helices and 
side chains orientations. The slight differences in the structures could suggest different 
properties, including the allergenicity of the proteins. Indeed, in the previous section, we 
showed that the allergenicity of Blo t 21, Der f 21, Blo t 5 and Der p 5 were very different. 
Here, we present the CD spectrums and the stability tests on these proteins. These 
experiments are especially important for Der f 21 as no structural information is available for 
this protein. Der f 21 shares relatively lower sequence identity with Blo t 21 (32%), Blo t 5 
(35%) and Der p 5 (26%), thus, it was probable that this protein possesses different structural 
properties. Since the 3D structure of Der f 21 is not available, it would be interesting to study 
the secondary structure and the stability of this protein in comparison with Blo t 21, Blo t 5 
and Der p 5 using CD experiments.  
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All GST-tags were removed from each protein using thrombin and purified by the gel 
filtration column; the highly purified proteins were dialyzed against 1 X PBS buffer prior to 
the far-UV CD experiments. The CD spectrums were overlaid as shown in Figure 3.8. In 
general, all proteins have typical α-helical secondary structures with double minimal peak at 
~208 nm and ~222 nm. A closer examination of the spectrums indicated that the minimal 
peaks of these proteins were not identical, which usually meant that the content of the α-
helical structures were different in these proteins (Johnson 1990). Indeed, the 3D structures of 
Blo t 21, Blo t 5 and Der p 5 were quite different as discussed earlier. The CD spectrum of 
Der f 21 showed slightly different “dip” in minimal peaks compared to the other three 
proteins. This result suggested  that Der f 21 should be sharing similar secondary structures 












3.6.2 Thermal denaturation experiment 
We sought to investigate the stability of Blo t 21 compared to Blo t 5, Der p 5 and Der 
f 21 using the CD thermal denaturation experiment. All proteins were subjected to heat 
denaturation at 90°C and subsequently cooled down to 25°C while the spectrums were 
recorded (Figure 3.9). As it can be seen, all proteins were unfolded at 90°C based on the 
Figure 3.8 The CD spectrum of Blo t 21, Der f 21, Blo t 5 and Der p 5. All proteins
showed typical α-helical CD profile with two minimum peaks at wavelength 208 nm and 222
nm. The CD spectrums were acquired using similar parameters and all proteins were buffered
with 1 X PBS.   
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increase in the molecular ellipticity (mdeg). However, when the temperature was reduced to 
25°C, only Der p 5 and Der f 21 appeared to be fully renatured (Figure 3.9B and 3.9C); Blo t 
5 seemed to be able to partially refold while Blo t 21 remained unfolded when the temperature 
was reduced (Figure 3.9A and 3.9D). The ability of the protein to refold largely depends on its 
primary sequence (Anfinsen 1973). The content of the solvent in which the protein is 
subjected to the temperature and the presence of a molecular chaperon are also the crucial 
factors that govern the protein folding. The sequence identity between Der p 5 and Der f 21 is 
only 26%, much lower than the 39% shared between Blo t 21 and Blo t 5. The refoldability of 
Der p 5 and Der f 21 could be due to the content or the arrangement of the hydrophobic 
residues in their primary sequences, which was obviously different compared to Blo t 21 and 
Blo t 5 based on their sequence alignment. This phenomenon could be important if the IgE 
epitopes on Der f 21 and Der p 5 were conformational; such resiliency would be a problem as 


















Figure 3.9 The CD spectrum of Blo t 21, Der f 21, Blo t 5 and Der p 5 at different
temperatures. All proteins are denatured at 90°C. B) Der f 21 and C) Der p 5 could be
renatured when the temperature is allowed to cool down from 90°C to 25°C. While A) Blo t
21 could not be renatured and D) Blo t 5 could be partially renatured. 
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 Thermal-induced protein unfolding was monitored by CD approach within the range 
from 30°C to 95°C. Figure 3.10 showed that the stability of Der f 21 is the highest (Tm = 
~87°C), followed by Der p 5 (Tm = ~73°C), Blo t 21 (Tm = ~ 54.5°C) and Blo t 5 (Tm = 
~51.4°C). Similarly, Weghofer and coworkers reported high thermal stability of Der p 21, a 
homologous protein of Der f 21 (Weghofer, Dall'Antonia et al. 2008). In addition, the authors 
also reported the refoldability of Der p 21 using similar experiments. Der f 21 and Der p 21 
shares 69% amino acid sequence identity, which could explain their similar thermal stability. 
In the same study, it was also demonstrated that Der p 21 and group 5 allergens from dust 
mite (Der p 5 and Lep d 5) showed limited cross-reactivity. Owing to its high sequence 
identity with Der p 21, it is possible that Der f 21 share low cross-reactivity with group 5 
allergens from dust mites as well. Furthermore, our results indicated that Der f 21 does not 
highly cross-react with Blo t 21, thus making Der f 21/Der p 21 a distinctively different 
allergen from dust mite. The details of the cross-reactivity between Blo t 21 and Der f 21 will 
be presented in the section 3.12.4. 
 In summary, our results show that Der f 21 and Der p 5 are much more stable than 
Blo t 21 and Blo t 5. Both proteins exhibit remarkable refoldability that was not observed in 
Blo t 21 and Blo t 5. The refoldability of Der f 21 and Der p 5 could be important for their 
allergencity, depends on the nature of their IgE epitopes, which remained elusive thus far. Our 
results show that the allergencity of Der p 5 is generally lower compared to Blo t 5, which 
agreeed with the previous finding (Kuo, Cheong et al. 2003); while the allergenicity of Der f 
21 was comparable to Blo t 21 in some cases. There seemed to be a correlation between the 
stability and the allergenicity among Blo t 21, Der f 21, Blo t 5 and Der p 5: Der f 21 and Der 
p 5 showed higher stability but generally lower allergenicity while Blo t 21 and Blo t 5 were 
less stable but demonstrated significantly higher allergenicity. Despite the lower allergenicity, 
a highly stable allergen tends to persist longer in the environment while maintaining its 
allergenic properties, hence heighten the chances of exposure to the atopic individuals. The 
remarkably higher stability of Der f 21 and Der p 5 could be one of the factors that allowed 

















3.7 Site-directed mutagenesis and IgE epitope mapping of Blo t 21 
The multiple sequence alignment was carried out using the group 21 and group 5 
allergen from different species of dust mite that are available in the National Center for 
Biotechnology Information (http://www.ncbi.nlm.nih.gov/) and Allergome 
(http://www.allergome.org) data bank. There are several isoforms exist for each of these 
allergens (isoallergen), i.e., allelic polymorphisms that result in substitutions of amino acid at 
certain positions in the allergen (Christensen, Riise et al. 2010). Only one of each variant that 
was cited in other publications was selected for sequence alignment analysis. Group 21 
allergen isolated from three species of dust mite, i.e. B. tropicalis (Blo t 21), D. pteronyssinus 
(Der p 21) and D. farinae (Der f 21); and group 5 allergens identified in five species of dust 
mites, i.e. B. tropicalis (Blo t 5), D. pteronyssinus (Der p 5), D. farinae (Der f 5), 
Lepidoglypus destructor (Lep d 5), Aleuroglyphus ovatus (Aleo 5), Suidasia medanensis (Sui 
m 5.02) and Tyrophagus putrescentiae (Tyr p 5.01) were chosen for the analysis. 
Figure 3.10 Thermal denaturation experiment for Blo t 21, Der f 21, Der p 5 and Blo t 5.
Among four proteins, Der f 21 has the highest melting temperature (Tm) of ~ 87°C, followed
by Der p 5 with the Tm of ~ 73°C. The Tm of Blo t 21 and Blo t 5 are quite similar, which are
~ 54.5°C and ~51.4°C, respectively.  
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Subsequently, multiple sequence alignment was conducted by employing CLUSTALw 
software (Higgins 1994).  
 As shown in Figure 3.11, residues which share different biochemical properties such 
as Lys in group 21 allergens compared to Gln, Gly or  Ala in group 5 allergens (first boxed 
residues), are selected for the mutagenesis studies. The selection of these residues was based 
on the inhibition assay conducted by Gao et al. (2007) showing that Blo t 21 and Blo t 5 were 
cross-inhibiting each other at a low-to-moderate level. Cross inhibition of the allergens is 
decided by the mutual sharing of IgE epitopes, thus, if both allergens are sharing the residues 
that interact with the same IgE antibodies, they should highly cross-react to each other. For 
example, IgE antibodies binding to peanut allergens, Ara h 1, can cross-react with 
homologous proteins in other legumes like Gly m 1 from soybean (Sicherer and Sampson 
2000). Conversely, low cross inhibition is often attributed to the usage of different residues in 
IgE binding. In general, charged amino acid residues are considered as the most likely 
candidate for IgE binding as most of them are solvent accessible. Based on these criteria, 
eighteen amino acid residues were chosen for the subsequent mutagenesis studies. Four amino 
acid residues that are gray shaded in Figure 3.11 were chosen based on the IgE epitope 
mapping on Blo t 5 conducted by Chan et al (2008). These residues were described as a linear 
epitope found in Blo t 5 based on multifaceted immunoassay. Interestingly, all these residues 
are highly conserved across all group 21 and group 5 allergens except Der f 5 and Der p 5, in 
which the first Glu is substituted for Leu. Coincidently, it was reported that cross-reactivity 
between Der p 5 and Blo t 5 were low (Kuo, Cheong et al. 2003). Therefore, the cross-























 Based on the sequence alignment, eighteen charged residues were selected. These 
residues were either conserved or sharing similar properties of residues among group 21 
allergens, but of different properties compared to group 5 allergens. Four residues (Glu-74, 
Asp-79, Glu-84 and Glu-89) which are conserved across all group 5 and group 21 allergens 
were chosen as well. Each of these residues was mutated to Ala and the corresponding mutant 
was tested for its IgE binding reactivity. Skin prick test was conducted on fifteen volunteers 
with written consents, among which twelve showed positive test results against the wild-type 
Blo t 21 protein. The initial screening of the wild-type Blo t 21 protein and its single mutants 
was conducted using the twelve patients' sera, labeled as P1 to P12 and the result is shown in 
Figure 3.12. 
 The reduction in IgE binding by the mutated proteins compared to the wild-type 
protein was observed. Only the mutation of a particular residue that resulted in more than 
20% of reduction in IgE binding was scored as significant. As shown in Figure 3.13, out of 
eighteen residues selected for mutagenesis studies, four indicate a significant reduction of IgE 
Figure 3.11 Sequence alignment of group 21 and group 5 allergens from dust mites. The 
boxed residues with distinct properties between group 21 and group 5 allergens are selected for 
mutagenesis studies. The residues shaded in gray are the IgE epitopes mapped in Blo t 5
(Chan, Ong et al. 2008). Signal peptides predicted using SigalP 3.0 Server (Emanuelsson et al. 
2007) are underlined. Boundaries of α-helices α-1, α-2, and α-3 are shown as cartoon diagram 




binding in 50% or more of the patients’ sera. Mutation of residue Glu-89 to Ala (E89A) 
conferred the most drastic IgE reduction, which was demonstrated in 11 of 12 (89.67%) 
serum samples tested, followed by 8 of 12 (66.67%) in mutant D79A, 7 of 12 (58.33%) in 
mutant D96A and 6 of 12 (50%) in mutant E84A. All residues appeared to be charged and 
four residues (Glu-74, Glu-84, Glu-89 and Asp-96) are located in the α-helices while residue 
Asp-79 was located in the loop region between α-2 and α-3. Coincidently, residues Asp-79, 
Glu-84 and Glu-89 corresponded to the major epitopes mapped in Blo t 5 previously seemed 





















Figure 3.12 The prescreening to evaluate the sensitivity against wild type Blo t 21 was done 
using sera from twelve volunteers. Two different dilutions of the sera were used, i.e. 1:5 ratio 
(dark grey) and 1:10 ratio (light grey) to estimate the suitable dilution of sera required for future 
experiments.  
Figure 3.13 Percentage prevalence of volunteers with more than 20% reduction in IgE
binding against 18 single mutants of Blo t 21. Among 18 single mutants of Blo t 21,




 It was reported that the IgE epitopes mapped on Blo t 5 were located at the continuous 
stretch of sequence (loop region between α-2 and α-3) and thus formed a major putative linear 
epitope (Chan, Ong et al. 2008). However, based on the mutagenesis studies conducted as 
well as the 3D structure of Blo t 21, at least a part of the putative IgE epitopes on this protein 
could be conformational. The NMR structure of Blo t 21 revealed that residues Glu-89 and 
Asp-96 were close to each other and could form a conformational epitope. Additionally, by 
mutating residues Asp-79, Glu-84 and Glu-89 (corresponding to three major epitopes mapped 
in Blo t 5 -Asp-81, Glu-86 and Glu-91- ) to Ala, significant reduction in IgE binding to Blo t 
21 could be achieved. This observation suggests that Blo t 21 and Blo t 5 could be sharing 
common IgE epitopes, thus explaining the low-to-moderate cross-reactivity between these 
two allergens. 
 Even though residue Glu-74 did not show a significant reduction in IgE binding as a 
single mutant, it was included in the subsequent multiple mutations’ studies because it was 
identified as a major IgE epitope in Blo t 5. We suspected that by combining residue Glu-74 
with the nearby residues such as Asp-79 and Glu-84, a more significant reduction in IgE 
binding could be achieved. We found that residues Glu-74, Asp-79, Glu-84 and Glu-89 
(corresponding to Glu-76, Asp-81, Glu-86 and Glu-91 in Blo t 5) are oriented differently 
based on the structures of Blo t 21 and Blo t 5 (Figure 3.14A and 3.14B, respectively). Based 
on the surface diagram of Blo t 21, residues Glu-74, Asp-79 and Glu-84 seems to form an IgE 
binding cluster while residue Glu-89 is forming a separated cluster with residue Asp-96.  
 These observations imply that there could be at least two IgE binding clusters in Blo t 
21, which is different from the proposed single linear IgE epitope identified in Blo t 5. 
Surprisingly, the surface distribution of these residues on Blo t 21 is very similar to Der p 5 
(Figure 3.14C). However, our results show that the allergenicity of Der p 5 is generally low as 
compared to Blo t 21. Since no information is available for the IgE epitopes of Der p 5, it 
would be difficult to explain its weak IgE binding based on just the 3D structure. This 
phenomenon could be attributed to many reasons,  such as the Leu substitution at position 73 
in Der p 5 compared to the Glu residue found at the corresponding position in Blo t 21. 
70 
 
 It is imperative that the overall protein structure is maintained subsequent to the 
mutations to ensure that the reduction in IgE binding is solely due to the removal of epitope 
residues. In the next section, the monitoring of the overall folding of the Blo t 21 multiple 

























Figure 3.14 Distribution of the residues corresponding to Glu-74, Asp-79, Glu-84, Glu-89 
and Asp-96 of Blo t 21 in the 3D structures of Blo t 5 and Der p 5. The distribution of these 
residues is very similar in A) Blo t 21 and C) Der p 5 but slightly different in B) Blo t 5 based 
on the ribbon diagrams as well as the surface diagrams. The charged residues are colored red
(negative charged) and blue (positive charged) respectively; the hydrophobic residue is colored 








3.8 Circular Dichroism (CD) of Blo t 21 and its mutants 
Many publications on the development of hypoallergen emphasized on the 
maintenance of the overall folding of the mutants compared with the wild-type proteins 
(Swoboda, De Weerd et al. 2002; Buhot, Chenal et al. 2004) (Chan, Ong et al. 2008). The 
reduction in IgE binding of the mutants should be contributed by the removal of the unique 
epitope residues and not due to the conformational changes. In most cases, substitution of a 
single residue for Ala should not affect the overall folding of the protein (except Gly and Pro 
due to the unique properties of their side chains). However, when more than one amino acid 
are involved (multiple mutations), it would be very crucial to examine the secondary fold of 
the mutants.  
 The mutagenesis study on Der f 13, a group 13 allergen identified in D. farinae, 
involved the substitution of four charged amino acids for Ala (E41A, K63A, K91A and 
K103A). The 3D structure of Der f 13 indicated that all putative IgE epitopes were located in 
the β-strands and solvent accessible. Based on the CD spectra, the multiple mutants (triple 
and quadruple mutants) showed similar secondary folds as the wild-type Der f 13 (Chan, Ong 
et al. 2006).  The substitution of these charged amino acids for Ala did not alter the overall 
fold of the protein and therefore were considered as the “real” IgE epitopes. Similar study 
conducted on Blo t 5 also demonstrated that the substitution of four charged amino acids 
(E76A, D81A, E86A and E91A) for Ala did not alter its CD profile. The 3D structure of Blo t 
5 showed that these amino acids were surface exposed and located in the unstructured loop 
connecting helix α2 and helix α3, hence, substantial conformational change would be very 
unlikely (Chan, Ong et al. 2008). 
 The CD spectrums showed that the overall folding of the Blo t 21 single mutants were 
similar compared with the wild-type protein (data not shown). However, some multiple 
mutations such as the double mutant D79A_E84A, quadruple mutants 
E74A_E84A_E89A_D96A and E74A_D79A_E84A_D96A implied loss in secondary 
structures based on their CD profile (Figure 3.15). Other mutants including double mutants 
E84A_D89A and triple mutant E84A_D89A_D96A seem to degrade rapidly upon removal of 
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the N-terminus GST-fusion tag by thrombin digestion when the SDS-PAGE failed to show 
visible bands corresponding to the size of the digested mutants. No readable signals were 
achieved even after concentrating these untagged mutants. Interestingly, the quadruple mutant 
of Blo t 21 (E74A_D79A_E84A_E89A), which corresponds to the 4A mutant of Blo t 5 
(E76A_D81A_E86A_E91A) also demonstrated similar degradation problem, while the latter 
showed similar CD profile compared to wild-type Blo t 5.  
These results consistently show that the substitution of residue Glu at position 84 for 
Ala together with the similar mutation of either residues Glu-79 or Asp-89 could disrupt the 
structural integrity of Blo t 21. Sequence alignment shows that this loop region is highly 
conserved in Blo t 21 and Blo t 5 (>75%), but a closer look at these residues reveal some 
substitutions of amino acids which could affect the local conformation of these proteins. For 
example, residue Asp-81 in Blo t 21 which corresponds to position 83 in Blo t 5, is substituted 
for Asn. Another notable substitution occurs in position 90 in Blo t 21, which is an Ala 
compared to Glu-92 found in Blo t 5. It is debatable that such substitution could alter the 
structure of the proteins, but it seems that the structural integrity of Blo t 21 is highly 
dependent on the charge-charge interaction. The replacement of the negatively charged Asp 
and Glu with a hydrophobic Ala could disrupt the delicate interaction that maintained the 
local structure and ultimately unfolds the protein. Nevertheless, it should be noted that the 
single mutants E79A and D89A indicated similar CD spectrums as compared to the wild-type 
Blo t 21. In addition, these mutants did show a notable reduction in IgE binding when 










Figure 3.15 Comparison of the CD spectrum of Blo t 21 and its mutants. Most of the
multiple mutants are showing similar CD profile with the wild type Blo t 21. However, some
mutants: D79A_E84A, E74A_E84A_E89A_D96A and E74A_D79A_E84A_D96A are


















3.9 Multiple mutations of epitope residues further reduce IgE binding 
 In order to investigate the effect of multiple mutations on the IgE binding to Blo t 21, 
three double mutants, two triple mutants and one quadruple mutant were chosen. The double 
mutant 2A (E74A_D79A), 2B (E74A_E84A), 2C (E74A_E89A) and 2D (D79A_E89A) were 
generated to investigate the combinatorial effect of residue Glu-74 with the neighboring 
residues in further reducing the IgE binding. In order to investigate the IgE binding of the 
putative new IgE epitope cluster composing of residues Glu-89 and Asp-96, we have also 
synthesized the double mutant 2E (E89A_D96A). Two triple mutants 3A 
(E74A_D79A_E89A) and 3B (E79A_E89A_D96A) were generated to investigate the 
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combinatorial effect towards the allergenicity contributed by two putative clusters of IgE 
epitopes according to the 3D structure. The quadruple mutant 4A 
(E74A_D79A_E89A_D96A) was generated to encompass all combinations of the putative 
IgE epitopes. Note that some combinations were not included as the mutants showed aberrant 
CD profiles or degraded after thrombin cleavage. The multiple mutants were then tested for 
their IgE binding reactivity using eight patients' sera with relatively higher IgE titers.  
As shown in Figure 3.16, the double mutants show varying reduction in IgE binding 
in different patients’ sera. Overall, mutant 2A demonstrates the most significant reduction in 
IgE binding compared to other double mutants. In patients P3, P6, P11 and P12, this mutant 
shows more than 40% reduction when compared to the wild-type Blo t 21; whereas in patients 
P1, P8 and P10, this mutant could only reduce the IgE binding by slightly more than 20%. 
Patient P2 hardly shows any significant reduction for mutant 2A, as well as all other double 
mutants. Double mutant 2B shows lesser reduction in IgE binding as compared to mutant 2A 
in general, and mutant 2C shows significant reduction in IgE binding in patients P10 and P11. 
Mutant 2D shows more than 40% reduction in IgE binding for patient P1, and ≥20% for 
patients P3 and P6. As for double mutant 2E, significant reduction in IgE binding could be 
observed in patients P10, P11 and P12 (≥40%), while for the rest of the patients, the reduction 
is not as significant.  
 While the triple mutant 3A does not show much reduction when compared to its 
corresponding double mutant 2A, mutant 3B seems to show further drop in IgE binding 
compared to all double mutants in all patients except for patient P6. The most significant 
reduction could be observed in patients P10, P11 and P12 (≥70%). Finally, the quadruple 
mutant 4A was able to further reduce the IgE binding as compared to the triple mutants in all 
cases except for patient P12, in which no further reduction could be observed. Remarkably, 
the reduction was ≥80% as compared to the wild-type Blo t 21 in patients P6, P10 and P11. 
The average reduction exhibited by the quadruple mutant 4A was about 70% in all patients.  
These results indicate that residues Glu-74, Asp-79, Glu-89 and Asp-96 should be the 
major IgE epitopes in Blo t 21; with residues Glu-74 and Asp-79 forming one epitope cluster 
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while residues Glu-89 and Asp-96 forming another. Despite the notable reduction in IgE 
binding observed in the single mutants’ screening, residue Glu-84 was excluded from the 
multiple mutation studies. As mentioned earlier, mutating this residue together with either 
residue Asp-79 or Glu-89 resulted in the unfolding/degradation of the protein. The exclusion 
of residue Glu-84 from the 4A quadruple mutant could be the limiting factor that prevented 
the further reduction in IgE binding for some patients (P1 and P2). Coincidently, residues 
Glu-74, Asp-79 and Glu-89 were also identified as the major IgE epitopes in Blo t 5 (Glu-76, 
Asp-81 and Glu-91 in Blo t 5) (Chan, Ong et al. 2008). These residues could be responsible 
for the partial cross-reactivity between Blo t 21 and Blo t 5. Nevertheless, residue Asp-96, 
which is a Lys residue at the corresponding position in Blo t 5 (Lys-98), could be a unique 
epitope identified in Blo t 21. In order to evaluate whether residue Lys-98 is also an IgE 
epitope in Blo t 5, we mutated it to Ala (K98A). The IgE binding capability of the Blo t 5 












































Figure 3.16 Comparing the allergenicity of multiple mutants with the wild type Blo t 21
using ELISA experiment. Overall, the quadruple mutant 4A shows the most significant
reduction in IgE binding as compared to the wild type protein as well as the other mutants.
Double mutant 2A (E74A_D79A) shows the most significant drop in IgE binding among all
double mutants in most sera; triple mutant 3B (E79A_E89A_D96A) shows more significant
reduction compared to 3A (E74A_D79A_E89A) in most sera.  
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3.10 Residue “Asp-96” - A unique IgE Epitopes in Blo t 21? 
 In an attempt to show that residue Asp-96 is a unique IgE epitope found in Blo t 21, 
we mutated the corresponding residues in Blo t 5, i.e. Lys-98 to Ala. The single mutant E91A 
and double mutant E91A_K98A from Blo t 5 were also included in the ELISA experiments. 
Similar mutants from Blo t 21 were included in this experiment as a positive control (E89A, 
D96A and E89A_D96A). The Blo t 21 single mutant D96A showed a notable reduction in IgE 
binding, though not as significant as indicated by the E89A mutant when compared to the 
wild-type Blo t 21. The double mutant E89A_D96A showed a further reduction in IgE 
binding in all patients when compared to the single mutants (Figure3.17A). On the other 
hand, no reduction in IgE binding could be observed for the Blo t 5 single mutant K98A in all 
sera; while mutant E91A showed a notable drop in IgE binding in most patients when 
compared to the wild-type Blo t 5. The double mutant E91A_K98A did not show a further 
reduction in IgE binding when compared to the E91A single mutant (Figure 3.17B).  
This experiment shows that residue Asp-96 is a unique IgE epitope in Blo t 21. In Blo 
t 5, residue Lys-96 bears an opposite charge compared to the negatively charged Asp residue 
in Blo t 21. The surface charge distributions in the designated region of Blo t 21 and Blo t 5 
are also different due to the Lys to Asp substitution (refer to section 3.4). It is highly possible 
that residue Glu-89 and Asp-96 form a conformational IgE epitope in Blo t 21 that interacts 
with a unique IgE antibody. Since Blo t 5 lacks of this particular conformational epitope, this 
could be one of the factors that results in its low cross-reactivity with Blo t 21. 
 Interestingly, residue Asp-96 is substituted for Glu in Der f 21 at the corresponding 
position (Glu-99). Glu shares similar properties with Asp, but different properties with residue 
Lys, which is located at position 98 in Blo t 5. In addition, all the putative IgE epitopes 
mapped in Blo t 21 are conserved in Der f 21. Therefore, it is possible that Glu-99 is also 
forming an IgE epitope with Glu-92 in Der f 21, corresponding to Glu-89 and Asp-96 in Blo t 
21. It would be interesting to investigate the effect of E99A mutation in Der f 21 to find out 
whether residue Glu-99 could be an IgE epitope for this protein. 
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3.11 Does Der f 21 shares similar epitope with Blo t 21? 
 In Der f 21, the residue corresponding to Asp-96 in Blo t 21 is substituted for Glu-99; 
whereas the other major four IgE epitopes are conserved, i.e. Glu-77, Asp-82, Glu-87 and 
Glu-92 (refer to section 1.7 for sequence alignment). However, the allergenicity test showed 
that Der f 21 has distinctively different IgE binding capacity compared to Blo t 21 as shown 
previously. We sought to investigate whether residue Glu-99 is involved in the IgE binding in 
Der f 21, since the property of Glu is essentially identical to Asp. Two single mutants E92A 
and E99A as well as a double mutant E92A_E99A were prepared, and the allergenicity of 
these mutants was observed using direct ELISA experiment. Overall, the Der f 21 double 
mutant did not show a similar IgE binding pattern as the Blo t 21 double mutant 
(E89A_D96A), which was consistently less allergenic than the wild-type protein.  
 As shown in Figure 3.18, the single mutant shows no significant change in the IgE 
A. 
B. 
Figure 3.17 Specific ELISA experiment for E89A_D98A (Blo t 21) and E91A_K98A (Blo
t 5) double mutants. A) In Blo t 21, the double mutant E89A_ D96A shows notable
reduction in IgE binding compared to the single mutants and the wild type protein. B) In Blo t
5, only single mutant E91A shows reduced IgE binding compared to the wild type protein, no




binding as compared to the wild-type Der f 21. As for the double mutant, only P10 serum 
showed a significant reduction in IgE binding; P3 and P6 sera shows a slight reduction while 
P1 serum does not show any difference in IgE binding when compared to the wild-type 
protein. Interestingly, the double mutant indicates an increase in IgE binding when compared 
to the wild-type Der f 21 for the rest of the patients' sera. This phenomenon is especially 
remarkable in serum P8, in which no binding to IgE could be observed for the wild-type 
protein and single mutants but significantly high binding to IgE is observed in the double 
mutant. This peculiar increment in the IgE binding was also observed in some of the Blo t 21 
mutants (data not shown), and it could be explained by the unfolding of the protein due to the 
mutations as shown in the CD spectra. However, the CD spectrum of the Der f 21 double 
mutant was identical to the wild-type protein as well as the single mutants. One possible 
explanation is that the substitution of the charged residues for hydrophobic Ala would create 
an interacting surface that favors the binding of an unrelated IgE antibody with 
complementary paratopes. It is not surprising that the effects of the mutations would vary, 
depending on the amino acid used for substitution (Frank, 2002). However, there is no 











Figure 3.18 Specific ELISA experiment for E92A_E99A in Der f 21. Significant reduction 
in IgE binding can be achieved in sera P10 by the double mutant E92A_E99A as compared to 
the wild-type Der f 21, but this mutant shows an increase in IgE binding compared to the 




To summarize, Blo t 21, Der f 21 and Blo t 5 should not use the same IgE epitope 
despite their moderate sequence identity. The IgE epitope mapping experiments suggest that 
residue Asp-96 is a unique epitope in Blo t 21, and it could be the residue that distinguishes 
group 21 from group 5 dust mite allergens. However, the result of the study on the double 
mutant of Der f 21 is not conclusive. In this study, significant reduction of IgE binding by the 
Der f 21 double mutant when compared to the wild-type protein could only be observed in 
serum P10, among a total of eight patients' sera; but the increment in binding due to the 
mutation could also mean that Glu-92 and Glu-99 were interacting with IgE antibodies. 
Otherwise, the mutation should not affect the binding at all. 
3.12 Inhibition Assays  
3.12.1 End-point Inhibition assays  
 The inhibition assay conducted by Gao and coworkers (2007) demonstrated that the 
cross-reactivity between Blo t 21 and Blo t 5 was low-to-moderate. Similar study was 
conducted by Kuo et al (2003) on Blo t 5 and Der p 5, which demonstrated that these 
allergens were not cross-reacting to each other, thus, they should use different IgE epitopes to 
elicit allergic responses. These results suggest that Blot 21, Blo t 5 and Der p 5 are distinct 
allergens despite their similar 3D structures. A closer look at the protein sequences of these 
allergens indicates a number of amino acid substitutions that could be the reason underlying 
their generally low cross-reactivity. We conducted inhibition assay to compare the cross-
reactivity among these three allergens using a single point at 100 μg/ml of inhibitors. In this 
experiment, only six patients’ sera that showed significantly higher sensitivity to Blo t 21 
were chosen in order to achieve a more reliable data.  
 Figure 3.19 shows that in most patients’ sera, Blo t 21 and Blo t 5 are not able to fully 
inhibit each other even at 100 ug/mL of protein, which generally agrees with the cross 
inhibition assay done by Gao et al. (2007). Generally, the results suggest that Blo t 21 could 
inhibit the IgE binding to Blo t 5 much better than the contrariwise. Nevertheless, the cross-
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reactivity profile between wild-type Blo t 21 and Blo t 5 is different across the patients. For 
example, Blo t 5 seems to be able to inhibit the IgE binding to Blo t 21 much better (>28%) 
compared to the other four patients, which generally show no inhibition at all. In patients P3, 
P6 and P12, Blo t 21 could inhibit the IgE binding to Blo t 5 at a significantly lower level 
(<30%) compared to the other three patients. In patient P2, Blo t 21 could inhibit the IgE 
binding to Blo t 5 up to 70%. The IgE inhibition of Blo t 21 against Der p 5 is generally 
moderate-to-high except for patient P2, which shows no inhibition at all.  
The allergenicity of Der p 5 was generally low when compared to Blo t 21 and Blo t 5 
as shown previously in section 3.5. In some cases, it seems that even the wild-type Der p 5 
protein could not efficiently inhibit the IgE binding to itself (P1 and P2; <60%). This result 
was expected, as the IgE binding to Der p 5 was very weak to begin with. Surprisingly, Der p 
5 seems to be able to inhibit the IgE binding to Blo t 21 much better than Blo t 5 in most 
cases. This phenomenon is especially remarkable in patients P2, P8 and P12, in which Blo t 5 
is not able to exhibit any inhibition against Blo t 21 but Der p 5 shows an inhibition up to 
30%. Overall, Der p 5 is not able to inhibit the IgE binding to Blo t 5 except for patient P3, in 



































This is the first experimental data describing the cross inhibition between Blo t 21 and 
Der p 5. Based on our data, Der p 5 could inhibit the IgE binding to Blo t 21 up to 30% and in 
most cases, much better than Blo t 5. A probable inference is that Der p 5 should share some 
IgE epitopes with Blo t 21 but not with Blo t 5. Moreover, in most patients, Der p 5 could not 
inhibit the IgE binding to Blo t 5 at all. Both Blo t 21 and Blo t 5 seem to be able to inhibit the 
IgE binding to Der p 5 very well. We propose that Blo t 21 and Blo t 5 bear the surface 
epitopes which could interact with the Der p 5-specific IgE antibodies, thus achieving almost 
full inhibition as shown in the assays. On the other hand, Der p 5 was not able to inhibit the 
Figure 3.19 The cross-reactivity among Blo t 21, Blo t 5 and Der p 5 were examined by
endpoint inhibition assay. The sera are pre-absorbed overnight with Blo t 21 (dark grey
bars), Blo t 5 (light grey bars) and Der p 5 (white bars) at 4 °C. Wavelength 655 nm was used




IgE binding to both Blo t 21 and Blo t 5 even at a high concentration probably because the 
latter bears extra IgE epitopes that could bind to other IgE antibodies. It should be noted that 
the cross inhibition of Der p 5 against Blo t 21 and Blo t 5 is very different, which is expected 
since it was known that Blo t 21 and Blo t 5 should use different IgE epitopes based on their 
low-to-moderate cross-reactivity. 
 In summary, this experiment shows that Blo t 21, Blo t 5 and Der p 5  cross-react 
among one another up to moderate level. According to the sequence alignment of these 
allergens, most of the putative IgE epitopes mapped on Blo t 5 are also present in Blo t 21 and 
Der p 5. It is possible that these common charged residues are responsible for the cross-
reactivity among these allergens. Different but related IgE epitopes were demonstrated to be 
able to interact with the same IgE antibody (Frank 2002). In the previous experiment, we 
showed that Blo t 21 could have a conformational epitope (Glu-89 and Asp-96), which is not 
found in Blo t 5. In Der p 5, Leu residue at position 73 is substituted for Glu residue in Blo t 
21 and Blo t 5 at the corresponding positions based on the sequence alignment. These 
differences could result in the formation of different IgE epitopes in these allergens. Indeed, 
most residues in the putative IgE binding site corresponding to that in Blo t 5 are similar in 
Blo t 21 and Der p 5, but different adjacent residues could affect the overall IgE interacting 
surface and ultimately, influence the type of IgE antibodies that could bind to it (Frank 2002). 
In this research, we attempted to identify the major IgE epitopes on Blo t 21, but in reality, 
there could be more IgE epitopes that are yet to be identified on this protein. Likewise, it was 
mentioned that Blo t 5 could also have some minor IgE epitopes (Chan, Ong et al. 2008), and 
the IgE epitope on Der p 5 is unknown thus far. Therefore, more experiments need to be 
conducted in order to better understand the relationship of the allergenic properties among 
these allergens. 
 
3.12.2 The effect of L73E mutation in Der p 5  
We speculate that the overall lower allergenicity of Der p 5 when compared to Blo t 5 
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is due to the Glu for Leu substitution at position 73 in this protein. Residue Leu-73 
corresponds to residue Glu-74 of Blo t 21 and based on our mutagenesis studies, the latter 
should be a major IgE epitope in Blo t 21. Coincidently, the corresponding residue in Blo t 5, 
Glu-76, was also reported to be a major IgE epitope in this protein (Chan, Ong et al. 2008). 
According to the sequence alignment, all other putative IgE epitopes mapped in Blo t 5 and 
Blo t 21 are conserved in Der p 5 (Asp-78, Glu-83, Glu-88 and Asp-95). Therefore, it is 
possible that the L73E mutation of Der p 5 would result in improved allergenicity compared 
to the wild-type protein. 
The replacement was carried out using site-directed mutagenesis approach and the 
allergenicity of the L73E mutant was compared with wild-type Der p 5 and Blo t 5 using 
ELISA experiment. Based on the overlaid CD spectrums, the secondary structure of the 
mutant is identical to that of Der p 5 wild-type (Figure 3.20). As shown in Figure 3.21, mutant 
L73E shows an improved IgE binding reactivity compared to the wild-type Der p 5. The 
increase in IgE binding is especially remarkable in patients P11 and P12. In these patients, the 
IgE binding to the L73E mutant is almost as good as Blo t 5, thus agreeing with our 
hypothesis that the mutation would “restore” the IgE binding to Der p 5. However, this 
phenomenon was not observed in the other six patients. In brief, mutant L73E shows a slight 
increment in IgE binding for patients P1, P3 and P6. For patient P8, even though mutant L73E 
indicates improvement in IgE binding compared to the wild-type protein, but apparently, the 
allergenicity is not “restored” as it is still significantly lower compared to that of Blo t 5. 
Patient P2 does not show any improvement in IgE binding to mutant L73E compared to the 
























 To summarize, it appears that the replacement of residue Leu with Glu at position 73 
in Der p 5 does improve its allergenicity as shown in most patients’ sera. However, the 
improvements are not uniform and the effects do not seem to be identical in all patients’ sera. 
This mutation does not seem to “restore” the allergenicity of Der p 5 as postulated. We 
hypothesize that the Der p 5 mutant L73E could mimic the allergenicity of Blo t 5 when all 
four putative major IgE epitopes are present in this protein. As a result, the IgE binding 
reactivity of this mutant should be at least similar, if not identical to Blo t 5. Nevertheless, the 
Figure 3.21 The allergenicity of Der p 5 L73E mutant compared to wild type Der p 5
and Blo t 5. Most sera show higher sensitivity to Blo t 5 compared to wild type Der p 5. The
single mutant L73E shows significant increase in IgE binding when compared to the wild
type Der p 5 in some sera. 
Figure 3.20 The CD spectrum of Der p 5 and its L73E mutant. The overall secondary
structure of the L73E mutant (dashed line) is identical to that of Derp 5 wild type (solid line).




improvement in the IgE binding with this mutation is intriguing; it suggests that the IgE 
binding site of Der p 5 should be in proximity to residue Leu-73, at least in some cases. 
Otherwise, the mutation should not affect the IgE binding to Der p 5. More experiments need 
to be done in order to identify the IgE epitopes of Der p 5. 
 
3.12.4 Inhibition assays of Blo t 21 vs Der f 21 
It was demonstrated that Der p 21,  a homologous protein of Der f 21, showed no 
relevant cross inhibition with group 5 allergen from dust mite (Weghofer, Dall'Antonia et al. 
2008). According to our allergenicity test, Der f 21 seems to have distinct IgE binding activity 
compared to that of Blo t 21. In addition, this protein also shows different physical properties 
based on the CD experiments as discussed earlier. These results suggest that Der f 21 could be 
a unique allergen that uses distinctive epitopes to elicit the allergenicity. We performed 
inhibition assays to investigate the cross-reactivity between Der f 21 and Blo t 21. 
As shown in Figure 3.22, Der f 21 could moderately inhibit the IgE binding to Blo t 
21 in all five patients (≤45%). Note that the other three patients were not included in this 
experiment because they are not highly sensitized to Der f 21 (refer section 3.5). Interestingly, 
Blo t 21 seems to be able to inhibit the IgE binding to Der f 21 in patients P1 and P11. 
Coincidently, both patients show stronger binding to Blo t 21 based on our ELISA 
experiment. This suggests that Blo t 21 could share the same IgE epitopes with Der f 21 while 
using additional epitopes that could not be recognized by Der f 21 specific IgE antibodies. 
However, patients P6 and P10 who showed stronger binding activity to Der f 21 compared to 
Blo t 21 did not exhibit the similar effect. Der f 21 was only able to inhibit the IgE binding to 
Blo t 21 at 20% and 45% in patients P6 and P10, respectively. For patient P3, Blo t 21 was 
unable to exhibit inhibition against Der f 21 even though it showed higher sensitivity to Blo t 
21. It seems that the cross-reactivity between Blo t 21 and Der f 21 does not correlate with 




 In conclusion, the cross-reactivity between Der f 21 and Blo t 21 is low-to-moderate 
and thus, Der f 21 should be considered as a unique allergen. Based on the allergenicity test, 
at least 50% the Blo t 21 sensitized individuals are co-sensitizing to Der f 21. Therefore, it 
would be necessary to identify the IgE epitopes of this allergen. Based on the sequence 
alignment, all putative IgE epitopes mapped on Blo t 21 are conserved in Der f 21. However, 
these epitope residues do not seem to behave similarly in Der f 21 as they do in Blo t 21. In 
this case, structural information could also be useful in aiding the explanation of the 

































3.13 Peptide ELISA 
3.13.1 Surface charge distribution at the putative IgE interacting site of Blo t 
21, Blo t 5 and Der p 5 
 In the previous sections, we showed that the cross-reactivity between Blo t 21 and 
Blo t 5 is generally low, which was consistent  with the data reported by Gao et al (2007). 
Using our samples, we also demonstrated that Blo t 5 and Der p 5 are not highly cross-
reactive to each other, coinciding with the published data (Kuo, Cheong et al. 2003). 
Additionally, we showed that Blo t 21 and Der f 21 are not able to inhibit the IgE binding to 
each other very well. Together with the allergenicity test on these proteins, we hypothesize 
that they should be using  different IgE epitopes to interact with the IgE antibodies. Based on 
the peptide ELISA conducted on Blo t 5, Chan and coworkers (2008) showed that the 
sequence consisting of residues 81DLNILERF88 was very important in IgE binding, in which 
two major IgE epitopes, i.e. Asp-81 and Glu-86 (Figure 3.23D) were involved. Their results 
also showed that the peptides that did not contain either of these epitopes could not bind to the 
IgE antibodies from 10 patients' sera. It seems that both residues Asp-81 and Glu-86 are 
essential for the IgE binding to the peptides derived from Blo t 5. Coincidently, these residues 
Figure 3.22 The cross-reactivity between Blo t 21 and Der f 21. Der f 21 can inhibit the
IgE binding to Blo t 21 at low-to-moderate level in most sera. There is no general trend that
can be observed for the inhibition of Blo t 21 against Der f 21. Blo t 21 seems to be able to
inhibit the IgE binding to Der f 21 at high level for P1 and P11, but the inhibition is low-to-




are conserved in Der p 5, Blo t 21 and Der f 21 as well (Figure 3.23D). Sequence alignment 
based on these eight residues derived from all four proteins indicates the sequence identity 
ranged from 37% to 62%.  
Figure 3.23 shows the distribution of the charged residues that are included in the 
peptides used in the subsequent ELISA experiments. Although the amino acid sequences are 
highly conserved in this region of Blo t 21, Blo t 5 and Der p 5, the overall charge 
distributions are very different.  Note that the putative IgE epitopes mapped in Blo t 21 and 
Blo t 5 are contributing to the surface charge in different manners as well. Additionally, the 
surface topology in this region is also unique to all these proteins. These differences might 
contribute to the formation of a unique interacting surface to accommodate the specific IgE 
antibodies. Usually, an antibody could interact with an epitope comprised of 10-15 amino 
acids, of which about five contributed to most of the binding energy, while the adjacent 
residues would facilitate the accommodation of an antibody to the epitope (Frank 2002). 
Therefore, it would not be surprising that these proteins are interacting with different IgE 
antibodies despite having high sequence similarity.  
The 3D structures of Blo t 21, Blo t 5 and Der p 5 shows, in consensus, that the first 
three residues were located in flexible loop region while the subsequent five residues are 
located in the structured region of these proteins. Theoretically, the peptides should represent 
the flexible or unstructured regions in the parent proteins, thus, this implies that the IgE 
antibodies are actually interacting with the unstructured part of the parent proteins. However, 
as shown in Figure 3.23D, residue Glu-86 which is located in the α-helical region of Blo t 5 
seems to play a crucial role in the IgE binding based on the previous peptide ELISA 
experiment (Chan and Ong et al. 2008). It is possible that the unfolding of this structured 
region would not affect the IgE recognition as residue Glu-86 is very close to the unstructured 
region. It would be interesting to investigate the IgE binding to this region derived from all 
four proteins, as it would aid in explaining the differences in terms of the immuno-properties 






















3.13.2 Peptides show different IgE binding activities 
 The peptides were designed based on the sequence alignment of Blo t 21, Der f 21, 
Blo t 5 and Der p 5, which encompassed four residues corresponding to the putative IgE 
epitopes mapped in Blo t 5, i.e. Glu-76, Asp-81, Glu-86 and Glu- 91, as well as three 
additional residues flanking each terminus (Figure 3.23D). An additional peptide derived from 
Der p 5 with the substitution of Leu-73 for Glu-73 was also included in an attempt to mimic 
the putative IgE epitopes mapped in Blo t 5. Based on our ELISA results, the L73E 
substitution in Der p 5 increased the IgE binding of this protein significantly in some cases. 
Figure 3.23 3D distribution of charged residues at the putative IgE binding site of A) Blo
t 5, B) Blo t 21 and C) Der p 5. D) Sequence alignment of the peptides derived from the
proteins used in this study. The charged residues are colored in blue and red representing the
positive and negative charges, respectively. Secondary structure diagram is indicated on top
of the sequences and the numbering of all residues is corresponding to that of Blo t 5. Der f
21 is only included in the sequence alignment since its 3D structure is not available. Four
putative major IgE epitopes which were mapped in Blo t 5 are indicated by arrows. Diagrams
are generated using PyMOL (Delano 2002). 
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We hypothesize that the similar substitution in the Der p 5 peptide could increase its 
allergenicity compared to the wild-type peptide. Overall, the results show that the Blo t 21-
derived peptide could react better than the other peptides, especially for patients P2, P3, P8 
and P11 (Figure 3.24). Coincidently, these patients showed relatively low sensitivity to Blo t 
5-derived peptide. Conversely, patients P1 and P12 who reacted better to Blo t 5-derived 
peptide showed relatively low sensitivity to Blo t 21-derived peptide. The Der f 21-derived 
peptide had much lower reactivity as compared to the Blo t 21-derived peptide in general. 
This observation is in sync with the previous ELISA experiments, which showed that Blo t 21 
is more allergenic than Der f 21 in most cases. Patient P10 who showed the highest sensitivity 
to Der f 21 protein in the previous ELISA experiment also registered the highest reactivity to 
the Der f 21-derived peptide. However, patient P6 who demonstrated higher sensitivity to Der 
f 21 compared to Blo t 21 reacts similarly to Der f 21 and Blo t 21-derived peptides. 
Interestingly, Der p 5-derived peptide showed a rather similar trend as Blo t 5-derived peptide, 
and the L73E substitution in the Der p 5-derived peptide did not appear to improve its 
allergenicity as indicated in the whole protein ELISA. Previous experiment showed that the 
L73E mutant of Der p 5 demonstrated significantly higher IgE binding as compared to its 
wild-type protein. However, this phenomenon was not observed in the peptide ELISA 
experiment. The Leu-73 to Glu-73 mutation could result in a modified surface topology that 
might interact with an unrelated IgE antibody. Conceivably, this modified surface epitope 
might only be allergenic when present in the structured protein by possibly altering the local 
surface charge distribution. 
 As shown in the previous section, Blo t 5 could react to most of the patients' sera 
much better than Blo t 21, similar phenomena would be expected in the peptide ELISA 
experiments since all residues corresponding to the putative IgE epitopes mapped in Blo t 5 
are present in Blo t 21. These residues, i.e. Glu-74, Asp-79, Glu-84 and Glu-89, are also 
responsible for the IgE binding of Blo t 21 based on our mutagenesis studies. However, the 
peptide ELISA showed that five patients (P2, P3, P8 P10 and P11) were reacting much 
weaker to Blo t 5-derived peptide as compared to the Blo t 21-derived peptide, whereas two 
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patients who were more sensitized to Blo t 5-derived peptides showed weaker reactivity to the 
Blo t 21-derived peptide. These results imply that the IgE antibodies that bind to the Blo t 21 
and Blo t 5-derived peptides are different.  
The overall higher allergenicity of Blo t 5 could be attributed to the presence of other 
IgE epitopes in this protein. On the other hand, the relatively lower sensitivity to Blo t 5-
derived peptide when compared to Blo t 21-derived peptide could be due to the presence of a 
unique IgE antibody that recognizes the specific sequence in the Blo t 21-derived peptide. The 
sequence 81DLNILERF88 which was shown to be the important IgE binding site in Blo t 5, 
was substituted for 79DLDLLEKF86 in Blo t 21. The replacement of Asp to Asn at position 81 
would probably allow binding to the Blo t 21-specific IgE antibody. In addition, the other two 
substitution: Leu to Ile and Lys to Arg at position 82 and 85 respectively, could also 
contribute to the specific interaction with IgE antibodies. In fact, a substitution of even one 
atom group at the binding site could lead to a significant change in the interaction with the 
antibodies (Van Regenmortel 1998). It was demonstrated that three Blo t 5-derived peptides 
bearing the important IgE binding residues were able to react very well to the sera from ten 
patients, with some of the absorbance exceeding the linear detection range of the spectrometer 
(Chan, Ong et al. 2008). The overall lower reactivity of the Blo t 5-derived peptide in our 
study could be explained by the higher dilution of the sera, which was 1:10 instead of 1:1 
ratio as stated in the aforementioned publication. The purpose of our peptide ELISA 
experiment was to compare the allergenicity among the peptides derived from four different 
proteins, thus, such high concentration of sera would not be necessary. Moreover, in order to 
investigate the allergenicity of the peptides as compared to their parent proteins, using a same 
























 This experiment suggests that in most patients, the Blo t 21-derived peptide could 
represent the linear epitope of the protein. In addition, it also unequivocally supports our IgE 
epitope mapping data, which shows that the major IgE epitopes are indeed located in this part 
of the protein. As for Der f 21, Blo t 5 and Der p 5, the peptides may not be able to represent 
the antigenic part of the protein in most cases. Nevertheless, the results demonstrate that even 
with high sequence identity and the presence of putative major IgE epitopes, the peptides may 
not necessarily exhibit the same degree of IgE binding. Apparently, other factors such as 3D 
structure, amino acid constituent in the epitope region and the content of the polyclonal 
antibodies are also playing a pivotal role in the allergenic manifestation of these allergens. 
 
 
Figure 3.24 Results of the ELISA experiment using peptides derived from Blo t 21, Der f
21, Blo t 5 and Der p 5. Overall, most of the patients’ sera show higher sensitivity to Blo t
21-derived peptide. Coincidently, these patients are showing relatively low sensitivity to Blo t
5-derived peptide. Patients P1 and P12 show higher sensitivity to Blo t 5-derived peptide
compared to Blo t 21-derived peptide. The sensitivity towards Der f 21-derived peptide is
relatively low among all patients except P10. Interestingly, Der p 5-derived peptide is
showing a rather similar trend as Blo t 5. However, the L73E modification does not improve
the allergenicity of Der p 5-derived peptide. 
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CHAPTER 4 DER F 7: RESULTS & DISCUSSION 
 
4.1 Characterization of Der f 7 
After removing the N-terminal His-tag, the recombinant Der f 7 is 200 residues in length, 
which includes the full-length recombinant Der f 7 and four residues (Gly, serine, Glu and 
Phe) from the thrombin cleavage site. The recombinant Der f 7 was shown as a single band in 
the SDS-PAGE at the molecular weight of approximately 25 kDa. As shown in Figure 4.1A, 
the purity of the recombinant Der f 7 is very high following the gel filtration and is suitable 
for crystallization. The gel filtration experiment indicated that the recombinant Der f 7 was a 
monomer in solution (Figure 4.1B). The purified Der f 7 was subjected to CD experiment to 
estimate the content of its secondary structure. As shown in Figure 4.2, the CD spectrum 
indicates that Der f 7 consists of the mixture of α-helices and β-sheets with the minimum peak 
at 220 nm, which is identical to the CD profile of Der p 7. The crystallization of Der f 7 was 
conducted before the crystal structure of Der p 7 was available. Therefore, the molecular 
replacement technique was not possible since there was no homologous protein could be used 
as the suitable template. We prepared SeMet protein crystal to perform the MAD experiment. 
The SeMet protein was subjected to MALDI-TOF mass spectrometry to confirm the 
incorporation of the selenium. As it can be seen in Figure 4.3, the mass shift of 219.59 Da 
when comparing the mass spectra of the native recombinant Der f 7 with the SeMet 


































Figure 4.2 Circular dichroism of Der f 7 and Der p 7. Both proteins show similar CD
profile with a minimal peak at around 220 nm. The subsequent CD denaturation experiments
are carried out using 220 nm as the reference point. 
 
Figure 4.1 SDS-PAGE and gel filtration profiles of Der f 7. The recombinant Der f 7 was
subjected to gel electrophoresis using 15% SDS-PAGE followed by Coomassie staining. A)
The gel-filtration profile of Der f 7 estimates the monomeric state of the protein. B) Lane 1,
protein markers. Lane 2, purified native recombinant Der f 7. The purified SeMet recombinant











4.2 Crystallization and data collection of SeMet recombinant Der f 7 
 The initial crystals of Der f 7 were too small and fragile for the diffraction studies, 
despite the observable polarization (Figure 4.4A). The crystallization was further optimized 
by varying the pH of the reservoir buffer, the concentration of the protein as well as the 
crystallizing temperature. The best diffracting crystals of recombinant Der f 7 were grown 
from a reservoir solution consisting of 0.1 M Bis-Tris pH 7.4 and 28% PEG MME 2000 at 
20°C. The SeMet crystals of recombinant Der f 7 were grown to approximately 0.34 * 0.25 * 
0.2 mm within 1 week (Figure 4.4B).  
 A high-resolution data set was collected to 2.24 Å using the best crystal of SeMet 
recombinant Der f 7 (Figure 4.5). The crystals of recombinant Der f 7 belonged to the space 
group P212121 with two molecules in one asymmetric unit. The unit cell parameters were a = 
50.2 Å, b = 58.7 Å, c = 123.8 Å and the solvent content was ~ 43.7% with Matthews constant 
of 2.16 Å3/Da (Kantardjieff & Rupp, 2003), assuming the presence of two molecules in one 
asymmetrical unit. The detailed statistics for the SeMet crystal of recombinant Der f 7 can be 
seen in Table 4.1. Overall, the quality of the data collected using SeMet crystal was better 
than that of the native crystals (data not shown). Therefore, the subsequent structural 
determination was carried out using the data collected from the SeMet crystal. 
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Figure 4.3 Mass Spectrometry of native and SeMet Der f 7. The substitution of Se atoms was
confirmed using MALDI-TOF MS experiments. The mass shift of approximately 219.59 Da from
the native recombinant Der f 7 A) and SeMet recombinant Der f 7 B) indicates the substitution of

























Figure 4.5  Diffraction pattern of SeMet Der f 7. The best SeMet recombinant Der f 7
crystal was diffracted to 2.24 Å resolution. Data collection was done on beamline BL-13B at
National Synchrotron Radiation Research Center (NSRRC), Taiwan. 
A B 
0.17 mm
Figure 4.4 Crystals of recombinant Der f 7. A) Initial crystals formed by native















4.3 Crystal Structure of Der f 7 
The final model of Der f 7 was solved and consisted of two molecules in one 
asymmetrical unit, in which one molecule was interacting with another in an inverted fashion 
(Figure 4.6). This model agreed very well with the Matthew’s constant of 2.16 Å3/Da as 
described earlier. There are 63 well-defined water molecules added in the model, and 
refinement was continued until the R-value converged to 0.24 (Rfree = 0.29) for reflections 
I>σ (I) to 2.8 Å resolution. The model had good stereochemistry, with all residues within the 
allowed regions of the Ramachandran plot (Table 4.2) analyzed by PROCHECK (Laskowski 
et al. 1993). The structure of Der f 7 has a “super-roll” conformation as described in the 
CATH database (Pearl, Todd et al. 2005). The N-terminal consisted of an α-helix, followed by 
eleven β-sheets that wrap around the C-terminal α-helices. The first two β-sheets separated by 
a flexible loop (Lys-7 to Gln-25 and Met-32 to Val-34) were aligned in an antiparallel manner 




with the third β-sheet (Gly-52 to Arg-62). Following the third β-sheet, there was a short α-
helix (Leu-64 to Gln-66) and two short β-sheets (Met-67 to Arg-69 and Asn-74 to Lys-76). 
There were six antiparallel β-sheets discontinued by flexible loops (Val-82 to Val-90, Val-95 
to Leu-105, Thr-111 to Gln-119, Val-122 to Ile-129, Thr-136 to Val-142 and Asn-147 to Ile-
152) before the protein ended with a long C-terminal α-helix (Pro-160 to Leu-193) (Figure 
4.10). The N-terminal helix seems to form a cleft together with the end of the C-terminal 
helices as well as the adjacent β-sheets. Based on the analysis of several homologous proteins, 
which will be discussed in further detail in the next section, this cleft could interact with an 
unknown ligand that could be important for the biophysical function of Der f 7 (Figure 4.7A).  
The overall structure of Der f 7 is very similar to Der p 7, as they shared 86% 
sequence identity. When superimposed, these proteins showed a backbone R.M.S.D. of 
0.577Å (Figure 4.8). The surfaces of both proteins were highly charged with predominantly 
negative charges (Figure 4.9). In general, the structure of Der f 7 shows low-to-moderate B-
factor as depicted in Figure 4.7B. A few regions showed particularly high B-factor: from 
residues E24 to T28, R43 to D49, H91 to D93 and P130 to I135. Coincidently, Mueller and 
coworkers also reported that residues from R43 to I47 were missing in chain B of Der p 7 
structure. The first five residues are untraceable in both chains of Der f 7 structure, but all 
chains of Der p 7 show complete set of residues at the N-terminus. When superimposed, both 

























r.m.s. Root mean squared. 
Rcryst = Σ ||Fo| - |Fc||/ Σ|Fo| calculate from the working data set. 
Rfree was calculated from 5% of data randomly chosen not to be included in refinement. 














Table 4.2 Refinement statistics for Der f 7  
 
Figure 4.6 The final model of Der f 7 crystal structure. There are two molecules in one
asymmetrical unit, in which one molecule is interacting with another in an inverted fashion.
This model agrees with the Matthews constant of 2.16 Å3/Da (Kantardjieff & Rupp, 2003).

































Figure 4.7 Ribbon diagram of Der f 7 crystal structure. A) Der f 7 consists of both α-
helices (red colored) and β-sheet (blue colored) secondary structures. The N-terminal helices
seemed to form a cleft together with the end of the C-terminal helices as well as the adjacent
β-sheets which could be a ligand binding site for Der f 7. Models are generated using
MOLMOL software (Koradi, Billeter et al. 1996). B) shows the Der f 7 structure from chain
A colored by relative B factor, where red is high (>80) and blue is low(<30). Models are
generated by PyMol (Delano Scientific). 
Figure 4.8 Superimposition of Der f 7 and Der p 7. The overall structure of Der f 7 (green
colored) is very similar to Der p 7 (red colored), its homologous protein sharing 86%
sequence identity. When superimposed, these proteins showed a backbone root means square
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Figure 4.9 Surface charge distribution of Der f 7 and Der p 7. The surface of both proteins
is highly charged. It seems that negatively charged patches (red colored) dominate both
proteins, and Der f 7 seems to bear slightly more positive charge patches (blue) compared to
Der p 7. Surface charged diagrams are generated using MOLMOL software (Koradi, Billeter
et al. 1996). 
Figure 4.10 Secondary structure topology of Der f 7. There are altogether three α-helices
(cylinders) and eleven β-sheets (block arrows) in Der f 7. The numbers of the residues are
labeled marking the beginning and the end of the secondary structures. Loops and




4.4 Structural homology 
 Despite its high sequence identity with Der p 7, there is no clue regarding the possible 
function of Der f 7. It was reported that Der p 7 could be related to a family of proteins 
involved in human innate immune recognition of bacterial lipid products. However, there was 
no direct experimental evidence that supports the hypothesis. Even though Der p 7 was shown 
to bind to polymyxin B (PB), the binding was very weak and therefore, implying that PB was 
not a natural ligand for Der p 7 (Mueller, Edwards et al. 2010). Since Der f 7 shows such a 
high sequence and structural homology with Der p 7, it is conceivable that Der f 7 could also 
interact weakly with PB and possibly, with another similar natural ligand binding to Der p 7. 
 The software DALI (Holm and Rosenstrom 2010) was employed to identify the 
proteins which are likely to be related to Der f 7 based on the overall protein folding. More 
than 500 hits were returned from the search and the top fifteen hits with the marginal match 
scores (z-score) of more than 10 were chosen for analysis (Table 4.3). Not surprisingly, the 
top matches are the maltose-binding periplasmic protein tagged Der p 7, followed by juvenile 
hormone binding protein (JHBP), bactericidal/permeability-increasing protein (BPI), takeout-
like protein and cholesterol ester transfer protein. Interestingly, some major allergens also 
appear in the list, i.e., major pollen allergen Bet v 1, major cherry allergen Pru av 1 and major 
carrot allergen Dau c 1. The structure of these allergens belongs to the fold superfamily 
known as steroidogenic acute regulatory protein (StAR) related lipid transfer domain 
(START), which is initially identified as a lipid binding domain.   
 The striking similarity between Der f 7 and the JHBP from insects may imply similar 
functions shared by these proteins. JHBP is essential for transporting the juvenile hormone 
(JH) in the hemolymph of butterflies and moths (Kolodziejczyk, Bujacz et al. 2008). In 
insects, juvenile hormone is crucial in ensuring the growth of larvae, while preventing the 
metamorphosis cycles (Nijhout 1994). It is known that dust mites, albeit distinctively different 
from insects, also have the juvenile (larvae) stage. Hence, it is possible that the group 7 
allergens from dust mites, owing to their high structural homology with JHBP, could be 
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involved in regulating the development of dust mites. The other insect-related protein that 
shows high homology with Der f 7 is the takeout-like protein, which was postulated to be 
involved in various aspects of the physiology and behavior of insects (Hamiaux, Stanley et al. 
2009). The superimposition of Der f 7 with JHBP and takeout-like protein yielded an 
R.M.S.D. of 3.6 Å over 173 Cα atoms and 4.4 Å over 171 Cα atoms, respectively (Figure 
4.11A and 4.11B). Coincidently, JHBP and takeout-like protein are known to bind to 
hydrophobic ligands, which is similar to the allergens composed of START domains. 
Similar to Der p 7, Der f 7 shows significantly high structural homology to the N-
terminal domain of bactericidal/permeability-increasing protein (BPI). BPI is a protein with 
potent killing activity against gram-negative bacteria by interacting with the surface 
lipopolysaccharide. An R.M.S.D. of 3.4 Å over 173 Cα atoms was achieved by overlaying the 
3D structure of Der f 7 with the N-terminal domain of BPI protein (Figure 4.11C). Figure 4D 
shows the whole structure of the BPI protein. As it can be seen, the ligand (red sticks) is 
bound to the cleft similar to the one described in Der f 7 as well as Der p 7. The similar cleft 
found in JHBP from silkworm was also demonstrated to be interacting with the juvenile 
hormone III (Suzuki et al., unpublished data). Therefore, it is possible that Der f 7 would 




























1 3h4z-A 27.2 1.1 191 568 84 MBP-Der p 7 
4 2rck-B 13.4 3.6 173 208 12 JHBP 
7 2rqf-A 12.0 4.1 174 227 11 BPI 
8 3a1z-C 11.8 4.8 173 212 11 Hemolymph 
JHBP 
12 1ewf-A 11.3 3.4 173 456 15 BPI 
13 3e8w-
A 
11.1 4.4 171 219 11 Takeout-like 
protein 
15 2obd-A 10.5 3.9 174 472 11 Cholesteryl ester 
transfer protein 
367 1h2o-A 3.5 4.1 105 159 11 Pru av 1 allergen
383 1fm4-
A 
3.4 3.9 103 159 8 Bet v 1 allergen 
525 2wql-A 2.6 4.5 104 152 10 Dau c 1 allergen 
 
































4.5 NMR Studies on Der f 7 
 The cDNA of Der f 7 was subcloned into a modified pET-32a expression vector and 
was expressed at a high level in E. coli BL21 cells as a soluble His-tagged fusion protein at 
about 26 mg/L of His-tagged fusion protein in M9 minimal medium. Overnight thrombin 
digestion was carried out to remove the N-terminal His-tag, and the protein was purified to 
homogeneity using gel filtration column. The highly purified protein was dialyzed against 20 
Figure 4.11 Superimposition of Der f 7 with its homologous structures. Der f 7 is colored
green in all panels. A) Der f 7 overlaid with takeout-like protein (cyan), B) JHBP (magenta)
and C) BPI protein (orange). D) The crystal structure of BPI protein with two domains




mM phosphate buffer at pH 7 and remained highly soluble at the concentration of 1 mM with 
no visible precipitation for seven days. 
 CD spectra showed that the secondary structure of Der f 7 was a mixture of α-helices 
and β-sheet, consistent with the CSI which showed that Der f 7 consisted of at least seven β-
sheets flanked by two α-helices (Figure 4.13). A complete set of NMR spectra were acquired 
for Der f 7 as mentioned in the previous sections. The two-dimensional 1H15N-HSQC is 
reasonably well with 185 countable amide resonance excluding the prolines and side chains 
(Figure 4.12). The completeness of the backbone assignment is about 86% (160 out of 185 
residues assigned) but the overall side chains’ assignment is less than 60%. Attempts to 
improve the completeness of the side-chain assignment by including the HCCH-TOCSY 
experiment were unsuccessful. Even though more side-chain protons could be assigned using 
HCCH-TOCSY spectrum, there were still about 20% of the side-chain protons which 
remained unresolved. The side-chain proton assignments were completely missing in two 
regions of the protein (Lys-40 to Gly-52 and Tyr-103 to Pro-110). It was later revealed that 
these regions are highly flexible based on the crystal structure of Der f 7. The solution 
structure of Der f 7 using NMR was extremely challenging as most of the side-chain atoms 
were missing in the spectrums. Coincidently, Mueller and coworkers had also reported similar 
problem while attempting to solve the structure of Der p 7 using NMR (Mueller, Edwards et 
al. 2010). As a result, we attempted to crystallize Der f 7 and solved its 3D structure using X-
ray crystallography method. Even though the data acquired from the NMR experiments 
were not used for the structure determination of Der f 7, it proved to be useful in the 
subsequent experiments, including ligand binding and dynamics studies. The backbone 
assignment was not complete but it was sufficient for the aforementioned experiments with an 
aid of the crystal structure of Der f 7. The ligand binding study was conducted on Der p 7 
using NMR experiments, and it was demonstrated that this allergen could bind weakly to 
polymyxin B. Similar studies had been carried out on Der f 7 using PB as well as other 

































Figure 4.12 The two dimensional 1H15N-HSQC of Der f 7 with backbone assignment
shows that this protein is well-folded with generally well-dispersed amide resonances. The
NMR spectrums were processed using NMRPipe software and the peaks assignment was
done using SPARKY software. 
Figure 4.13 Chemical Shift Index (CSI) of Der f 7. Both terminus of Der f 7 consist of two
α-helices which are separated by at least 10 β-sheets, agreeing with the crystal structure of this
protein. Therefore, the NMR data should be reliable for the subsequent functional studies.  
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4.6 IgE Epitope mapping of Der f 7 
 Ever since the discovery of the group 7 allergen from dust mites by Shen and 
coworkers (Shen, Chua et al. 1993), numerous immunological characterizations had been 
conducted on the two representative proteins: Der f 7 and Der p 7, isolated from house dust 
mite D. farinae and D. pteronysinnus, respectively. Initially, the allergenicity of group 7 
allergens from dust mite was characterized by means of immunoassay such as radio-immuno 
assay (RIA), immunoblots and skin prick test. All these experiments demonstrated that the 
group 7 dust mite allergens were clinically important and therefore, should be considered as a 
major source of allergen. Despite the relatively low prevalence of reactivity against the 
allergic sera (~50%), Der p 7 was, in some cases, shown to elicit a much higher IgE response 
when compared to Der p 2 protein, a major group 2 allergen from dust mites (Shen, Chua et 
al. 1996). Several monoclonal antibodies (mAbs) were also raised against Der f 7 and Der p 7 
and were subsequently used to study their allergenicity and cross-reactivity (Shen, Chua et al. 
1995; Shen, Chua et al. 1996; Shen, Lin et al. 1997).  
 
 Recently, there were updates on the putative IgE epitopes on the Der f 7. Using 
twenty overlapping peptides, Shen and coworkers showed that the binding activity of one of 
the mAbs, HD12, was inhibited by the peptides bearing common residues Leu-48 and Phe-50 
in Der f 7. These residues were located at the flexible region between β-2 and β-3 of Der f 7 
crystal structure (Figure 4.26). Since HD12 was shown to be able to inhibit the IgE binding 
up to 26%, it was also proposed that Leu-48 and Phe-50 could be the IgE binding residues as 
well. The authors suggested that the aforementioned residues were responsible for the 
specificity of HD12 mAbs against Der f 7 since the corresponding peptides derived from Der 
p 7 were not able to inhibit the HD12 antibody binding to Der f 7 (Shen, Tam et al. 2011). 
These results implied that Der f 7 and Der p 7 were using different epitopes to interact with 




According to their earlier studies, there were four mAbs that could specifically 
interact with Der f 7 - HD2, HD4, HD10 and HD12 - (Shen, Lin et al. 1997). It was shown 
that HD10 and HD12 antibodies were cross inhibitory, but HD2 and HD4 antibodies, which 
were cross inhibitory to each other, were not cross inhibiting with HD10 and HD12 
antibodies. It is possible that the HD2 and HD4 mAbs were interacting with different part of 
the Der f 7, thus explaining the lack of cross-reactivity with HD10 and HD12 antibodies. 
Indeed, the binding of both HD2 and HD4 antibodies to the wild-type Der f 7 were not 
inhibited by any of the peptides tested. Perhaps the HD2 and HD4 antibodies were interacting 
with the conformational epitopes in the Der f 7. In the same report, the authors had also 
mentioned HD19, a mAb that could specifically interact with Der p 7. It was demonstrated 
that the peptides derived from Der f 7 were unable to inhibit the binding activity of this 
antibody. Additionally, the corresponding sequence in Der p 7 was 46GIIDL50 with substitution 
of Ile and Leu at position 48 and 50, respectively. Both data suggested that Der p 7 could be 
using unique epitopes to interact with different antibodies. 
 In this section, we attempt to investigate the IgE binding to residues Leu-48 and Phe-
50 in both Der f 7 and Der p 7 using different approaches. As mentioned earlier, Shen and 
coworkers employed multiple peptide ELISA experiments to study the HD12 mAbs binding 
to Der f 7. This method proved to be effective in identifying the linear IgE epitopes as the 
peptides could at most represent the flexible and continuous regions in a protein. In some 
cases, even the flexible loop in a protein could be subjected to steric hindrance due to its 
proximity to the neighboring residues. As it can be seen in Figure 4.26, the position of residue 
Phe-50 near the hydrophobic core of Der f 7 could hinder its accessibility to the antibodies. In 
this case, the peptide derived from this region may not represent the real situation in the 
whole protein. In addition, there is no direct evidence showing that residues Leu-48 and Phe-



















 4.6.1 Single mutant D159A & double mutant L48A_F50A 
Using site-directed mutagenesis, we mutated both residues Leu-48 and Phe-50 to Ala 
in Der f 7. Similarly, residues Ile-48 and Leu-50 were mutated in Der p 7 and both double 
mutants were expressed and purified using the protocol described in chapter 2. The 
experimental procedure for ELISA was similar as described in the previous sections except 
that the Ni-NTA HisSorb™ ELISA plate (QIAGEN) was used. Maxiosorp™ ELISA plates 
(NUNC) showed inconsistent results even for the wild-type proteins (high standard 
deviations), probably due to the inconsistent binding of the proteins onto the plates. The Ni-
NTA HisSorb™ ELISA plate could be a more reliable choice as it was reportedly designed for 
optimal binding to His-tagged proteins (QIAGEN).   
Figure 4.27 shows that all patients are responding well to the wild-type proteins, 
though with different sensitivities. Even with the same dilution (1:10 ratio), patient P6 was 
almost twice as sensitive as patient P3. Briefly, Patient P3 showed slightly higher sensitivity 
to the Der f 7 compared to Der p 7. The Der f 7 double mutant showed reduced IgE binding 
Figure 4.14 Locations of residues 48, 50 and 159 in Der f 7 and Der p 7 3D structures. The
putative IgE epitopes are shown as sticks and labeled in the magnified diagram. As it can be
seen, residue Leu-48 and Phe-50 in Der f 7 (green colored) are substituted for Ile-48 and Leu-
50, respectively in Der p 7 (red colored), while residue Asp-159 is conserved in both proteins.
Diagram generated using PyMOL software (DeLano Scientific). 
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compared to the wild-type protein. In contrast, the Der p 7 double mutant did not show any 
reduction in IgE binding when compared to the wild-type protein. On the other hand, patient 
P6 showed almost equal IgE binding to wild-type Der f 7 and Der p 7 as well as their double 
mutants. Based on the results, it seems that residues Leu-48 and Phe-50 were probably the 
IgE epitopes for patient P3 but not P6. Consistently, the Der p 7 double mutant did not show 
any reduction in IgE binding in both patients’ sera. This result agreed with the peptide ELISA 
experiment conducted by Shen et al (2011), which demonstrated the lack of inhibition of 
HD12 antibody by the peptides comprised of residues Ile-48 and Leu-50 from Der f 7. Our 
results showed that residues Leu-48 and Phe-50 could be involved in IgE binding in Der f 7 
for certain individuals; larger sample size would be needed in order to further study their IgE 
binding reactivity. 
 In a separate account, Chou and coworkers described the critical role of residue Asp-
159 in the IgE binding as well as the cross-reactivity between Der f 7 and Der p 7 (Chou, Tam 
et al. 2011). This residue is located in the loop region between β-11 and α-3 based on the 3D 
structure of the proteins (Figure 4.26). The authors performed dot-blot inhibition experiments 
by pre-absorbing the sera with the same set of peptides derived from Der f 7 (Shen, Tam et al. 
2011). Their results showed that only the peptides with common sequence 156SILDP160 were 
able interact with IgE antibodies in 2 out of 30 patients’ sera tested. They later mutated 
residues Ile-157, Leu-158, and Asp-159 to Ala in the Der f 7 using site-directed mutagenesis 
and showed that these mutants have reduced IgE binding activities. Subsequently, using the 
dot-blot inhibition assay, the authors showed that only D159A mutant was unable to inhibit 
the IgE binding to the wild-type Der f 7 and Der p 7, thus concluded that Asp-159 was a core 
amino acid responsible for the IgE binding in these proteins.  
A closer examination of the results provided by Chou and coworkers revealed several 
questionable points. Firstly, it was shown that the single mutants I157A, L158A, and D159A 
demonstrated drastic reduction in IgE binding compared to the wild-type Der f 7 based on the 
dot-blot assay in two patients’ sera. Curiously, only D159A mutant was unable to inhibit the 
IgE binding to the wild-type protein. Theoretically, if a mutation resulted in a drastic 
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reduction in IgE binding compared to the wild-type protein, its inhibition of IgE binding to 
the wild-type protein should be reduced as well. However, based on their results, the IgE 
inhibition activity of I157A and L158A single mutants seemed to be as good as the wild-type 
protein itself. Secondly, the peptide derived from Der p 7, Dp7-16 
(151HIGGLSILDPIFAVL165) which was essentially identical to the corresponding peptide 
derived from Der f 7, Df7-16 (151HIGGLSILDPIFGVL165), except for the  Ala to Gly 
substitution at position 163, was showing much higher inhibition to the wild-type Der f 7 
(89%) compared to the peptide Df7-16 (62%). Since the proposed antigenic determinant triad 
“ILD” was conserved in both peptides, it was rather peculiar that these peptides have such 
different inhibition activities. Thirdly, out of 30 patients’ sera, only 2 (patients 990 and 1045) 
were exhibiting results consistent with the author’s hypothesis, in which only one set of data 
was presented.  
 We mutated residue Asp-159 to Ala in both Der f 7 and Der p 7 using site-directed 
mutagenesis and prepared the mutants similarly as the wild-type proteins. As shown in Figure 
4.27, the D159A single mutant does not show any reduction in IgE binding in both patients 
when compared to the wild-type proteins. Patient P3 showed a slight increment in IgE binding 
for the D159A mutant when compared to the wild-type Der f 7. A similar phenomenon was 
observed in the Der p 7 as well. Our results contradicted with the previous study that 
described Asp-159 residue as a critical amino acid involved in IgE binding of Der f 7 and Der 
p 7. Of course, it is very hard to derive any meaningful conclusion based on such a small 
sample size. Nevertheless, together with the data provided by Chou and coworkers, in which 
they showed that merely ~7% (2/30) of the samples were supporting their hypothesis, it 
would be reasonable to conclude that residue Asp-159 is not a major IgE epitope in both Der f 




















4.6.2 Cross inhibition between Der f 7 and Der p 7 
 The high sequence and structural homology shared by Der f 7 and Der p 7 prompted 
us to believe that the immunological properties of these proteins were similar, if not identical. 
However, based on the RIA experiment conducted on 41 asthmatic sera by Shen and-
coworkers, it turned out that Der p 7 seemed to be much more allergenic than Der f 7 (Shen, 
Chua et al. 1995). Out of 41 samples, it was reported that 17 (41%) were reactive to both 
proteins, in which 76.5% (13/17) showed much higher sensitivity to Der p 7. In most cases, 
sera with high binding activity to Der p 7 were showing only one third (30%) reactivity to Der 
f 7. Clearly, the patients were co-sensitized to both allergens, but there was a distinct 
difference in terms of their reactivity towards these allergens. Owing to their similarities, it is 
very likely that they shared some IgE epitopes, thus explained their cross-reactivity (Chou, 
Tam et al. 2011). However, based on the RIA experiment, it is highly possible that Der p 7 has 
more IgE epitopes than Der f 7. Therefore, it is conceivable that these proteins would have 
limited cross-reactivity.  
Figure 4.15 Specific IgE ELISA experiment comparing the allergenicity of Der f 7 and
Der p 7 as well as their mutants. Dark gray bars represent the Der f 7 and its mutants while
light gray bars represent Der p 7 and its mutants. All experiments were done using Ni-NTA




 The end-point inhibition assay using 100μg/ml of the inhibitor (Der f 7 or Der p 7) 
was performed in order to examine the cross-reactivity between Der f 7 and Der p 7. As 
shown in Table 4.5, the Der p 7 can inhibit the IgE binding to Der f 7 very well for both 
patients’ sera, whereas the IgE inhibition of Der f 7 against Der p 7 seems to be slightly 
weaker. Note that even the positive controls were showing only moderate inhibition (45.8-
59.5% inhibition) in almost all cases except for the Der p 7 control in patient P6 (82.3% 
inhibition). Interestingly, the similar results were observed previously using the Maxisorp™ 
plates, although with high standard deviations (data not shown). The consistently moderate 
inhibitions as shown by the positive controls in our results implied that either the 
concentration of the inhibitor was not sufficient, or the affinity of the inhibitors towards the 
IgE antibodies was low. Either way, our results showed that the cross-reactivity between the 
Der f 7 and Der p 7 was generally high; with Der f 7 having slightly lower inhibition against 
Der p 7, at least for these two patients. Again, such a small sample size was hardly sufficient 
to represent the real cross-reactivity between these two proteins. More experiments need to be 




4.6.3 Putative IgE epitopes on Der f 7 and Der p 7 
 The cross-reactivity between pairs of highly homologous proteins had been studied in 
other groups of allergens isolated from dust mites. Chapman and coworkers showed that two 
group 1 major allergens from dust mites, Der f 1 and Der p 1 sharing 81% sequence identity 
were highly cross-reacting to each other. However, the anti-Der p 1/Der f 1 murine 
Patients 
% Inhibition % Inhibition 
Inhibitors Inhibitors
Der f 7 (+) Der p 7 Der f 7 Der p 7 (+)
P3 46.8 57.2 45.8 52.1 
P6 53.4 59.5 67.7 82.3 
Table 4.5 Endpoint inhibition assay for De f 7 and Der p 7. The Ni-NTA HisSorb plate
was coated with 1μg/well of Der f 7 or Der p 7. Both sera were pre-absorbed with 100μg/ml
of proteins for 24 hours at 4°C. Results are presented as an average values in percentage. 
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monoclonal antibodies was shown to be unable to inhibit the binding of the specific human 
IgE to Der p 1, thus suggesting that Der p 1 and Der f 1 have different epitope binding sites 
for IgE and monoclonal antibodies (Chapman, Heymann et al. 1987). When the 3D structures 
of Der f 1 and Der p 1 were resolved later, the non-conserved residues were mapped on the 
surface diagrams in an attempt to explain the species-specific phenomenon as described by 
Chapman et al (1987). Chruszcz and coworkers showed that there were four non-conserved 
patches on the surface of Der f 1 and Der p 1, which could aid in identifying the residues 
responsible for the cross-reactivity and species-specificity of these proteins (Chruszcz, 
Chapman et al. 2009).  
Likewise, Der f 2 and Der p 2, two major group 2 dust mite allergens were shown to 
be highly cross-reactive to each other. Interestingly, studies on the IgG binding to various 
isoforms of these proteins revealed different cross-reactivity. Der p 2 isoform, namely Der p 
2.0101, showed low cross-reactivity with the natural Der p 2 (nDer p 2) compared to other 
isoforms tested (Der p 2.0102 and Der p 2.0103). The cross-reactivity of Der p 2.0101 
isoform with nDer p 2 was restored by mutating residue D114 to N114, based on the sequence 
alignment with other isoforms. The authors concluded that the cross-reactivity of Der f 2 and 
Der p 2 was the result of conserved antigenic surface; substitution of even a single residue 
(D114N) could also result in a dramatic change in the cross-reactivity (Smith, Benjamin et al. 
2001).   
 We attempted to identify the surface epitope of group 7 dust mite allergen by 
mapping the non-conserved residues between Der f 7 and Der p 7 on the crystal structure. 
This approach could help to identify the non-cross-reacting IgE epitopes between Der f 7 and 
Der p 7. As shown in Figure 4.28, 23 out of 29 non-conserved residues could be labeled on 
the surface diagram of Der f 7. Note that one of the postulated IgG/IgE epitopes Phe-50 was 
buried based on the surface diagram, so as other unlabeled non-conserved residues. Several 
surface patches were quite different between Der f 7 and Der p 7. A few patches which 
comprised of residues Q25K, A55D, E60Q, A124E and K179A on the Der f 7 structure were 
particularly interesting. These substitutions from charged for non-charged residues or vice-
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versa could be a plausible explanation for the significant difference in terms of the 
allergenicity between these proteins. The rest of the residues were sharing similar properties, 
such as D18E and T111N. Nevertheless, it is still possible that these residues could be unique 
IgE epitopes in either protein, as the L48 for I48 substitution in the Der p 7 peptides indeed 












To summarize, the IgE epitopes on Der f 7 and Der p 7 should be very similar based 
on their sequences and structural identities. However, Der p 7 seems to possess more IgE 
binding epitopes compared to Der f 7 since its allergenicity was much higher according to the 
data provided by Shen and coworkers (Shen, Chua et al. 1995). Residues Leu-48 and Phe-50 
in Der f 7 might not be the major IgE epitopes, which is not surprising as they were only 
shown to bind to mAbs, even though it was reported that the particular mAbs was cross 
inhibitory with IgE antibodies up to 26% (Shen, Tam et al. 2011). On the other hand, residue 
Asp-159 was very unlikely to be a major IgE epitope in Der f 7 and Der p 7 based on our 
results and the published data (Chou, Tam et al. 2011). By comparing the non-conserved 
residues between Der f 7 and Der p 7 aided by the crystal structure, we proposed that residues 
Lys-25, Asp-55 and Glu-124 could be the unique IgE epitopes in Der p 7. More experiments 
need to be done in order to determine the IgE binding sites in these proteins. 
(L) 
Figure 4.16 Surface diagram of Der f 7 in four different orientations. The conserved and
non-conserved residues between Der f 7 and Der p 7 are colored in blue and red, respectively
on the surface diagrams. The non-conserved residues are labeled and the bracketed labels




4.7 Ligand binding studies 
 Thus far, the function of group 7 allergen from dust mites still remained a mystery. 
Even though the structure-based comparison using DALI server indicated a few homologous 
structures with known functions and ligands, but the previous studies on the ligand binding of 
Der p 7 failed to provide meaningful information (Mueller, Edwards et al. 2010). According 
to the authors, the attempts to bind Der f 7 to various types of lipid such as lipopolysaccharide 
(LPS), distearoyl phosphotidyl choline (DSPC), lyso- palmitoyl PC and N-octyl-glucoside 
were not successful based on the 2D 1H15N-HSQC experiments. Surprisingly, the addition of 
polymyxin B that was known to sequester the LPS showed peak perturbations in the 2D 
1H15N-HSQC. Based on the mapping of the strongly perturbed residues in the Der p 7 crystal 
structure, the interaction site of PB resembled the ligand binding site of the homologous 
proteins, which was the cleft formed by the N and C-terminus of the protein. The striking 
resemblance led the authors to believe that the Der p 7 could be interacting with an unknown 
lipid, which was the common feature of several allergens (Thomas, Hales et al. 2005). It was 
suspected that these natural lipid adjuvants could be important in eliciting allergenicity for 
some allergens (Trompette, Divanovic et al. 2009). 
 In this section, the search for a possible ligand that could interact with group 7 
allergens continues. It was shown that juvenile hormone III could complex with the 
homologous protein of Der f 7 - Juvenile hormone binding protein (JHBP) - from silk worm 
(Suzuki et al., unpublished data). Juvenile hormones are commonly known to be responsible 
in ensuring the growth of the larva, while preventing metamorphosis in insects (Nijhout 
1994). Although dust mite belongs to a distant family from insect (Arachnid), it is known to 
undergo a larvae stage (Colloff 2009). The striking structural similarity of group 7 dust mite 
allergens and the insects JHBP prompted us to study the binding of JHIII to Der f 7. In 
addition, an analogue of JHIII -methoprene- was also included in the ligand binding studies. 
Methoprene was shown to be effective at suppressing the population growth of D. farinae 
(Downing, Wright et al. 1990), hence, it is a viable candidate as a ligand for Der f 7.  Lastly, 
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the binding of PB to Der f 7 was also examined using the 2D 1H15N HSQC. 
 
 The 2D 1H15N HSQC spectrums indicated no peak perturbation with the addition of 
JHIII and methoprene at 1:1 ratio into the Der f 7 samples (data not shown). Similar results 
were obtained regardless of the extension of incubation time or increased ligand concentration 
(up to 1:5 ratio). These results showed that JHIII and methoprene were not interacting with 
the Der f 7. On the other hand, the addition of PB into the Der f 7 sample resulted in 
conspicuous peak shifts at 1:1 ratio (Figure 4.29). Subsequently, the peak shifts were analyzed 
and plotted against the residue number as shown in Figure 4.30. Several residues were 
showing significant perturbation, i.e. Ala-15, Ile-16, Ile-129, Leu-64, Ile-135, and Lys-194. 
These residues, together with the other ten residues with moderate perturbations were mapped 























Figure 4.17 Peaks perturbation in the 2D-1H15N HSQC of Der f 7 upon addition of
Polymyxin B (PB). A number of peaks are perturbed upon addition of PB at 1:1 ratio. Red


















Figure 4.31 shows the comparison of the possible ligand interacting residues between 
Der f 7 and Der p 7. As it can be seen, the interaction site is similar between these proteins, 
but it seems that there are differences in the residues involved in the binding. The common 
residues that could be involved in the binding were Glu-78 and Asn-196, both located in the 
flexible regions. The other putative interacting residues were considerably different in these 
proteins. For example, residues Glu-11 and Ile-12 at the N-terminal α-helix were mapped on 
the Der p 7 crystal structure, but these residues were only weakly perturbed in Der f 7. 
Instead, residues Ala-15 and Ile-16 were the only two residues that were shown to be strongly 
perturbed in the N-terminal α-helix of Der f 7 structure. There is little information that can be 
obtained from this data, since PB is not a natural ligand for the group 7 dust mite allergens. 
Nevertheless, the comparison between the PB binding to Der f 7 and Der p 7 revealed that 
these proteins were using mostly different residues to interact with PB. Interestingly, \ some 
substitutions occurred in this region of thetwo proteins, such as the substitution of Ile-16, Ile-
29, Gly-77 and Ile-135 in Der f 7 for Val-16, Phe29, Ser-77 and Met-135 in Der p 7. 
Figure 4.18 Chemical shift perturbation plot of Δδ versus residues of Der f 7 for the 
PB titration experiment. Solid line represents the mean value and the dashed line




Coincidentally, these residues were not mapped in the Der p 7 structure, probably due to their 













 In conclusion, there is still no known ligand that could show better binding than PB to 
both Der f 7 and Der p 7 thus far. However, the binding to PB was weak and most likely 
unspecific. According to all the ligand binding data, it seems that Der f 7 and Der p 7 showed 
better affinity to a more hydrophilic substrate: PB is cationic, basic and acts like a surfactant 
with an estimated octanol-water partition coefficient of -5.62 (Molinspiration 
Cheminformatics, Slovensky Grob, Slovak Republic). Other ligand candidates which were 
more lipophilic in nature: DSPC (8.339), JHIII (4.27), methoprene (4.065), lyso- palmitoyl 
PC (-1.303) and N-octyl-glucoside (-1.432) did not show decent interaction with these 






Figure 4.19 The 3D structure of Der f 7 and Der p 7 showing the possible residues
involved in PB binding. A) The residues that have significant chemical shift perturbation as 
shown in Figure 4.32 are colored red in Der f 7. B) Similar experiment was conducted on Der p 










CHAPTER 5   CONCLUSION & FUTURE WORK 
5.1  Structural studies and imuno-characterization of Blo t 21 
Earlier studies showed that most dust mite-sensitized patients were co-sensitized to 
Blo t 21 and Blo t 5. Several publications demonstrated that allergens sharing high protein 
sequence identity usually would share similar IgE epitopes. The key question of our study is 
whether the generation of hypoallergen for Blo t 21 is necessary since it is sharing relatively 
high protein sequence identity with Blo t 5 (39%). Even though the cross-reactivity between 
these allergens were shown to be limited, but the underlying factors associated with this 
phenomenon was unknown. Therefore, we sought to explain the disparities between Blo t 21 
and Blo t 5 with aids from the 3D structures, as well as means of immunological approaches.  
 In this thesis, we present the high-resolution three-dimensional structure of Blo t 21, a 
novel major allergen isolated from B. tropicalis. The 3D structure of Blo t 21 was successfully 
determined using NMR techniques with a backbone R.M.S.D. of 0.51 Å and heavy atom 
R.M.S.D. of 1.35 Å. The overall structure of Blo t 21 consists of a three antiparallel α-helical 
bundles arranged in a clockwise manner that resembles that of the Blo t 5. Despite sharing 
similar folding topology, the 3D structure of Blo t 21 is quite different from Blo t 5. When 
superimposed, these proteins yield the Cα R.M.S.D. of 3.39 Å. In addition, the surface 
charged diagram also shows that the distribution of charged residues of these two proteins is 
very different. 
The differences in the 3D structure could contribute to the low-to-moderate cross-
reactivity between Blo t 21 and Blo t 5. The IgE epitopes on Blo t 21 which were identified 
and confirmed using various functional assays are forming at least two epitope clusters as 
shown in its three-dimensional structure, in which one of them is a conformational epitope. 
This characteristic is significantly different from that in Blo t 5, which was shown to use a 
putative linear epitope in IgE binding. The two epitope clusters on Blo t 21 are considerably 
far apart from each other. Hence, there should be more than one IgE molecule binding to Blo t 
21 at the same time. One of the epitope clusters which consists of residues Glu-74 and Asp-
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79, could be interacting with the same IgE molecule that also binds to Blo t 5, thus explaining 
their cross-reactivity. However, another epitope cluster that comprised of residues Glu-89 and 
Asp-96, may bind to an IgE molecule that is unique to Blo t 21. Residue Glu-89 and Asp-96 
are located close to each other based on the 3D structure of Blo t 21, thus, could form a 
conformational epitope. These observations indicate that Glu-89 and Asp-96 are two unique 
IgE epitopes found in Blo t 21. 
Previously, Chan and coworkers (2008) showed that the sensitized sera could react to 
the peptides derived from the immunodominant region of Blo t 5, thus concluding that Blo t 5 
bears a putative linear epitope. The sequence identity between Blo t 21 and Blo t 5 in this 
particular region is quite high (62%), and all the putative IgE epitopes determined in these 
proteins are present in this stretch of amino acids. We performed ELISA to compare the 
allergenicity of the peptides derived from this region of Blo t 21 and Blo t 5, with the initial 
hypothesis that their IgE binding activity should be similar. Surprisingly, the results show that 
most sera react much better to the Blo t 21-derived peptide compared to the Blo t 5-derived 
peptide. Similar peptides derived from Der f 21 and Der p 5 show distinct binding activities as 
well. These results show that the IgE antibodies interacting with this part of the protein are 
highly sequence dependant. The presence of the putative major epitopes in the homologous 
peptides derived from Blo t 21 and Blo t 5 does not seem to be the determining factors for the 
IgE binding. Rather, it seems that the adjacent amino acids are playing a major role in 
defining the IgE epitopes as well. This experiment also implies that the limited cross-
reactivity between Blo t 21 and Blo t 5 is not just due to the presence of a unique 
conformational epitope, but also a linear epitope that recognizes unique IgE antibodies in Blo 
t 21. 
We have also included Der f 21 and Der p 5 in this thesis. The physical and 
immunological studies reveal that these two allergens are distinctively different from Blo t 21 
and Blo t 5. Most of our patients’ sera react weakly to Der p 5, but respond fairly well to Der f 
21. Based on the limited cross-reactivity between Der f 21 and Blo t 21, we propose that Der f 
21 might be using a different set of IgE epitopes. Additionally, the generally weak 
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allergenicity exhibited by Der p 5 suggests that the IgE epitope of this protein should be 
different as well.  
5.2   Future directions: Blo t 21 
1) It has still remained uncertain whether our 4A mutant can be used as a hypoallergen 
for immunotherapy purposes. The potential of this mutant as a hyproallegen will be 
examined using means of in vivo approaches, including skin prick test, cytokine 
releasing profile and mouse immunization. 
2) It would be interesting to identify the residues that confer a higher allergenicity to the 
Blo t 21-derived peptide. A set of peptides will be designed using the same 
boundaries with replacement at specific positions based on the sequence differences 
between Blo t 21 and Blo t 5. For example, residue Asp at position 81 in the Blo t 21-
derived peptide will be replaced with Asn, matching the Blo t 5 sequence. 
Subsequently, the allergenicity of these peptides will be tested using ELISA. The 
replacement of a critical residue should reduce the IgE binding drastically compared 
to the original Blo t 21 peptide. Using this method, we should be able to pinpoint the 
residue(s) responsible for the higher allergenicity exhibited by Blo t 21. 
3) Previously, Naik and coworkers (2008) studied the monoclonal antibodies’ binding 
site of Blo t 5 using NMR approaches. Based on their studies, the mAbs binding sites 
are different from the IgE epitopes mapped later by Chan and coworkers (2008). It 
would be interesting to study the mAbs binding to Blo t 21. For instance, can the Blo 
t 21-specific mAbs inhibit the binding of Blo t 21 to IgE antibodies? 
4) Our results show that Der f 21 and Der p 5 have limited cross-reactivity with Blo t 21 
and Blo t 5. Identifying the IgE epitopes of these proteins could help to explain their 
distinct allergenic properties compared to Blo t 21 and Blo t 5. In addition, 
determining the 3D structure of Der f 21 would be interesting as it will help to locate 
the IgE epitopes. 
5) The studies on the IgE epitopes mapping and cross-reactivity can be expanded to the 
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other group 5 and 21 allergen from different mite species (Lep d 5, Sui m 5, Sui m 21, 
Ale o 5 etc.). Sequence alignment shows that all four putative major IgE epitopes 
mapped in Blo t 5 and Blo t 21 are conserved in these allergens. However, there is 
limited data on the level of sensitization and cross-reactivity among the group 5 and 
21 allergen from other mite species. Identifying the IgE epitopes and level of cross-
reactivity in other mite species will provide us with a better picture on the allergenic 
properties of these proteins.  
5.3   Crystal structure and IgE epitopes of Der f 7 
Der f 7 was identified as a major allergen based on its IgE binding reactivity with 
46% of sera from asthmatic children assayed by RIA technique (Shen, Chua et al. 1995). 
Besides that, the same authors also examined its interaction with mAbs extensively. Mueller 
and coworkers determined the crystal structure of its homologous protein, Der p 7 and it was 
shown to bind with polymyxin B (PB). Nevertheless, the weak binding implied that PB was 
not the natural ligand of Der p 7. The peptide immunoblot experiment conducted by Shen and 
Chou in the separate accounts suggested that residues Leu-48, Phe-50 and Asp-159 were the 
IgE epitopes in Der f 7. However, their data were not conclusive. Solving the structure of Der 
f 7 would be necessary to aid in identifying the major IgE epitopes in this allergen. 
Here, we present the 3D structure of Der f 7 determined using X-ray crystallography 
technique. The initial attempts using NMR approaches were not successful due to the lack of 
NOEs that can be unambiguously assigned in order to obtain the final structure. The best 
crystal was diffracted to 2.24Å resolution using the synchrotron beamline. The final model 
was refined to the R-value converged to 0.24 (Rfree = 0.29) for reflections I>σ (I) to 2.8 Å 
resolution, and comprised of two molecules in an asymmetrical unit, with generally good 
stereochemistry. The 3D structure of Der f 7 consists of two α-helices forming the N and C-
terminus, with the latter wrapped around by eleven β-sheets. This structure is essentially 
identical to that of Der p 7, with slight differences in the flexible regions when superimposed. 
The structure-based homology search using DALI server retrieved a list of lipid binding 
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proteins, which suggested that Der f 7 could interact with a lipid-like compound. 
Der f 7 and Der p 7 were migrating in a non-conventional manner in SDS-PAGE. At 
pH 7, Der f 7 runs as 26 kDa, 25 kDa and 18 kDa bands while Der p 7 runs as 28 kDa, 25 kDa 
and 18 kDa bands. On the other hand, Der f 7 runs as a single band (25 kDa) while Der p 7 
runs as two bands (28 kDa and 25 kDa) in SDS-PAGE at pH 9. It was later revealed that the 
band “splitting” was not due to protein degradation, rather, the aberrant mobility in SDS-
PAGE seems to be affected by the composition of the charged residues. Our current data are 
not sufficient to explain these phenomena, but it led us to further study the stability of Der f 7 
and Der p 7 at different pHs. We found that both proteins were much more stable at pH 7 
compared to pH 9, with the Tm differed by at least 7°C. The factors underlying the higher 
stability of Der p 7 remain elusive. Attempts to stabilize Der f 7 via replacing charged 
residues mimicking that of Der p 7 were unsuccessful. Nevertheless, there could be a 
correlation between the physical properties of these proteins and their respective allergenicity. 
Shen and coworkers (1995) showed that Der p 7 is significantly more allergenic than Der f 7 
in all sensitized test subjects. Furthermore, these allergens were shown to be interacting with 
different mAbs.  
 Based on the ELISA experiments, we showed that by replacing residues Leu-48, Phe-
50 and Asp-159 to Ala in Der f 7, no significant reduction in IgE binding can be observed 
when compared to the wild-type protein. Therefore, these residues are unlikely to be the 
major IgE epitopes in Der f 7. The mapping of the non-conserved residues between Der f 7 
and Der p 7 on the 3D structure of Der f 7 revealed that residues Lys-25, Asp-55 and Glu-124 
could be the unique epitopes in Der p 7. The corresponding residues share different properties 
in Der f 7: Gln-25, Ala-55 and Ala-124, respectively, while the rests of the non-conserved 
residues are sharing similar properties, i.e. Ile to Val, etc.   
 The absence of peak shifts in the 2D-1H15N HSQC spectrums upon the addition of 
JHIII or methoprene into the Der f 7 NMR samples indicated that these are not the probable 
ligands for Der f 7. Not surprisingly, Der f 7 shows notable peak perturbations with the 
addition of PB, but the affected residues are quite different from those reported previously in 
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Der p 7. We found that there are some substitutions of amino acids in the mutual binding sites 
of Der f 7 and Der p 7, i.e. Ile-16 and Ile-29 in Der f 7 are substituted for Val-16 and Phe-29 
in Der p 7. Nonetheless, the information is inconclusive since PB is not a natural ligand for 
these proteins. Identifiation of the natural or homologous ligand for these proteins can be 
interesting since the bound forms could have different allergenic properties.  
5.4   Future direction: Der f 7 
1) The formation of a 18 kDa component in the SDS-PAGE is still a mystery. As 
mentioned, Shen and coworkers detected a similar component in the natural extract 
that interacts with specific mAbs. However, the identity of this component is 
unknown, though it was assumed to be a degraded form of Der f 7. It would be 
interesting to find out whether the 18 kDa component formed by the recombinant 
protein at pH7 also shows selective binding to the mAbs. This may help to explain the 
“splitting” phenomenon in SDS-PAGE. Similar experiment can be done based on 
Shen and coworkers’ work, but the recombinant protein instead of natural extracts 
will be used.  
2) There are only two sensitized sera used in our immunological work, therefore, the 
results are not conclusive. More samples will be needed to study the IgE binding to 
the Der f 7 mutants Q25K, A55D and A124E. In addition, cross-reactivity between 
Der f 7 and Der p 7 will be tested as well. 
3) Broader screening of lipid-like compounds will be carried out to identify the natural 
or homologous ligand for Der f 7. Subsequently, the IgE binding reactivity of the 
bound form will be compared to the apo-form. 
4) The major IgE epitopes of Der f 7 is still unknown. More residues will be chosen for 
mutagenesis studies based on the crystal structures of Der f 7 and Der p 7. A more 
comprehensive sequence alignment analysis, including the group 7 allergens from 
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Recipe for M9 medium 
 
To 773 ml of sterile water, add the following: 
 
200 ml   5X M9 
2 ml   1M MgSO4 
5 ml   20% Glucose 
0.1 ml   1M CaCl2 
4 ml   0.25 g/ml NH4Cl 




1.   5X M9 
 
30 g   Na2HPO4 
15 g   KH2PO4 
 2.5 g   NaCl 
 Add water to 1L 
 (Autoclave) 
 
2.   0.25 g/ml NH4Cl 
 
 50 g  NH4Cl, add water to 200 ml 
 (Autoclave, or filter-sterilize for 15N) 
 
3.   20% Glucose 
 
 40 g  Glucose, add water to 200 ml 
 (Autoclave or filter-sterilize for 13C) 
 
4.   1M MgSO4 
 
 19.72 g MgSO4, add water to 80 ml 
 (Autoclave) 
 
5  1M CaCl2 
 
 11.76 g CaCl2, add water to 80 ml 
            (Autoclave)  
 Appendix II 
 
Buffers for Ni-NTA Affinity Chromatography 
 
• Nickel binding buffer 
 
 5 mM   Immidazole 
 0.5 M   NaCl 




• Elution Buffer 
 
 0.5 M   Immidazole 
 0.5 M   NaCl 
 20 mM   Tris pH 8.0 
 
• Strip Buffer 
 
 100 mM  EDTA pH 8.0 
 0.5 M   NaCl 
 20 mM  Tris pH 8.0 
 
• Ni-Charge buffer 
 
 50 mM  NiSO4 
 
 
Buffers for Glutathione-Sepharose Chromatography 
 
• Phosphate Buffer Saline (PBS) 
 
 140 mM  NaCl 
 2.7 mM  KCl 
 10 mM  Na2HPO4 
 1.8 mM  KH2PO4 
 
• GST Elution Buffer 
 
 50 mM  Tris-Cl pH 8.0 
 10 mM  L-Gluthathione (reduced) 
 
• Column Regeneration Buffer 1 
 0.1 M   Tris-Cl pH 9.0 
 0.5 M   NaCl 
 
• Column Regeneration Buffer 2 
 
 0.1 M  Sodium acetate pH 4.5 





Recipe for SDS-PAGE 
 15% Separating Gel 4% Stacking Gel 
30% Acrylamide/0.8% Bis 3.5 ml 0.4 ml 
Resolving Buffer 1.75 ml - 
Stacking Buffer - 0.75 ml 
10% SDS 70 μl 30 μl 
141 
 
Water 1.68 ml 1.8 ml 
10% Ammonium 
P l h t
42 μl 30 μl 
TEMED 4.2 μl 3 μl 
 
 
1.    Acrylamide solution (30%, 0.8 % Bis) 
2.    Resolving gel buffer: 1.5 M Tris, pH 8.8 
 
 For 200 ml, 36.3 g of Tris adjust to pH 8.8 with HCl 
 
3.    Stacking gel buffer: 0.5 M Tris, pH 6.8 
 
 For 200 ml, 12.1 g Tris, adjust to pH 6.8 with HCl 
 
4.    10% Ammonium persulphate: 1 g Ammonium persulphate in 10 ml water 
5.    10X Tank buffer: for 2 liters 
 
 60 g Tris base 
 288g Glycine 
 200 ml 10% SDS solution 
 Add water to 2 liters 
 
6.    2X SDS gel sample buffer: for 50 ml 
 
 5 ml   Glycerol 
 6.25 ml  0.5 M Tris pH 6.8 
 12.5 ml  10% SDS 
 2.5 ml   β-mercaptoethanol 
 0.01 g   Bromophenol blue 
 Add water to 50 ml 
 
7.    Stain stock: 1% Coomassie Brilliant Blue G (Stir and filter) 
8.    Destaining solution: for 2 liters 
 
 140 ml  Acetic acid 
 100 ml  Methanol 
 Add water to 2 liters 
